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EFFECTS OF WRITING THERAPY ACROSS
PTSD AND CHRONIC STRESS
Jennifer E. Lewis, Ph.D.
Western Michigan University, 2003
Research supports the effectiveness of writing therapy in reducing physical
health problems and increasing positive feelings (Pennebaker & Beall, 1986). More
recently, research indicates that writing about traumatic experiences is as effective as
EMDR in reducing symptoms of Post Traumatic Stress Disorder (Largo-Marsh &
Spates, 1997). The current study assessed the treatment efficacy of writing therapy for
individuals with varying degrees of stress related symptoms. Specifically, this study
examined writing treatment for Post-Traumatic Stress Disorder and work-related
chronic stress or "burnout."
The study utilized a pretest-posttest comparison group design. Repeated
measurements !)n primary dependent variables were collected at pretest through 2month follow-up.
Assessment instruments included the Maslach Burnout Inventory (MBI), the
Clinician Administered PTSD Scale for DSM-IV (CAPS-DX), the State-Trait Anxiety
Inventory (STAI- State), Subjective Units of Distress rating (SUDs), Beck Depression
Inventory-II (BDI-11), Coping Resources Inventory (CRI), and Health Care Visits
Questionnaire.

Subjects were assigned to participant groups based upon their scores on the
Clinician Administered PTSD Scale (CAPS-DX) and the Maslach Burnout Inventory
(MBI). Treatment consisted of four weekly sessions, each 30 minutes in duration. The
structured writing treatment was targeted at the traumatic event or stressful work
situation identified as most presently distressing. A total of 16 participants completed
the study through 2-month follow-up with 8 participants in each group.
Results of this study indicated that participants in the Burnout condition
showed significant decreases in symptom reports of depression as measured by the
Beck Depression Inventory-II. These gains were maintained through 2-month follow
up. Participants in the PTSD group showed no significant improvement on any
dependent measures. However, moderate to large effects sizes were found for these
analyses, suggesting that an increased sample size may have resulted in the detection
of significant improvements in symptom reports across all dependent measures for
both conditions.
The main limitation of this study was the small sample size. The study
suffered from both difficulties recruiting participants as well as attrition.
Recommendations for future research in this area include monetary incentive for
participation. This research is best viewed as a pilot study, the results of which
warrant further investigation.
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CHAPTER!
INTRODUCTION
Research indicates that 60% of men and 51% of women in the general
population reported at least one traumatic event at some point in their lives {Kessler,
Sonnega, Bromet, Hughes, & Nelson, 1995). Although not everyone who experiences
a traumatic event will develop Post-Traumatic Stress Disorder (PTSD), lifetime rates
of the disorder vary across studies from 1% to 12.3% of the population (Breslau,
Pavis, Andreski, & Peterson, 1991; Kessler et al., 1995; Norris, 1992; Resnick,
Kilpatrick, Dansky, Saunders, & Best, 1993). These numbers represent people who
have (a) come into contact with mental health professionals, and who (b) meet full
criteria for the disorder. Not represented are those who have experienced a traumatic
incident but never seek help or who have any number of distressing symptoms, but do
not meet full criteria for PTSD. One recent study found that rates for partial PTSD
following a traumatic event in a random sample of people in a midsize Canadian city
were 3.4% for women and 0.3% for men (Stein, Walker, Hazen, & Forde, 1997).
Although no epidemiological studies have reported on the health care costs
associated with PTSD, evidence suggests the disorder is quite costly. Greenberg,
Sisitsky, and Kessler (1999) used data from the National Comorbidity Study and
estimated that the cost associated with anxiety disorders to be approximately $63.1
billion. The researchers reported that the greatest cost to society was that of direct
1
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nonpsychiatric medical treatment costs which accounted for 54% ofthe total. This
research indicated that direct psychiatric treatment cost accounted for an additional
31%, suggesting that undiagnosed or misdiagnosed patients contribute significantly to
the burden on the economy. Ofparticular note, this study found that PTSD and panic
disorder had the highest rates ofservice utilization ofboth direct psychiatric medical
service utilization (hospitalizations, visits to family doctors, psychiatrists,
psychologists, social workers, counselors, and other specialists) and indirect
workplace outcomes (work cutback days) (Greenberg et al., 1999).
Based on the number ofpeople affected and the cost to society, it is obvious
that the sequelae oftrauma remain an important area for continued research.•
Although many treatments for symptoms ofPTSD are currently available, no single
treatment has proven effective in reducing all symptom clusters related to the
disorder. To date, exposure based therapies, those in which a person is asked to
repeatedly recall the trauma in detail, have proven most effective in overall symptom
reduction (Waller, Cullen, & Spates, 1997). Research on the effectiveness ofwriting
about traumatic events showed reductions in physical health problems as well as
increasing feelings ofgeneral well-being (Pennebaker, Kiecolt-Glaser, & Glaser,
1988; Smyth, Stone, Hurewitz, & Kaell, 1999). More recently writing treatment has
been shown to reduce symptoms ofPTSD as well (Largo-Marsh & Spates, 1997).
The current study is designed to assess the treatment efficacy ofwriting therapy for
individuals with varying degrees ofstress-related symptoms including clinical Post
Traumatic Stress Disorder as well as chronic stress or burnout.

CHAPTER II
REVIEW OF THE LITERATURE
Post-Traumatic Stress Disorder
Diagnostic Criteria
According to the DSM-IV (American Psychiatric Association [APA], 1994)
the criteria for diagnosis of Post-Traumatic Stress Disorder are as follows:
A. The person has been exposed to a traumatic event in which both of the following
were present:
(1) the person experienced, witnessed, or was confronted with an event or events
that involved actual or threatened death or serious injury, or a threat to the
physical integrity of self or others.
(2) the person's response involved intense fear, helplessness, or horror. Note: In
child_ren, this may be expressed instead by disorganized or agitated behavior.
B. The traumatic event is persistently re-experienced in one (or more) of the
following ways:
(1) recurrent and intrusive distressing recollections of the event, including images,
thoughts, or perceptions. Note: In young children, repetitive play may occur in
which themes or aspects of the trauma are expressed.
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(2) recurrent distressing dreams of the event. Note: In children, there may be
frightening dreams without recognizable content.
(3) acting or feeling as it the traumatic event were recurring (includes a sense of
reliving the experience, illusions, hallucinations, and dissociative flashback
episodes, including those that occur on awakening or when intoxicated).
Note: In young children, trauma-specific reenactment may occur.
(4) intense psychological distress at exposure to internal or external cues that
symbolize or resemble an aspect of the traumatic event.
(5) physiological reactivity on exposure to internal or external cues that symbolize
or resemble an aspect of the traumatic event.
C. Persistent avoidance of stimuli associated with the trauma and numbing of general
responsiveness (not present before the trauma), as indicated by threy (or more) of
the following:
( l) efforts to avoid thoughts, feelings, or conversations associated with the
trauma.
(2) efforts to avoid activities, places or people that arouse recollections of the
trauma.
(3) inability to recall an important aspect of the trauma.
(4) markedly diminished interest or participation in significant activities.
(5) feelings of detachment or estrangement from others.
(6) restricted range of affect (e.g., unable to have loving feelings).
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(7) sense of a foreshortened future (e.g., does not expect to have a career,
marriage, children or a normal life span).
D. Persistent symptoms of increased arousal (not present before the trauma), as
indicated by two (or more) of the following:
(1) difficulty falling or staying asleep.
(2) irritability or outbursts of anger.
(3) difficulty concentrating.
(4) hypervigilance.
(5) exaggerated startle response.
E. Duration of the disturbance (symptoms in Criteria B, C, and D) is more than 1
month.
F. The disturbance causes clinically significant distress or impairment in social,
occupational, or other important areas of functioning.
Specify if:
Acute: if duration of symptoms is less than 3 months.
Chronic: if duration of symptoms is 3 months or more.
Specify if:
With delayed onset: if onset of symptoms is at least 6 months after the
stressor.
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Prevalence of Traumatic Events
A number of studies have documented the occurrence of traumatic events
across the lifespan. In a national probability study of 4,008 adult females, participants
were administered a modified version of the Diagnostic Interview Schedule (DIS)
(Robbins & Smith, 1983) that included a detailed assessment of trauma. (Resnick et
al., 1993). The study revealed that 68.9% of the sample reported having experienced
one or more of the following events during their lifetime: rape, molestation or
attempted sexual assault, physical assault, homicide of a dose friend or relative, and
non crime traumatic events (including natural disasters, serious accidents, serious
injuries, life-threatening situations, events involving perceived life threat or threat of
serious injury, and any other "extraordinarily stressful event").
More recently, Kessler et al. (1995) interviewed nearly 6,000 people, aged 15
to 54, in the only nationally representative study of the general population in the
United States. A modified version of the DIS was used in this study as well. Results
indicated that 60% of men and 51% of women in the general population reported that
they had experienced at least one traumatic event in their lives. Nearly 17% of men
and 13% of women reported that they had experienced more than three such events in
their lives.
Prevalence Rates for PTSD
Prevalence rates for PTSD in the general population indicate variation across
studies from 1% to 12.3% (Solomon & Davidson, 1997). It has been suggested that

7

the differences in rates are due to differences in measurement and sampling strategies
(Solomon & Davidson, 1997). Studies in which the Diagnostic Interview Schedule
(DIS) (Robins & Smith, 1983) for DSM-III-R (APA, 1987) was used to assess PTSD
revealed the lowest rates (Davidson, Hughes, Blazer, & George, 1991; Helzer,
Robins, & McEvoy, 1987). Kulka, Schlenger, and Fairbank (1991) reported that the
PTSD scale in the DIS for DSM-III is an insensitive measure relative to the
Structured Clinical Interview for DSM-III-R. In an effort ofcorrect some ofthe
shortcomings ofthe early DIS, Robbins and colleagues revised the PTSD scale ofthis
instrument. Th�se changes, namely initially listing specific traumatic events, appear to
improve recall ofevents which may lead to PTSD symptomatology. Using the revised
version ofthe DIS, Breslau et al. (1991) found a lifetime PTSD rate of9.2%.
In the study by Resnick, Kilpatrick, Dansky, Saunders, and Best (1993), a
more sensitive measurement strategy was employed in which people could report on
�riterion C and D PTSD symptoms without having to anchor specific symptoms to
SJ?ecific traumas. This study reported a rate of12.3% for PTSD, which although
relatively
high,
- was explained by the fact that the study was conducted with a sample
'
..
ofall women. Kessler et al. (1995) reported that women are more likely to report
'

•

I

I

e?'periencing PTSD than men (10.4% vs. 5%, respectively).
Chronicity ofPTSD
The DSM-IV definition of"chronic" PTSD is symptom duration of3 months
or longer (APA, 1994). Kessler et al. (1995) reported that about 30% ofparticipants
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with PTSD improved within the first year, leaving 70% whom did not improve.
Further, Kessler et al. reported that over a third of the PTSD sufferers still had
symptoms after 10 years. This study also indicated that participants who sought
professional treatment for PTSD reported a shorter average duration of symptoms (3
years) than those who did not (over 5 years). Breslau (2001) reported that individuals
with chronic symptoms (duration of symptoms greater than 3 months), as compared
to those with nonchronic PTSD (symptom duration less than 3 months) had a higher
total number of PTSD symptoms. Those with chronic PTSD also showed higher rates
of numbing and hyper-reactivity to stressor stimuli, anxiety or affective disorders, and
other comorbid medical conditions. Specifically, the study indicated that factors
related to chronic PTSD were family history of antisocial behavior and being female.
More recent studies have added that a history of alcohol abuse and history of
childhood trauma were associated with longer time to remittance from an episode of
chronic PTSD (Zlotnick, Warshaw, & Shea, 1999).
PTSD and Comorbidity
Conservative estimates suggest that those with PTSD are two to four times
more likely to have another psychiatric diagnosis including depressive disorders,
anxiety disorders, substance abuse and somatization than those without these
comorbid disorders (Kessler et al., 1995). Davidson et al. (1991) found participants
with PTSD to be 90 times more likely to report physical complaints than those
without, suggesting an important correlation between PTSD and somatization. In
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addition, Breslau et al. (1991) reported that 83% ofparticipants with PTSD also met
criteria for some other psychiatric disorder. Kessler et al. (1995) reported similar
findings: 79% ofwomen and 88% ofmen with PTSD reported a history ofat least
one other psychiatric disorder. A large study ofVietnam veterans diagnosed with
PTSD found 98.9% had at least one other psychiatric diagnosis, the most prevalent
comorbid conditions in this population being substance use disorders (73%),
antisocial personality disorder (31%), and major depression (28%) (Kulka, Schlenger,
& Fairbank, 1990).
An issue which continues to be the subject or debate is whether PTSD actually
'

'

cqnstitutes a distinct psychiatric disorder CNolfe & Keane, 1990; Yehuda &
I

:

I

Mcfarlane, 1995). Ifso, the question remains whether the current diagnostic criteria
'

'

adequately describe or capture the characteristics ofthe disorder. Research has
indicated that PTSD can be distinguished from other psychiatric disorders (Keane,
',

I

Taylor, & Penlc, 1997). However, factor analytic studies have demonstrated a twodimensional structure (Buckley, Blanchard, & Hickling, 1998; Taylor, Kuch, Koch,
'I

,

Crockett, & Passey, 1998) in which more depressive-like symptoms are accompanied
by symptoms unique to the diagnosis ofPTSD. Other studies support the three-factor
model ofPTSb (Foa, Riggs, & Gershuny, 1995) currently used in DSM-IV (APA,
1994). Orte recent study found support for the three-factor model in which the cluster
of avoidance/numbing symptoms was highly correlated with depressive symptoms and
the re-experiencingfmtrusicfn cluster was not highly correlated with the symptoms of
depression. The cluster ofhyperarousal symptoms fell between the two, but was
'1 '
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reported to be more closely correlated, yet distinct from depressive symptoms. These
findings suggest that the symptom structure of PTSD is more complex than two
dimensional but is distinct from other psychiatric disorders (Gaffney, 2003).
Risk Factors for the Development of PTSD
Exposure to a traumatic event is not sufficient to result in PTSD. On average,
about a quarter of those who experience one or more traumatic events will develop
the disorder (Green, 1994). Although researchers have not identified causal factors in
the development of the disorder, there are a number of factors that seem to put a
person at higher risk for development of PTSD. These risk factors may be categorized
as characteristics of the person exposed to trauma and characteristics of the trauma
experienced.
Characteristics of the person exposed include gender, personality, psychiatric
history, and family psychiatric history. Regarding gender, researchers have repeatedly
found that despite experiencing traumatic events less often than men, women develop
PTSD nearly twice as often as men (Breslau, Kessler, & Chilcoat, 1998; Kessler et
al., 1995). It has been suggested that this is related to characteristics of the trauma
which is discussed below.
Regarding factors of personality, Helzer et al. (1987) reported that PTSD
could be predicted by a history of behavioral problems including stealing, lying,
truancy, and vandalism before the age of 15 years. This report also indicated that the
rate ofPTSD increased with the number of behavioral problems. These behaviors are

11
often associated with the Antisocial Personality Disorder diagnosis. Another risk
factor, which emerged was abuse in childhood which increased the risk of developing
PTSD (Davidson et al., 1991). Several personality disorder diagnoses have been
associated with early and severe childhood trauma including Borderline Personality
Disorder (Cloitre, Scarvalone, & Difede, 1997) and Dissociative Identity Disorder
(formerly Multiple Personality Disorder) (van der Kolk, Pelcovitz, & Roth, 1996).
Premorbid psychiatric disorders including affective and/or anxiety disorders
were predictive of the development ofPTSD in men and women as well (Bromet,
Sonnega, & Kessler, 1998). Childhood mania has also been found to be a risk factor
for trauma exposure and PTSD (Wozniak, Crawford, & Biederman, 1999).
Regarding family psychiatric history, Davidson et al. (1991) reported that
persons diagnosed with PTSD were 2.8 times more likely to have a relative with a
history of psychiatric illness. Similarly, Breslau et al. (1991) and Bromet et al. (1998)
both found that a family history of anxiety and antisocial behavior increased the risk
of developing PTSD.
Studies related to characteristics of the trauma which may increase the
likelihood of developing PTSD include findings from the Epidemiologic Catchment
Area Survey in St. Louis (Helzer et al., 1987). This study reported that combat
survivors, particularly those who had been wounded, had the highest risk for
developing PTSD. The most frequently reported traumatic events reported by those
with PTSD were (1) life threat or close call, (2) seeing someone hurt or killed, (3)
physical attack, (4) accident, and (5) combat (Davidson et al., 1991). Breslau et al.
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(1991) found similar results except for rape which resulted in the highest rate of
PTSD (80%) and only in women. Kessler et al. (1995) found that rape was the
trauma most likely to result in PTSD in both men and women. In this sample, 65% of
men and 46% of women who reported rape as their most distressing trauma
developed PTSD. Norris (1992) found the highest rates ofPTSD in survivors of
sexual assault. This report also indicated motor vehicle accidents to have the most
adverse combination of frequency and impact (Norris, 1992).
Psychobiology ofPTSD
As research

has indicated, not everyone who experiences a traumatic event,

even the most likely to result in PTSD, will develop the disorder. The question
remains: Why do some people recover from traumatic experiences while others do
not? To some degree, advances in research regarding biologic changes related to
PTSD have helped to explain.
Over 50 years ago, it was hypothesized that from a physiological standpoint,
PTSD was characterized by a lowering of the threshold of stimulation accompanied
by a psychological state of readiness to respond to perceived danger (Kardiner,
1941). A review of the current research on the psychobiology ofPTSD indicates that
there are changes in physiologic reactivity and stress hormone secretion associated
with the development of the disorder (van der Kolk, 1997). There are several key
components of the human stress response involved in the symptom expression
associated with PTSD including corticotropin-releasing factor (CRF), the adrenergic

13
nervous system, and the hypothalamic-pituitary-adrenocortical (HPA) axis (Friedman,
2000). Under stressful conditions, the body releases CRF in order to activate the
necessary bodily functions that make the "fight or flight" response possible. If the
development of PTSD is related to an altered stress response, it follows that CRF
function would be abnormal in people diagnosed with the disorder (Friedman, 2000).
Research with a sample of Vietnam veterans did in fact show elevated CRF levels in
those diagnosed with PTSD (Bremner, Licinio, & Darnell, 1997). Continued research
with additional trauma populations is indicated.
Abnormal responses of the adrenergic system have also been demonstrated by
hyper-responsiveness of the sympathetic nervous system, elevated 24-hour urinary
catecholemine levels, and by abnormal sensitivity to the adrenergic a2 antagonist
yohimbine (Friedman, 2000). Studies have indicated that patients diagnosed with
J>TSD show excessive startle responses, panic attacks, dissociative symptoms, and
I

;

abnormalities in cerebral blood flow following yohimbine administration (Southwick,
Paige, Morgan, Bremner, Krystal, & Charney, 1999). In addition, recent studies with
Israeli patients seeking emergency room treatment following various traumatic events
showed that pa. tients with elevated pulse rate (excessive adrenergic response) were
more likely to develop PTSD than those whose pulse rate was not elevated following
the trauma (Shalev, Freedman, & Peri, 1998).
According to Yehuda (2000), the HPA axis dysregulation sets PTSD apart
from other psychiatric disorders. In studies with PTSD patients, research showed
lower cortisol levels, up..:regulation of glucocorticoid receptors, and supersuppression
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to dexamethasone indicating a unique HPA profile associated with this disorder
(Yehuda, 2000; Yehuda, Southwick, & Krystal, 1993).
In addition, researchers are examining the role of an endogenous anxiolytic,
neuropeptide Y (NPY) that is heavily concentrated in the brain stern, amygdala,
hypothalamus, and cortex. Researchers speculate that this neuropeptide serves to
attenuate the actions of CRF and other stress-released peptides (Friedman, 2000).
Studies with animals have indicated that NPY buffers the impact of the stress
response (Stout, Kilts, & Nemeroff, 1995). Recent studies with military personnel
during survival training suggest that those individuals with the highest levels of NPY
tolerated excessive amounts of stress better than those with lower levels (Morgan et
al., 2000).
Serotonin reportedly mediates a behavioral inhibition system in the brain that
helps to suppress behaviors motivated by emergencies or by previous reward (Depue
& Spoont, 1986; Gray, 1982; Soubrie, 1986). Research on serotonin levels in animals
has indicated that low serotonin is related to an inability to modulate arousal,
exemplified by an exaggerated startle response and increased arousal to novel stimuli,
handling, and pain (Gerson & Baldessarini, 1980). Decreased serotonin function has
been correlated with hostility, impulsivity, and self-directed aggression in patients
with borderline personality disorder and depression (Asberg, Traskman, & Thoren,
1976; Coccaro et al., 1989). These are diagnostic groups which frequently report
severe childhood trauma (Herman, Perry, & van der Kolk, 1989). It is hypothesized
that stress induced serotonin dysfunction may lead to impaired function of the

15
behavioral inhibition system. This in tum may be related to various behavioral
problems seen in PTSD such as impulsivity, aggressive outbursts, and compulsive re
enactment of trauma-related behavior patterns (van der Kolk, 1997).
The results of studies utilizing neuroimaging to document functional and
structural abnormalities of patients with PTSD (Bremner, Randall, & Scott, 1995;
Gurvitz, Shenton, & Pitman, 1995; Rauch, van der Kolk, & Fisler, 1996) indicate
decreased hippocampal volumes in patients with PTSD when compared to matched
controls. Gurvitz et al. (1995) reported that the severity ofPTSD was directly
proportional to the degree of hippocampal shrinkage. It is hypothesized that this
decrease is due to the long term effect of intrusive reliving of the trauma, most likely
mediated by cortisol-induced hippocampal cell damage (Gray, 1982). This in tum,
may prevent the proper evaluation and categorization of experience thus making
patients with PTSD vulnerable to react to newly arousing stimuli as a threat, with
�ggression, or with withdrawal (van der Kolk, 1997). However, this theory has yet to
be support,ed by research.
Rauch et al. (1996) and Shin et al. (1997), using positron emission
tomography,
reported a significant decrease in activation of the left inferior frontal
1,
.
area (Broca's area)_thought to be responsible for translating personal experience into
�ommunicable language. Research indicates that derealization and depersonalization
at the moment of the trauma is an important predictor for the long-term development
ofPTSD (Marmar, Weiss, & Schlenger, 1994; Shalev, Peri, & Caneti, 1996). Van der
Kolk (1997) suggests that the failure of the left hemisphere functioning during states
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of extreme arousal may play a role in the dissociative phenomena. Further, since an
intact Broca' s area is necessary for the labeling of emotions, impairment could result
in the experience of intense emotions without the ability to label them verbally. The
hypothesis suggests that traumatized individuals subsequently have difficulty
understanding and communicating their experiences (van der Kolk, 1997).
In another line of research, a correlation between PTSD and the use of
medical services was found (Saxe, Chinman, & Berkowitz, 1994). Immunologic
research was conducted on a group of women with self-reported sexual abuse and a
group of control subjects (Wilson, 1996). Results indicated that the immune function
was the same for both groups except for the CD45 lymphocytes, also known as the
"memory cells" of the immune system. These cells "remember'' previous challenges to
the immune system and are ready to respond to like challenges. The sexually abused
women had an increased ratio of these "memory cells" indicating that they had an
increased propensity to remember and respond to immunologic challenges in the
direction of trauma, similar to ratios found in patients with rheumatoid arthritis,
systemic lupus erythematosus, and sarcoid.
As the literature on the psychobiology of PTSD grows, so does our ability to
determine the most efficacious treatment for particular symptoms or symptom clusters
with which our clients present. It is generally assumed that helping patients involves
the processing of traumatic events through the use of words and symbols, proper
categorization, and finally, integration (van der Kolk, 1997) in order to alter the
conditioned physiologic and neurohormonal responses created by a,traumatic event.
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Further research is needed to determine to what degree the psychological processing
of a traumatic event can repair the biological changes that result.
Assessment of PTSD
The Clinician Administered PTSD Scale (CAPS) was designed specifically to
alleviate the limitations found in other structured clinical interviews currently available
for assessing PTSD (Blake et al., 1990). The CAPS-DX (Blake, Weathers, Nagy,
Kaloupek, Charney, & Keane, 1997) is an updated version of the original CAPS
designed to align interview questions with diagnostic criteria from the most recent
version of the Diagnostic and Statistical Manual ofMental Disorders, 4th edition

(DSM-IV; APA, 1994). Structured interviews for diagnosing PTSD currently in use
include the Anxiety Disorders Interview Schedule Revised (ADIS-R; DiNardo &
Barlow, 1988), the Diagnostic Interview Schedule (DIS; Robins, Helzer, Croughan,
Williams, & Spitzer, 1981), the PTSD Interview (PTSD-I; Watson, Yuba, Manifold,
Kucala,
& Anderson, 1991), the Structured Clinical Interview for DSM-IV(SCID-IV;
' .
Spitzer, Williams, Gibbons, & First, 1994), and the Structured Interview for PTSD
(SI-PTSD; Davidson et al., 1990).
Unique features of the CAPS-DX include the use of explicit behavioral
anchors or referents as the basis for clinician ratings. It also includes items that assess
for symptoms related to Criteria A through F according to the DSM-IV defined
construct of PTSD (APA, 1994). In addition, the interview assesses for the impact of
symptoms on social and occupational functioning, improvement in symptoms since
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the previous CAPS administration, overall response validity, overall PTSD severity,
and five associated symptoms (guilt over acts, survivor guilt, gaps in awareness,
depersonalization, and derealization). This instrument also utilizes the Life Events
Checklist, used-to determine exposure to 17 different traumatic events. This has been
particularly helpful in assessing Criterion A (the presence of a traumatic event
involving actual or threatened death with a response of intense fear, helplessness or
horror).
For each item, the interview provides standardized questions, which may be
used to elicit information about experiences or symptoms. For each symptom
reported, the interviewer uses the client's answer to assign a frequency rating as well
as an intensity rating. In addition, the verbal ratings for intensity are tailored to each
item. This feature is what distinguishes the CAPS from other instruments that require
the interviewer to rate symptoms along a single dimension of severity and/or to
determine the presence or absence of a symptom (Blake et al., 1990). The CAPS is
also structured to establish that all symptoms endorsed occurred within the same one
month (or one week with the CAPS-SX) time frame. Questions regarding current and
lifetime symptopis are assessed independently to ensure that relevant time frames are
clearly distinguished from one another (Blake et al., 1990).
Responses to the CAPS-DX may be used to determine if a person meets
DSM-IV diagnostic criteria for PTSD as well as providing continuous rating
calculations for
evaluating frequency and intensity of symptoms. In addition to the
'

'

scoring for intensity and frequency, there is an optional space for the interviewer to
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indicate any doubts regarding the accuracy and/or veracity ofthe interviewee's
responses (Blake et al., 1990). This information may be used to estimate the overall
validity ofthe information reported in the interview. The CAPS also includes a
summary sheet used for coding all symptom ratings. This detailed, one page sheet
aides the interviewer in determining that all items were addressed, coded
appropriately, and ifdiagnostic criteria were met. These features represent
improvements in administration and diagnosis over many ofthe PTSD clinical
interviews currently available. Since its original development, the CAPS has been
updated several times (Weathers, Keane, & Davidson, 2001). The instrument
continues to be widely used in both research and treatment settings (Schnurr,
Friedman, & Bernardy, 2002).
Current Treatments
Psychological Interventions
At its introduction into the DSM-III nearly 20 years ago, PTSD was
conceptualized as a complex phobia with widespread generalization producing
symptoms similar to a generalized anxiety disorder (Diagnostic and Statistical

Manual ofMental Disorders, 3rd edition; APA, 1980). At that time, psychological
treatments that were being used with other anxiety disorders were applied to patients
with PTSD. Lack ofimprovement in symptoms gave rise to the development of
cognitive behavioral therapies specific to PTSD. The two most commonly employed
treatments are exposure and anxiety management procedures.
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Exposure based treatments such as imaginal flooding and systematic
desensitization target feared situations, objects, memories, or images. These
treatments require patients to confront a feared stimulus in one of two ways: imaginal
exposure and in vivo exposure. In imaginal exposure, the patient is asked to recall
from memory and then recount the traumatic event as vividly as possible. With in vivo
exposure, the patient is asked to physically confront the feared place, activity, or
situation in which the trauma took place.
lmaginal flooding or implosive therapy requires that the client repeatedly
imagine the traumatic event until the event no longer evokes the high level of anxiety
present at the beginning of treatment. Treatment is terminated when the avoidance
and anxiety of the traumatic memories are reduced to levels that are manageable
and/or comfortable for the client. Outcome research with imaginal flooding
demonstrates efficacy with the procedure in war veterans (Fairbank, Gross, & Keane,
1983; Keane & Kaloupek, 1982). However, limitations with this research have been
noted, including the use of case studies and very small groups, or treatment groups
made up of only Vietnam veterans (Saigh & Bremner, 1999).
Systematic desensitization (SD) was one of the earliest exposure techniques
used for post-traumatic reactions (Wolpe, 1958). The procedure consists of a
combination of relaxation techniques and progressive exposure to a predetermined
series of imagined traumatic events. The treatment has been used extensively with
war-related PTSD and is useful in the treatment of various symptom constellations
(Saigh & Bremner, 1999). Uncontrolled studies and case studies showed partial
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reduction of trauma-related symptoms (Frank & Stewart, 1983, 1984). Again, this
research was limited by the need for additional studies with larger samples, control
groups and various PTSD populations (Saigh & Bremner, 1999).
Behavioral rehearsal involves placing the client back in the anxiety provoking
situation to "practice" the necessary behavior and may be used in conjunction with
relaxation techniques such as progressive muscle relaxation. This technique was
successful in reducing startle responses in a case study of an auto accident victim
(Fairbank, DeGood, & Jenkins, 1981) and is suggested specifically for persistent post
traumatic startle responses (Saigh & Bremner, 1999).
Anxiety management procedures utilize a set of skills such as relaxation,
breathing training, social skills training, cognitive restructuring, positive self-talk,
role-playing, and thought stopping.
Meichenbaum (1974) developed Stress Innoculation Training (SIT) as an
integrated cognitive behavioral approach to therapy. Theoretically, the emphasis of
SIT is on the development of a frame of reference of personal responsibility and
activity in order to manage stressful events (Saigh & Bremner, 1999). In addition the
technique attempts to decrease feelings of helplessness and passive victimization
(Saigh & Bremner, 1999). Research indicated positive results with the use of SIT
(Veronen & Kilpatrick, 1983) and it is one of the few behavioral treatments to be
used in studies with large populations. Again, the need for control groups has been
emphasized in the outcome research (Saigh & Bremner, 1999).
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In the years since systematic desensitization was developed, Prolonged
Exposure (PE) with or without relaxation has gradually taken its place. Two
controlled studies, both for women victims of assault, have examined the efficacy of
exposure treatments for PTSD in comparison to other cognitive behavioral treatments
and to wait list controls. In a study conducted by Foa, Rothbaum, Riggs, and
Murdock (1991), PE was compared to Stress Inoculation Training (SIT), supportive
counseling (SC), and a wait-list control. SIT and PE showed improvement on all
three PTSD symptom clusters following treatment. SC and wait-list conditions
showed improvement in only the arousal cluster symptoms. At 3-month follow-up,
55% of the PE group, 50% of the SIT group, and 45% of the SC group no longer

met diagnostic criteria for PTSD. In a second controlled study, Foa, Dancu, Hembree,
Jaycox, Meadows, and Street (1999), the researchers compared PE alone, SIT alone,
'

'

and the combination of PE and SIT to a wait-list control group. All active treatments
showed improvement on PTSD symptoms, stated anxiety, and depression at posttest.
By 12-month follow-up, 52% of the PE group, 42% of the SIT group, and 36% of
the PFJSIT group had good "end state functioning" as defined by low scores on
PTSD, depression, and anxiety measures.
One �ontrolled study showed additional efficacy for exposure-based
techniques in mixed forms of trauma as well (Marks, Lovell, Noshirvani, Livanou, &
Thrasher, 1998). Trauma victims with chronic PTSD were randomly assigned to
either PE alone, Cognitive Reprocessing (CR) alone, PE/CR, or relaxation alone. At
posttest, 53% of the PE group, 32% of the CR group, 32% of the PE/CR group, and
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15% ofthe relaxation group achieved good end state functioning. These treatment
gains were maintained at 6-month follow-up.
Another recently developed exposure-based treatment, Eye Movement
Desensitization and Reprocessing (EMDR) (Shapiro, 1989, 1995) requires the client
to perform rhythmic, saccadic eye movements while recalling details ofthe traumatic
event. Several meta-analyses have indicated significant improvements in PTSD
symptoms using this treatment (Van Etten & Taylor, 1998; Waller et al., 1997).
Recent data comparing EMDR with and without eye movements have suggested that
improvements are equivalent in both groups (Boudewyns & Hyer, 1996; Pitman, Orr,
Altman, Longpre, Poire, & Macklin, 1996). In addition, research indicated that
elimination ofthe cognitive component ofthe procedure did not reduce the
effectiveness in producing positive outcomes, lending support to the hypothesis that
EMDR is in essence, a form ofimaginal exposure treatment (Cusack & Spates,
1999).
Cognitive Processing Therapy (CPT) (Resick & Schnicke, 1992) for victims
ofrape utilizes components ofcognitive therapy and exposure. Participants received
education about PTSD symptoms and information processing theory. Exposure and
· cognitive therapy techniques were then utilized in a structured, weekly group therapy
format. The exposure component in this treatment involved writing a detailed account
ofthe assault and reading it during therapy sessions. The CPT group improved on
· both PTSD and depression symptoms at posttest while the wait list control showed
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no such improvement. At 6 months posttreatment the CPT group gains were
maintained.
Although the aforementioned treatments offer promise for clients with PTSD,
methodological limitations have been noted in the literature. These limitations include
attrition in patient populations, subjects receiving additional treatments, and the use of
only inpatient populations or individuals seeking treatment (Solomon, Gerrity, &
Muff, 1992}. In addition, there is increasing recognition of the need for a better
understanding of which components in what combinations are most likely to yield
treatment gains (Solomon et al., 1992).
Pharmacological Interventions
!

I •.

In addition to psychotherapeutic interventions, several types of medication
have been used in attempts to treat PTSD. Medication may be used in treating
patients with PTSD with one of two goals in mind (Davidson, 1997). One goal is to
use the medication as a way to eliminate debilitating symptoms so the person may
resume a normal life (Sargent & Slater, 1972). The other goal is to facilitate
r�solution of the traumatic experience by allowing the patient to confront and work
through the trauma (Hogben & Cornfield, 1981).
Published research on pharmacological therapies for PTSD is limited but
growing. However, results continue to be inconsistent making recommendations
difficult. Compounding the issue is the high rate of comorbidity in people diagnosed
'

'

with PTSD which requires that much care be taken in the selection of a
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pharmacological treatment (Friedman, 1998). In addition, little was known about the
psychobiology of PTSD until recently (van der Kolk, 1997) making it difficult to say
which drugs would reduce which clusters of symptoms.
Among the pharmacological treatments the most widely used to treat
symptoms of PTSD are tricyclic antidepressants, monoamine oxidase inhibitors such
as phenelzine, and serotoninergic agents such as fluoxetine, sertaline, and
fluvoxamine. The anticonvulsants carbamazepine and valproic acid, and
benzodiazepines such as alprazolam, clonazepam, and lorazepam have also been
prescribed. Clonidine and propranolol have been prescribed to reduce symptoms as
well. Yehuda, Marshall, and Giller (1998) reviewed the available studies and found
only seven controlled clinical trials reported at that time (Braun, Greenberg, Dasberg,
& Lerer, 1990; Davidson et al., 1990; Katz et al., 1995; Kosten, Frank, Dan,
McDougle, & Giller, 1991; Reist et al., 1989; Shestatzky, Greenberg, & Lerer, 1988;
van der Kolk et al., 1994). The remainder of the literature consisted of open trials,
case reports and retrospective chart reviews (Yehuda et al., 1998). In addition to the
lack of controlled, clinical trials, the combination of therapies to address the PTSD
symptom complex and the common presence of comorbid illnesses complicated an
accurate review of treatments (Sutherland & Davidson, 1994).
Tricyclic antidepressants have been the best-studied class of medications for
PTSD, with three randomized clinical trials (Davidson et al., 1990; Kosten et al.,
1991; Reist et al., 1989), three open trials, and several retrospective studies and case
reports. One of the two more methodologically sound of the studies is Davidson et
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al.'s (1990) randomized trial comparing amitriptyline (TCA) to a placebo in combat
veterans. The study utilized a mixed population of hospitalized and outpatient
veterans who had served in World War II, Korea, or Vietnam. Results indicated that
amitriptyline was superior to placebo on measures of PTSD including avoidant
symptoms as well as general measures of depression and anxiety. This study was
important because although responses at 4 weeks were not significant, at 8 weeks
they were. This study also showed the efficacy of drug over placebo regardless of
how long participants had experienced symptoms and regardless of inpatient versus
outpatient status.
Kosten et al. (1991) conducted the first randomized placebo-controlled study
and found phenelzine (MAOI) to be superior to both placebo and imipramine (TCA)
particularly with respect to intrusive and avoidant symptom clusters. Reports
indicated that phenelzine (MAOI) resulted in a 68% global improvement, compared
with a 45% improvement with imipramine (TCA) and a 28% improvement from the
placebo group. Specifically, phenelzine (MAOI) was helpful with the core symptoms
of intrusion and insomnia with a trend toward improvement in avoidance. This study
had an adequate number of subjects (n = 46) and therapeutic drug levels were
monitored for 8 weeks, enough time to determine specific effects of the medication on
symptom improvement. In addition, participants were from a Readjustment Veteran
Outreach Center, rather than a VA, most were employed and had no comorbid
substance use or major Axis I diagnoses. These factors may be considered to add to,
or detract from the significance of the results as comorbid Axis I diagnoses are so
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prevalent in this population. Thus, considering the number of people suffering from
PTSD who do have substance use disorders as well as comorbid Axis I disorders,
these results may not be generalizable to the majority of PTSD sufferers. In addition,
participants were involved in group therapy and 4 participants were also administered
benzodiazepines.
Overall, phenelzine (MAOI) appears to be superior to imipramine (TCA) for
PTSD, particularly for intrusive symptoms. The medication does not appear to be
well suited to combat avoidant symptoms, however. With MAOis in general, there is
also the danger of a hypertensive crisis from ingestion of foods containing tyramine
and from certain other medications. With phenelzine (MAOI) in particular, side
effects which contribute to drop out rates include the intensification of sleep
disorders, dizziness, erectile failure, delayed ejaculation and urination, constipation,
dry mouth, blurred vision, drowsiness, behavioral inhibition, blackouts, perceptual
changes, and hypomania (Davidson et al., 1990; Kosten et al., 1991).
As mentioned above,

Kosten et al.'s (1991) randomized trial compared

imipramine (TCA} to phenelzine (MAOI) and placebo, showing that imipramine was
more effective than phenelzine in global symptoms improvement. Both of these
studies considered comorbidity in evaluating treatment outcome but as mentioned
above, the Kosten et al. (1991) group had little in the way of comorbid disorders. In
addition, they both utilized standardized assessments for diagnosis and symptom
ratings.
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In general, the therapeutic effects oftricyclics have been modest, but clinically
relevant, particularly for hyperarousal and intrusive symptoms (Yehuda et al., 1998).
Because no single medication has been used, it has been harder to evaluate the
efficacy ofTCA.s given that they vary in the mechanisms and spectrums ofaction
across neurotransmitter systems (Yehuda et al., 1998). These medications appear to
work best after at least 8 weeks in trauma survivors with no comorbid diagnoses and
are effective for reducing the associated symptoms ofmood and anxiety in subjects
with PTSD (Yehuda et al., 1998).
More recently, a double blind, randomized, placebo controlled, multicenter
study examined the effectiveness ofthe reversible selective MAO type A inhibitor and
serotonin reuptake inhibitor, brofaromine (Baker et al., 1995). Due to its rapid
reversibility ofinhibition ofMAO, it reduces the risk ofa tyramine-induced
hypertensive crisis making it a safer choice for those PTSD patients who may be
prone to impulsivity and substance abuse. The study compared brofaramine (n = 56)
to placebo (n = 58) in with a sample ofcombat veterans. Both groups showed
significant reduction in symptoms as measured by the Clinician Administered PTSD
Scale (CAPS} scores, but no significant differences were seen between groups.
Selective Serotonin Re-uptake Inhibitors (SSRis) have been used to treat
PTSD as well. One randomized, double blind, placebo-controlled trial (van der Kolk
et al., 1994} examined the effect offluoxetine in two groups ofPTSD patients over a
5-week period. Participants were 31 war veterans and 33 civilian patients in a trauma
clinic. In addition to PTSD, over half ofthe participants in this study also met criteria
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for major depression. In the sample of completers (about 25% did not complete the
study), fluoxetine was found superior to placebo for overall PTSD symptoms and
dramatically improved depressive symptoms. In addition, improvement was noted in
numbing and hyperarousal symptoms but not in avoidance and intrusive symptoms.
The authors noted clear overall improvement in PTSD ·symptoms after a 5-week
period of drug treatment with 50% of subjects no longer meeting PTSD criteria after
10 weeks (van der Kolk et al., 1994).
A 12-week, double blind, placebo-controlled trial of the SSRI, sertraline was
conducted over 14 sites (Brady et al., 2000). This study included 187 patients who
met criteria for DSM-1/l-R PTSD and scored a minimum of 50 on the Clinician
Administered PTSD Scale (CAPS-2) at baseline. Results indicated that patients who
received sertraline showed significantly greater improvement than placebo on three of
four primary outcome measures including CAPS-2 score, Clinical Global Impression
Severity (CGI-S), and Clinical Global Impression- Improvement (CGI-I) scores.
Sertraline showed significantly greater improvement than placebo on CAPS-2 PTSD
symptom clusters of avoidance/numbing and incr�ed arousal. No significant
differences were found for re-experiencing/intrusion symptoms. Researchers reported
that sertraline was well tolerated with insomnia being the only adverse effect reported
significantly more often than in the placebo group.
A second, randomized, double-blind, placebo controlled study examined the
effects of sertraline when compared to placebo (Davidson, Rothbaum, van der Kolk,
Sikes, & Farfel, 2001). Outpatients with aDSM-III-R diagnosis ofPTSD were
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randomized to 12 weeks of either sertraline in flexible daily doses in the range of 50200 mg (n = 100) or placebo (n = 108). Primary outcome measures included the
Clinician Administered PTSD Scale (CAPS-2) total severity score, the patient-rated
Impact of Events Scale (IES), and the Clinical Global Impression-Severity (CGI-S)
and -Improvement (CGI-1) ratings. Acute treatment with sertraline resulted in a
clinically significant mean reduction from baseline in the range of 45% to 50% on the
two primary measures, the CAPS-2 and the IES. Researchers indicated that 70% of
this improvement occurred within 4 weeks of treatment. In addition, sertraline was
well tolerated by participants with 9% of the sertraline subjects, compared with 5% of
the placebo-treated subjects who discontinued treatment during the 12-week study
period due to adverse effects.
This study was limited in that entry criteria excluded patients with current
history of alcohol or substance abuse. In addition, a moderate or high level of current
symptom severity was required. These conditions may have compromised the
generalizability of the results. In addition, the effect of clinical variables including
gender, type of trauma, duration of illness, and presence of comorbid conditions was
not considered when evaluating treatment response.
SSRis have been noted as the first choice of pharmacology for all symptoms
ofPTSD by the Expert Consenus Guidelines (Foa, Davidson, & Frances, 1999) and
the SSRI sertraline has recently been approved by The Food and Drug Administration
(FDA) for the treatment ofPTSD.
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A controlled trial of a benzodiazepine in the treatment of PTSD found no
improvement in symptoms specific to PTSD in a 5--week trial of alprazolarn (Braun et
al., 1990). Modest improvements were found in reports of anxiety symptoms and
some improvement was noted in subjective well-being, but ratings on the PTSD scale
of diagnostic criteria and JES were not affected. It should be noted that the short
duration of the study and small number of subjects (n = 10) may have affected the
results. More recent trials with alprazolarn and clonazeparn have not shown any effect
on PTSD symptoms (Anderson, Rothbaurn, & Hodges, 2001; Ballenger, Davidson, &
Lecrubier, 2000). In addition, the harmful drug interaction in patients with comorbid
substance use/�buse disorders, and serious withdrawal symptoms make
benzodiazepin9s less often the drug of choice for clinicians.
The antiadrenergic agents such as alpha-2 agonists or beta-blockers have not
been systematically studied despite the established association between chronic PTSD
and adrenergic dysregulation (Friedman, Charney & Deutch, 1995; Yehuda &
McFarlane, 1997). In open trials, clonidine has been shown to reduce hyperarousal
and re-experiencing symptoms as well as improved mood and concentration
(Friedman & Southwick, 1995). However, patients who have a positive first response
to the drug may develop tolerance followed by the return of PTSD symptoms. Two
recent case reports indicated that clonidine could be replaced with another adrenergic
alpha-2 agonist, guanfacine, with complete suppression of PTSD symptoms for the
remainder of the course of treatment (Horrigan, 1996; Horrigan & Barnhill, 1996).
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Although no controlled, clinical studies have been conducted, anticonvulsants
have shown promise in two small, open-label studies (Fesler, 1991; Lipper, Hammett,
& Davidson, 1986). Results indicated that nightmares, flashbacks, and intrusive
recollections were reduced as well as reports of improvement in the quality and length
of sleep.
Thus, a number of pharmacological treatments for PTSD are available. Those
on which clinical trials have been run showed some promise for relieving patients of
one or more symptoms, but have not been shown to improve functioning or disability
(Davidson, 1997). It is also unknown to what extent civilian populations respond
differently than veterans and to what extent the type and severity of trauma may
contribute to differences in the response to treatment. Additional research is needed in
this area to support these preliminary findings.
Burnout
Definition
Burnout was defined by Maslach (1982) as "a syndrome of emotional
exhaustion, depersonalization, and reduced personal accomplishment that occurs
among individuals who do 'people work."' According to Pines (1982), burnout is
always caused by emotional stresses and occurs as a result of the intense involvement
with emotionally demanding situations over long periods of time. The term "burnout"
is regularly used in reference to professional workers including nurses, social workers,
psychologists, and policemen. Core symptoms of burnout include feeling emotionally
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empty or drained, development of a negative or cynical attitude toward the recipients
of one's service, and a loss of feelings of personal accomplishment in one's job
(Maslach, Jackson, & Leiter; 1996). As such, quality of work and ability to engage in
effective relationships with clients are adversely affected by burnout (Shannon &
Salebey, 1980).
Symptoms include depression, cynicism, boredom, loss of compassion, and
discouragement (Freudenberger & Robbins, 1979). In addition, burnout has been
linked to several indices of distress including poor physical health (Pines, 1982),
marital problems (Jackson & Maslach, 1982; Jayaratne, Chess, & Kunkel, 1986),
insomnia (Maslach & Jackson, 1979), and substance abuse (Jones, 1981; Pines,
1982). Several studies have also shown an association between burnout and various
work avoidance behaviors including absenteeism and tardiness (Drake & Yadama,
1996), the intention to leave one's job (Drake & Yadama, 1996; Jones, 1981) and
employee turnover (Pines, Aronson, & Kafry, 1981; Weinberg, Edwards, & Garove,
1983).
Assessment of Burnout
Although the construct of burnout has been studied extensively, only three
burnout measures have been reported in the literature: the Maslach Burnout Inventory
(MBI) (Maslach & Jackson, 1981, 1996), the Tedium Measure (Pines et al., 1981),
and the Meier Burnout Assessment (Meier, 1983). The Tedium Measure was
designed to be a more general survey, not necessarily aimed at people in emotionally
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demanding situations. It is particularly suited to assessing burnout in a corporate
organization or system (Stout & Williams, 1983). The Meier Burnout Assessment
was rationally derived with limited psychometric data available. Of the three
measures mentioned in the literature, the Maslach Burnout Inventory has the widest
usage.
The Maslach Burnout Inventory
The MBI was designed for use with people working in emotionally demanding
situations. More specifically, it was designed to assess a person's feelings and
attitudes regarding their work with people. Researchers continue to utilize this
instrument in both research and clinical settings. Recent studies include confirmatory
factor analysis and reliability studies in multiple languages (Abu-Hilal & el-Emadi,
2000; Yuen, Lau, Sheck, & Lam, 2002). In addition, the instrument continues to find
wide usage in clinical research assessing burnout in various populations including
nurses (Beckstead, 2002; Kalliath & Morris, 2002), dentists (te Brake, Gorter,
Hoogstraten, & Eijkman, 2001; Gorter, Albrecht, Hoogstaten, & Eijkman, 1999) and
teachers (Koustelios, 2001; Nagy & Nagy, 1992).
Three versions of the MBI are available: the Human Services Survey (MBI
HSS; Maslach & Jackson, 1996), which was designed for professionals in the human
services; the Educators Survey (MBI-ES; Maslach & Jackson, 1996), designed for
use with educators; and the General Survey (MBI-GS; Schaufeli, Leiter, Maslach, &
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Jackson, 1996), designed for use with workers in occupations other than human
services and education.
The MBI-Human Services Survey yields scores on three subscales: emotional
exhaustion, depersonalization, and personal accomplishment. High scores on the
emotional exhaustion subscale are indicative of emotional over extension or being
worn out by one's job. High scores on the depersonalization subscale are indicative of
a lack of concern or feeling for one's clients. Low scores on the personal
accomplishment subscale reflect feelings of incompetence or ineffectiveness in one's
work. Separate scores are attained for each subscale to reflect the degree to which
individuals experience the feelings assessed by the subscale.
The MBI-Educator's Survey was developed to identify burnout levels in
individuals working in educational or school settings. The instrument measures the
same three burnout subscales as the MBI-HSS. The one modification made was to
replace "recipient" to "student" on the questionnaire.
Both of the above mentioned surveys include a Demographic Data Sheet to
identify the subjects' age, sex, race, religion, marital status, education and
�mployment related information.
The MBI-General Survey was developed to assess burnout in occupations
without direct personal contact with service recipients or with only casual contact
with people. This assessment has three subscales including Exhaustion (Ex), Cynicism
(Cy), and Professional Efficacy (PE). Both the Exhaustion and Professional Efficacy
subscales of the MBI-GS are similar to the Exhaustion and Personal Accomplishment
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subscales of the MBI-HSS respectively. The Cynicism items on this survey reflect an
indifferent attitude toward work, referring to the work itself rather than to personal
relationships with people at work as in the Depersonalization subscale of the MBI
HSS. Similar to the MBI-HSS, a high degree of burnout is demonstrated by high
scores on both Exhaustion and Cynicism subscales and low scores on Professional
Efficacy. A Demographic Data Sheet was not developed for use with the MBI
General Survey, but the authors suggested that the Educator's Survey Demographic
Data sheet may be used with this survey.
Recommendations for Intervention
Burnout is not recognized as a mental disorder by the Diagnostic and
Statistical Manual, 4th edition (DSM-IV; APA; 1994). However, as evidenced by a
description of the constellation of symptoms, it is a significantly distressing and
debilitating condition for many people. Several recommendations for intervention
have been made in an effort to reduce the effects of burnout including personal stress
management, organizational socialization (Taormina & Law, 2000), .and developing a
"personal plan of action" (te Brake, Gorter, Hoogstraten, & Eijkman, 2001).
Writing Therapy
Theory
Since the inception of psychotherapy, theorists have suggested that emotional
expression is essential to positive mental health outcomes and that emotional
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inhibition has contributed to negative mental health outcomes (Breuer & Freud,
1966). More recently, researchers have reported a link between emotional expression
and improved health outcomes (Esterling, Antoni, Kumar, & Schneiderman, 1990;
Murray, Lamnin, & Carver, 1989; Spiegel, Bloom, Kraemer, & Gottheil, 1989).
Conversely, emotional inhibition has been linked to detrimental effects including
psychological distress and increased physical health problems (Jamner, Schwartz, &
Leigh, 1988; Jensen, 1987; Larsen, 1990).
Pennebaker (1989) proposed an "inhibition model" which suggested that the
effort exerted by constraining feelings, thoughts or behaviors is physiologically
stressful. The stress produced by the inhibition, acts on the body, exacerbating any
number of psychosomatic processes. Thus, disclosure of these feelings, thoughts, or
behaviors would, theoretically, relieve the stress and improve physical health and
mental well-being. Pennebaker (1993) found that participants who had not shared
past traumatic experiences exhibited more health problems than those who disclosed.
A study by Kagan, Reznick, and Snidman (1988) found that participants rated as
inhibited or "shy'' by others reported increased health problems when compared to
those rated less inhibited. More recent research supports this model of inhibition
including a study by Cole, Kemeny, Taylor, and Visscher (1996) who reported
increased physical health problems among men who concealed their homosexual
orientation.
According to Hembree and Foa (2000), there are three factors hypothesized
to be critical to the successful processing of traumatic events. These are emotional
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engagement with the trauma memory, organization of the trauma narrative, and the
correction of dysfunctional cognitions that are common immediately after a traumatic
event. Clinical observations reported by the researchers suggest that incomplete
sentences, repetitions, and speech fillers characterize the trauma narratives of patients
with chronic PTSD. In addition, it has been suggested that these narratives are often
discontinuous with respect to time and reflect a good deal of confusion. It has been
hypothesized that the natural process of healing from a traumatic event involves
organizing and articulating the traumatic memory. This hypothesis is supported by
research indicating that PTSD symptom severity three months following the traumatic
event was pred,icted by the degree of trauma narrative articulation (as measured by
reading level) (Amir, Stafford, & Freshman, 1998).
Empirical Literature
A series of studies by James Pennebaker has examined the effects of writing
about traumatic events on physical health and well-being. In one of the earliest
studies, Pennebaker and Beall (1986) conducted a preliminary investigation to
determine if writing about traumatic events would influence long-term measures of
health. The researchers also looked at short-term indicators of physiological arousal
and reports of negative mood as well as particular aspects of the writing itself
Participants were randomly assigned to groups and asked to write about their
most traumatic experience from one of three perspectives: (1) only facts of the
traumatic event, (2) only the emotions experienced due to the traumatic event, and (3)

(
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both facts and emotions. Results indicated that participants who wrote only about the
facts of the trauma were indistinguishable from controls that wrote about superficial
topics. The group who focused only on emotions related to the trauma reported the
study to be helpful, but showed no long-term health improvements. Only those
participants who wrote about both the facts of the trauma and their emotional
responses to it showed long-term health benefits. Thus, writing about an earlier
traumatic event was associated with long-term decreases in health problems as well as
short-term increases in physiological arousal.
Further investigation (Pennebaker et al., 1988) examined the effects of writing
about a traumatic experience on immunological function and other measures of
distress. It was predicted that individuals assigned to write about their most traumatic
experience would demonstrate an increased production of white blood cells in
response to stimulation (thus indicating increased immune system functioning) relative
to control subjects who wrote about superficial topics. Participants were 36 women
and 14 men, all healthy undergraduates, who were randomly assigned to one of two
writing conditions. Three general classes of data were collected: evaluations of and
responses to the written essays, long-term effects of the study, and individual
differences affecting responses.
The first class of data included degree of personal content of essays (rated by
independent judges), objective parameters of each essay (number of words, number of
self-references, and number of emotion words), and subject ratings on level of
personal disclosure and degree to which they had withheld this trauma from others. In
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addition, participants were asked to complete a questionnaire assessing the degree to
which they experienced each of eight symptoms (e.g., headache, pounding heart,
tense muscles) and six negative mood states (e.g., frustrated, guilty, depressed).
Four types of data assessed the long-term effects of disclosure of traumatic
experiences. One of the long-term effects included immune system functioning. As a
measure of immune function, this study examined the lymphocyte, or white blood cell
response to stimulation by substances called mitogens, which are foreign to the body.
An in vitro measurement of the proliferation of lymphocytes in response to
stimulation by these foreign bodies was conducted. Two types of mitogens were used
in this study, phytohemmagglutinin (PHA) and concanavalin A (ConA), both of which
stimulate the proliferation of T-lymphocytes thus indicating the ability of the immune
system to fight infection.
In addition, the number of health center visits over two time periods was
examined. These included the 5-month interval covering the beginning of the school
year to the time of the study, and from the beginning of the study to the end of the
study (roughly 6 weeks). Subjective ratings of distress were also collected. These
included subjects' general attitude about the experiment and changes in health related
behaviors since the beginning of the experiment. In addition, resting levels of systolic
and diastolic blood pressure, heart rate, and skin conductance level were measured
prior to each of the blood draws.
Prior to the first writing day, participants completed a battery of
questionnaires, had autonomic measures taken and blood drawn. The next day,
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participants began the writing portion of the study. Writing sessions were for 20
minutes each on 4 consecutive days and took place in individual, private rooms.
Specific instructions were given to each group. Immediately before and after the
writing session, participants were asked to complete questionnaires that assessed their
mood and physical symptoms. After writing each day, participants were asked to
evaluate their writing for that day. On the last day of writing, autonomic measures
were again taken and blood was drawn for a second time. Brief questionnaires were
then administered. Six weeks later, autonomic levels and blood samples were taken
and post-experimental questionnaires were then completed. Participants were then
extensively debriefed regarding the experiment.
The Health Center provided information regarding the number of visits made
by each participant for the 5 months prior to and the 6 weeks during the study. At 3
months following the end of the study, subjects were mailed a final questionnaire to
assess possible long-term effects of the experiment.
Results indicated that writing about traumatic events was associated with a
positive effect on the ability of the immune system to fight infections (as measured by
the blastogenic response of the T-lymphocytes to two mitogens), on health center use,
and on subjective distress at follow-up. The essays of the subjects who were asked to
write about a traumatic experience were significantly more personal, longer, and
included more self-references and more emotion words than the control group as
rated by objective measures. Regarding the self-reported physical symptoms and
emotional state questionnaire, these same subjects reported higher levels of physical
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symptoms and negative mood immediately following each writing session as
compared to control subjects. However, by follow-up, the self-reported ratings of
negative ,mood in the group writing about a traumatic experience had decreased, such
that there was no significant difference between the two groups.
In relation to the physiological measures, the group writing about a traumatic
experience demonstrated a higher overall mitogen response following baseline in
comparison with the control group. Regarding health center visits, these same
subjects evidenced a drop in visits relative to control subjects. However, the authors
note that this increase in health center visits for the control subjects probably reflects
normal seasonal illness rates for that time of year. Subjective reports regarding the
study revealed that although the participants who were asked to write about a
traumatic experience reported some negative feelings at the beginning of the study,
they were significantly happier than control subjects at the 3-month follow-up. Health
related behaviors such as smoking, consuming caffeine and alcohol and hours of
strenuous exercise per week showed no change.
Regarding individual differences in the participants writing about a traumatic
experience, the group was divided into high disclosers-those who self-reported
writing about a trauma they had not talked about before-and low disclosers-those
who wrote about a trauma they had shared with others in the past. High disclosers
wrote significantly more words than low disclosers and rated their essays as more
personal, although independent judges rated the two groups equally. In addition, high
disclosers had a marginally higher response to PHA stimulation than low disclosers
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and improved mitogen response across all mitogen concentrations relative to the low
disclosers. No significant differences were found in autonomic levels for the two
groups.
The authors highlight the importance of these results as supporting an
inhibitory model of psychosomatics, pointing to the effectiveness of writing therapy- as
a general preventive therapy, and promoting awareness of the potentially direct and
cost-effective improvements in health that psychotherapy might be expected to
provide. It is generally accepted that stress can increase the incidence of illness. This
study supports the idea that the stress associated with the failure to confront a
traumatic experience, specifically the inhibition of such material, is associated with
physical effort. Pennebaker et al. (1988) suggest that over time, this can cause or
become illness. This study demonstrated that individuals who confront upsetting
experiences in their lives show improvements in physical healt� relative to controls
and the greatest health improvements were seen in those who wrote about topics
which they had actively held back from others in the past.
Several limitations to the study may be noted. Participants in this study were
psychologically healthy college men and women, a fairly homogeneous sample, thus
bringing generalizability of the results into question. In addition, the majority of
participants were women (n = 36 women; n = 14 men) with no analyses mentioned
regarding differences in responses between genders. Whether there were no
differences, or whether the researchers did not examine that variable, is unclear from
the review of the study.
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Greenberg and Stone {1992) sought to replicate the earlier findings of
Pennebaker et al. (1988) that disclosing about a trauma results in improved physical
health. In particular, they examined whether revealing previously undisclosed traumas
would result in in�reased health benefits. Subjects were 36 women and 24 men
college student volunteers with a mean age of 19.3 years. Subjects were randomly
assigned to a previously disclosed trauma (PDT) group, a previously undisclosed
trauma (PUT) group, or a control group. Before each writing session, participants in
the PDT group were specifically instructed to write only about traumatic
experience(s) they had discussed with another person. Participants in the PUT group
were specifically instructed to write only about traumatic experience(s) they had not
discussed with any other person. Participants assigned to the control group were told
to write only descriptions of specified activities, social events or plans they had,
leaving out any mention of their feelings or thoughts related to these topics.
Because the study was a replication, all of the measures used in the
Pennebaker et al. {1988), study were also used in this study with the exception of the
Positive and Negative Affect Schedule (PANAS; Watson, Clark, & Tellegen, 1988).
Greenberg and Stone (1992) also changed the time frame for reporting of physical
symptoms from the previous year to the previous month.
Results of this study failed to replicate the overall finding of Pennebaker and
Beall (1986) and Pennebaker et al. {1988) that writing about emotions related to past
traumatic experiences is associated with subsequent health benefits. No significant
differences were found between any of the groups on measures of overall visits to
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health care professionals for illness, nor on self-reported physical symptoms.
Greenberg and Stone (1992) suggest that differences may, in part, be due to the
differences in pre-existing health status of the participants in this study and that of
participants in previous studies. Subjects in this study had twice as many illness visits,
on average, at pretest than Pennebaker et al. 's (1988) participants suggesting that
although writing therapy may be useful in reducing future health problems, it is not
sufficient to cure preexisting or chronic health problems. However, in the current
study, self-reported doctor visits, in addition to objectively documented health center
visits were tracked and may therefore be subject to memory biases. In addition,
despite random assignment of subjects, significant differences were found between
trauma and control subjects on physical symptoms at pretest. Previous studies
(Pennebaker & Beall, 1986; Pennebaker et al., 1988; Pennebaker, Colder, & Sharp,
1990) did not report pretest assessment of between group differences so it is not
known whether they suffered pretest differences as well.
Significant differences between disclosed trauma and undisclosed trauma
subjects were found on measures of immediate mood and physical symptoms, such
that disclosed-trauma subjects reported greater immediate increases in negative mood
and physical symptoms and greater immediate decreases in positive mood when
compared to undisclosed trauma subjects. These results were not attributed to a
difference in the severity of trauma reveale4, as no significant differences on self
reported trauma severity were revealed. The researchers suggested this difference
might be due to participants remembering the disapproving or negative responses
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from others when the traumatic material was originally disclosed. However no
information was attained to verify this hypothesis.
On measures of longer term health and mood, disclosed trauma and
undisclosed trauma subjects did not significantly differ. It should be noted that this
finding may have been due to the continuous nature of the "disclosure" variable.
Participants may have selectively disclosed portions of traumatic material to
confidants and thus a partially disclosed trauma may have been appropriate for either
group. This suggests that the experimental manipulation of prior disclosure may be
less clear-cut than had been assumed.
Finally, no significant differences were found between severe and nonsevere
trauma subjects on immediate mood and symptom measures, but on measures of
physical symptoms in the 2 months following the study, severe trauma subjects
reported greater decreases. A significant negative association was found between
trauma severity and posttest illness visits, suggesting that trauma severity moderated
the longer-term health effects of essay writing in the study.
The study was limited such that the severe and nonsevere trauma groups were
not operationally established. That is, no clear criteria were given to participants
regarding what constitutes a severe trauma versus a nonsevere trauma. This is true of
the disclosure variable as well as subjects were not explicitly instructed on what
constitutes a disclosed trauma versus an undisclosed trauma.
In addition to studies that focus on particular physical health and general well
being measures, Pennebaker (1993) examined the content of the essays of the
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experimental groups in three of his past studies (Pennebaker, 1991; Pennebaker et al.,
1988, 1990). The rationale behind the analysis was that perhaps there was something
about the way the subjects used words, rather than the words themselves. A
composite outcome measure was computed by adding the primary dependent
measures together after converting them to z scores. The top third and bottom third
of this group were chosen as those showing the most and least improvement,
respectively. It should be noted that the bottom third of the participants did not get
worse; they simply showed no improvement. Essays were run through the Linguistic
Inquiry and Word Counts (LIWC) program (Francis & Pennebaker, 1992) to tabulate
the number of negative and positive emotion words, cognitive dimensions of insight
and causation, and several general text dimensions such as number of words and
percentage of unique words. General word usage (average across 3-4 days) and
changes in word usage (Day 1 compared to Day 3 or 4) were also examined.
Results indicated that participants whose health improved used significantly
more negative emotion words and fewer positive emotion words than those who
showed no improvement. Subjects in the improved conditions showed evolution in
their writing from fewer to more cognitive words over time. In addition, subjects in
the improved condition showed a significant drop in unique words over time
,compared to the subjects showing no improvement. This measure has been suggested
as a crude indicator of psychological coherence, hence those subjects who showed
improvement seem to become more focused in their writing.
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Independent judges were also used to comment on characteristics such as
negative and positive emotion words, self-reflection and the degree to which the
essays were organized. Judges ratings of these measures were in the same direction as
the LIWC analysis. In addition, subjects who showed health improvements over time
were rated as having written more cohesive, organized essays over time and those
who showed no improvement were rated as having a gradual deterioration of their
essays over time.
In order to address the link between word usage and autonomic activity, a
Computerized Autonomic Retrieval of Morphemes and Even Neologisms
(CARMEN) machine was developed. Study participants could now type their
thoughts on the computer keyboard and the apparatus would link each word to
concurrent autonomic levels. Results indicated that language was more closely linked
to skin conductance level (SCL) than to heart rate. In addition, the expression of
negative emotion was most often associated with increased SCL and positive
emotions with decreased SCL. The author concluded that both catharsis and insight
might be at work when disclosing traumatic experiences, but in different ways. In
addition, the construction of a story through the process of writing seems to be more
beneficial than having a constructed story when one begins. Pennebaker (1993) goes
on to suggest that in the short run, this disclosure may be psychologically painful and
physiologically arousing, but in the long run results in improved physical and
psychological health benefits.
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Spera, Buhrfeind, and Pennebaker (1994) hypothesized that recently
unemployed professionals who disclosed the experience ofjob loss through writing
would show less stress and increased motivation to obtain new employment. In
addition, it was hypothesized that they would show greater success in achieving re
employment than those who wrote about job-related but nontraumatic topics and
those who did not write at all. Participants were 62 men and 1 woman with a mean
age of 54 years. On average, participants had been with their former employer, a large
computer and electronics firm, for 20 years and had been in engineering or other
professional positions. Participants were randomly assigned to one of three groups:
the experimental writing group (EW), the control-writing group (CW), or the
nonwriting control group (NWC). The nonwriting control group could not participate
in the writing portion of the study due to scheduling conflicts, but agreed to complete
questionnaires before and after the study.
At the beginning of the study, participants were asked to complete a health
questionnaire and the Transition-Search Behavior Questionnaire, which assessed job
search activities, motivation and anxiety levels during the career transition period as
well as specific behaviors such as alcohol consumption. At this time, age, weight,
blood pressure and heart rate were also recorded. One week following the initial
meeting, the writing portion of the study began. Participants in the two writing
groups, EW and CW, were asked to write for 20 minutes on 5 consecutive days. The
EW group was told to write about their deepest thoughts and feelings surrounding the
layoff and how their personal and professional lives had been affected. The CW group
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was told to write about their activities related to seeking new employment, but to
refrain from revealing opinions or feelings about their situation.
At the end ofeach writing session, participants were asked to complete a
questionnaire assessing to what extent they experienced various physical symptoms
and negative moods. In addition, they were asked to disclose how personal the
writing was and how much emotion they revealed. On the final day ofwriting, all
participants were asked to complete a final writing questionnaire which asked about
their feelings toward the study. In addition, participants were asked to complete the
Transition-Search Behavior Questionnaire again. Participants were then asked to
return in 12 days to have their blood pressure, heart rate and weight recorded and to
complete the Transition-Search Behavior Questionnaire for a final time. This was
repeated on the last week ofeach month for three months. In addition, subjects kept
interview logs that they turned in to their outplacement consultants. The
outplacement center kept records ofthe number ofphone calls received and the
number ofjob-related letters generated by participants.
Results indicated that subjects in the experimental condition (EW) rated their
essays as significantly more personal and revealing ofemotion than those in the
control group (CW). In addition, participants who wrote about the trauma oflosing
their jobs (EW) were significantly more likely to find reemployment in the months
following the study than control subjects (CW). Three months after the 5-day writing
period, 5 participants in the EW condition secured employment. At this same time, no
participants in the CW condition had secured employment and 2 subjects in the NWC
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condition secured employment. After 8 months, only 5 ofthe 21 participants in the
CW condition had secured full-time employment. Three of22 participants in the
NWC condition had secured employment and 10 of19 participants in the EW
condition had secured full-time employment. Interestingly, the higher reemployment
rates were not significantly related to an increase in phone calls, making more
contacts or sending out more letters. In addition, there were no significant differences
between groups on physiological measures ofstress. It was suggested that the socially
supportive atmosphere ofthe outplacement center, at which the unemployed workers
had been meeting served to decrease stress levels in the unemployed, thus minimizing
differences on this variable. In addition, participants in all groups had been out of
work for 6 months or more, allowing them some time to adjust to their unemployed
status.
The authors emphasized the importance ofaddressing the psychological issues
ofjob loss in order to achieve reemployment. They emphasized the need for a period
of"psychological processing" before engaging in active employment seeking
activities. Participants expressed the need for the Writing in Transition Project to be
offered much sooner than it had been.
· This study had several limitations. First, with only one female participant, the
results cannot generalize to women who have lost their jobs and are seeking
employment. Future studies should focus on an equal distribution ofmale and female
participants. In addition, the group was a highly educated and professional group.
Participants had a college education and worked in a very technical environment.
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Future studies need to be conducted with participants with less education, and/or a
wider range of occupations.
In addition, the presence of coping skills and support systems in the lives of
the participants were not directly assessed. Research indicates that the presence of a
social support system can improve negative responses to a traumatic event (Solomon,
Mikulincer, & Avitzur, 1988). It is possible that the participants in the experimental
writing condition (EW) had more social support and greater coping skill than those in
the other groups. Future studies should assess to what extent participants have access
to social support and the degree of coping skills they possess.
A 1995 study by Petrie, Booth, Pennebaker, Davison, and Thomas examined
whether expressing emotions through writing about stressful or emotional topics
would influence the immunological response to a hepatitis B vaccination program.
Forty medical students in their third year of training volunteered for the study. They
were 19 women and 21 men with an average age of21.5 years from Auckland
University in New Zealand. None of the participants showed any immunity for the
hepatitis B virus. Participants were randomly assigned to write about either emotional
or control topics. Participants wrote in a small, darkened basement room on a
personal computer for 4 consecutive days.
Participants in the control group were asked to write about different aspects
of the use of their time each day and were asked to write in purely descriptive terms
with a minimum use of emotion. The experimental group was asked to write about
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the most traumatic and upsetting experiences of their whole life and to write about the
same topics each day.
Blood for immunological assays was collected on the day after the completion
of the 4 writing days, the day before the group was to receive their first hepatitis B
vaccination. Blood was again collected immediately before the 1- and 4-month
booster vaccinations and at a 6-month follow-up.
The CARMEN software program that measures autonomic activity while
participants are typing text measured skin conductance. In addition, participants were
asked to complete a six-item physical symptom rating and a six-item mood rating
before and after each writing session. Upon completion of each writing session,
participants were asked to rate how personal, meaningful and revealing they were of
their emotions during the writing, and how much they had held back from sharing this
trauma with others.
The Linguistic Inquiry and Word Count (LIWC; Francis & Pennebaker, 1992)
text analysis program was used to objectively measure essay content. Essays were
classified according to emotional expression (e.g., negative or positive) cognitive
strategies (e.g., insight, causation, acceptance), content domains (e.g., friends, school,
sex) and language composition (e.g., pronouns, self-reference, past tense).
Results indicated that the experimental group expressed significantly higher
amounts of negative emotions such as depression, anxiety and anger. This group used
significantly more insight words and rated their essays as significantly more personal
and more meaningful and rated them as covering topics they had before not shared
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with others. Skin conductance levels (SCL) for the experimental group decreased
significantly over the 4-day period. Conversely, the control participants' SCL declined
initially and then increased by the end of the treatment. Pretest measures showed no
differences between groups on the self-reported mood and physical symptom
measures. However, at the end of each writing session,·participants in the
experimental condition reported significantly more sadness and guilt after writing. In
addition, these same participants reported significantly higher scores for "pounding
heart" after each writing session, but no significant differences were noted for other
physical symptoms.
Congruent with the study hypotheses, participants in the experimental group
showed increasingly higher levels of hepatitis B antibodies over time compared with
control subjects. The researchers suggested that changes in immune function
prompted by emotional disclosure may have potentially important health
consequences for the development of protection against infectious diseases. Although
the current study was conducted using healthy adults, its significance may be
applicable in more marginal situations in which individuals have compromised systems
or with vaccinations that are less effective.
Other researchers have begun to point to cognitive changes brought about by
writing as a possible explanation for the physical and psychological health
improvements. Murray and his colleagues (Donnelly & Murray, 1991; Murray et al.,
1989) conducted a series of studies comparing writing therapy to psychotherapy and
examined the critical role of such cognitive changes. Cognitive change was measured
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by judges who evaluated transcripts on the degree to which participants exhibited a
better understanding of the problem as well as an awareness of alternative
explanations for the traumatic experiences. Participants were randomly assigned to
one of three groups: those who wrote about a traumatic experience (WT), those who
talked to a therapist about a trauma (TT), and those who talked to the therapist about
superficial topics (TS). Participants who either wrote about a trauma, or talked to the
therapist about a trauma (WT and TT), expressed greater emotion and evidenced
greater cognitive changes across the 4 days of the study. The WT and TT groups also
self-reported cognitive change. These findings are congruent with those of
Pennebaker (1989) who reported that participants assigned to the experimental group
in his studies consistently report that having written about the trauma allows them to
think about it differently.
Pennebaker and Francis (1996) underscore the difficulty in defining and
measuring long-term cognitive change as a mediator of health improvement.
Particularly problematic is the determination of what dimensions of mental activity
best predict long-term improvement. Another cognitive factor related to the writing
procedure involves the accessibility of the trauma and what Pennebaker and Francis
(1996) call "chronic construct accessibility'' reasoning that writing about an event
should make it more broadly accessible, thus individuals should be able to identify and
recall more dimensions of the trauma. This translates into a kind of automatic
accessibility, which is associated with less effortful, conscious processing of the
trauma one has written about. A third cognitive factor related to writing about a
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trauma is the way it is represented in memory and how that changes by the act of
talking or writing about the incident.
The linguistic coding of the trauma by the process of talking or writing about
it implies some degree of coherence, self-reflection and the use of multiple
perspectives (Clark, 1993). Pennebaker and Francis (1996) reason that, from a
linguistic perspective, the use of certain categories of words should reflect these
cognitive dynamics. For example, individuals who analyze the cause and meaning of
an event are more likely to use causal words and phrases such as because, reason,
cause, etc. People who are trying to work through or understand an event are more
likely to use words associated with insight such as realize, understand, and
reconsider.
Research has also hinted that merely labeling an emotion may actually help
reduce its intensity (Berkowitz & Troccoli, 1990; Keltner, Locke, & Audrain, 1993;
Schwarz, 1990). In this way, feelings about a trauma that are still new and not yet
clearly formed, may be transformed into labeled emotions by the very act of writing or
talking about them (Pennebaker & Francis; 1996). Following this line of reasoning,
simply analyzing the use of emotion words such as angry, happy, sad should indicate
the degree of labeling that has taken place.
Pennebaker and Francis (1996) attempted to identify the degree to which
certain cognitive processes could account for health and behavior changes associated
with writing about emotional events. The researchers recruited students in their first
semester of college and asked them to write about either their deepest thoughts and
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feelings about coming to college, or about superficial topics for 20 minutes a day for
3 consecutive days. The week before and the week after the writing, two cognitive
tasks were administered to tap schematic judgments and construct accessibility
relevant to coming to college.
The essays were analyzed in two ways. The Linguistic Inquiry and Word
Count (LIWC; Francis & Pennebaker, 1992) program was used to evaluate the
degree to which individual's essays contained specific types of emotional and
cognitive words. In addition, judges were asked to rate each essay along similar
dimensions to assess the validity of the LIWC program. Long-term measures of
physician visits, grade point average, and psychological adjustment were also
/

collected. The linguistic ratings of the LIWC and independent judges were then used
together to predict long-term changes in health, grades, and adjustment.
Subjects were 44 female and 28 male college freshman or transfers in their
first semester of college. Participants were assigned to either an experimental writing
(EW) or control writing (CW) group. EW participants were asked to write about
their deepest thoughts and feelings about coming to college. The CW group was
asked to write about any object or event of their choosing, as objectively and
dispassionately as possible. Participants were asked to write for 20 minutes. After the
last writing session, students were administered several self-report measures to assess
their mood and beliefs concerning their essays and the experiment. Participants were
asked to rate the degree to which their essays were personal and emotional, and to
rate the overall value of the experiment for them.
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Six weeks later, on the last day of classes, participants were asked to complete
a final questionnaire assessing how well they had adjusted to college. Two open
ended questions were asked regarding what the participant thought the study was
about and to explain any negative or positive effects it may have had on them. On the
final day of classes, students were debriefed on the study.
The LIWC analyses, unlike that of the judges, indicated that word usage
within and across essays was related to long-term health changes. The more the EW
group increased their use of insight.:.related and causal words, the more their health
improved. The researchers concluded that the use of words such as these indicate that
the students were attempting to understand and find causal meanings for their college
related experiences. Trends in the data also indicated that all students were attempting
to construct coherent narratives. Unexpectedly, the CW participants who used greater
numbers of causal and insight-related words showed declines in measures of health.
Pennebaker and Francis (1996) suggest that the process of trying to find meaning
where there is none may be maladaptive.
Results of the analyses of the expression of emotion in language by
participants were unexpected as well. The use of negative emotion words was
unrelated to long-term health changes. For the EW participants, the more positive
emotion words used, the more their physical health improved. This result is in
contradiction to earlier findings (Pennebaker, 1993), which showed health
improvements in subjects who used more negative emotion words and fewer positive
emotion words than subjects who did not improve. Among the CW group, the more
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positive emotion words and the fewer negative emotion words used, the more doctor
visits they made following the study. Pennebaker and Francis (1996) compare this to
the repressive coping style in which people work to put on a positive impression,
which leads to poorer health (Jamner et al., 1988). They remark on the importance of
examining a variety of personality indicators in future research to compare with
language use.
The language dimensions were correlated with health changes, but were not
correlated with grade improvements, although the writing technique itself was in
general, associated with greater academic performance. The researchers suggest that
other dimensions of writing that are not associated with cognitive or emotional
language directly may be correlated with grades. Pennebaker and Francis (1996)
suggest that future research explore whether people who write about traumas then
ruminate about them less, allows them to focus on schoolwork more effectively.
Further, it may be that, in the short run, writing about the trauma is associated with
more immediate health improvements, but in the long run, may lead to subsequent
cognitive processing which ultimately influences other areas of people's lives (Wegner
& Erber, 1993).
The researchers also emphasize the importance of the writing paradigm itself
It is the participants who chose the topics and directions they agree to disclose.
Perhaps the chosen topics are the driving force influencing health change rather than
language itself They suggest that the analysis of language may reflect important
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cognitive and emotional processes rather than influencing the underlying processes
and suggest further analysis into natural speech and written language.
Other studies have attempted to examine various components of the writing
therapy paradigm, such as the mode of expression. Murray and Segal (1994)
conducted a study to test the hypothesis that the differential effects of psychotherapy
and written expression on residual negative mood were due to the vocal expression
inherent in psychotherapy. Sixty female and 60 male college students were recruited
and randomly assigned to one of four groups. Participants either spoke into a tape
recorder with no one present, or wrote for the same time period. Topics were either
one of the most traumatic experiences of their lives, or trivial topics. The procedure
occurred over 4 consecutive days, and required that each participant write or talk into
the tape recorder for 20 minutes per session.
Results of the study indicated that both writing and talking about a trauma had
therapeutic effects, and equally so. Dependent measures included a mood scale to
assess changes in mood from beginning to end of each session (and from session to
session), pre- and postsession questionnaires to assess recency, painfulness, and how
often the trauma is thought of, and measures on content ratings of all written material.
The two procedures were equally effective in producing change in self-report
measures Iincluding an immediate elevation of negative mood and a slight residual of
negative feelings about oneself. The researchers suggested that this upsurge in
negative mood could potentially result in producing a high drop-out rate, thus limiting
the practical use of the procedure.
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Brewin and Lennard (1999) hypothesized that a randomly assigned group of
college students writing long hand about a stressful event would report greater
arousal of negative affect, greater disclosure, and greater perceived benefit than the
group assigned to write about a stressful event on the typewriter. Participants
demonstrated the ability to type before being assigned to groups. In addition to the
two trauma writing groups, typing trauma (TT) and writing trauma (WT), there were
two control groups: typing control (TC), in which participants were asked to type a
description of the days events; and the writing control group (WC), in which
participants were asked to write long-hand about the day's events.
Results indicated that participants writing long-hand about a traumatic event
(WT) as compared to typing about a traumatic event (TT) did in fact self-report
greater negative affect as measured by the Positive and Negative Affect Schedule
(PANAS; Watson et al., 1988), greater disclosure, and greater perceived benefit.
Brewin and Lennard (1999) suggest that the act of typing may provide an
additional load on working memory, such that, even for moderately experienced
typists, it may reduce the capacity for self-focus and emotional involvement. They
suggest that this may lead to lower subjective distress. Alternatively, it is suggested
that people are more familiar with sharing personal, emotionally laden material using
hand-written expression, and that typing is associated with more impersonal, school
or work-related information.
The study was limited by the student sample and may not generalize to other
populations. In addition, the study looked at a psychologically healthy group of
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people. A study such as this would be useful using more clinically relevant
populations. In future studies, examination of these same variables with subjects for
whom typing is no distraction, i.e., professional typists, could test the hypothesis the
authors suggest regarding the additional loading on cognitive resources.
Research Synthesis of Writing Therapy Studies
A meta-analytic review of the written emotional expression literature was
conducted to evaluate the overall significance and effect size of the brief writing task
(Smyth, 1998). This effect size was examined across three outcome measures:
psychological well being, physical health, and more general functioning. In addition,
this review sought to determine the moderating factors through which the effect of
the writing task could be attenuated or enhanced. The specific factors examined
included participant characteristics, dose, essay content instructions, outcome type,
and publication status. All studies contained a variant on Pennebaker and Beall' s
(1986) original writing task. Only randomized experiments were included and
following the predetermined criterion, 13 studies were examined.
Results of the meta-analysis indicated that written emotional expression
produced significant health benefits in health participants with an effect size of d = . 47
which represented a 23% improvement of the experimental group over the control
group. According to Smyth (1998), this effect size is similar to or larger than those
produced by other psychological, behavioral, or educational treatments (Barnes,
1986; Lipsey & Wilson, 1993; Meyer & Mark, 1995). Smyth (1998) adds that,
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although it is not possible to compare effect sizes between studies when outcome
measures are not the same, this effect is similar to that found in other quantitative
analyses of psychological interventions.
Six moderating variables across three outcome types were found to explain
significant within-group variance in effect size. Overall-effect sizes were moderated by
two variables. A higher percentage of males in a study were related to higher mean
effect sizes, as was longer periods over which writing sessions were spaced.
Psychological well-being effect sizes were moderated by three variables, each
increasing mean effect size: the use of student participants, instructions to write about
current traumas (as opposed to past traumas), and unpublished studies. In addition,
physiological functioning effect sizes were higher in studies that instructed
participants to write about past or current traumas (as opposed to past trauma only).
Student participants were found to have significantly higher effects for
psychological well-being outcomes than non-students. Smyth (1998) suggests that as
non-student participants were on average older than student participants (48.5 years
vs. 18.8 years, respectively), it is possible that more rigid views of the self made it
more difficult for the writing to produce change. However, that age was unrelat�d to
well-being outcomes lessens the plausibility of this explanation.
Results also indicated that writing may be more effective for males than
females. It was suggested that although traditional sex roles make it less likely for
men to disclose a trauma or express emotion than women (Ptacek, Smith, & Zanas,
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1992), they may experience greater benefit from lower prewriting levels of emotional
expression.
The amount of time over which the writing intervention was spaced was
positively related to the overall effect size, implying that lengthening the time course
of the writing task should increase its effect. Similarly, prolonged exposure strategies
are thought to provide greater opportunity for improvement (Foa & Riggs, 1993).
Effect sizes were higher for unpublished studies, contrary to the expectation
of publication bias which assumes that published studies will have higher effect sizes
(Smith, Glass, & Miller, 1980). However, it should be noted that effect sizes were
higher for unpublished studies within only one specific outcome type (psychological
well-being).
The instructional set regarding the trauma participants were to write about
was unrelated to overall effect size, but participants writing about only current
traumas had well-being outcomes superior to those of participants instructed to write
about any trauma (past or current). Smyth (1998) suggested that addressing ongoing
traumas linked more intimately to daily life may produce greater well-being change
than addressing past traumas that may be less relevant to daily experience.
Finally, short-term distress was increased by the writing task and was
unrelated to all long-term outcomes examined. Thus, although all studies reported
mean increases in distress, experiencing relatively more short-term distress does not
appear to lead to greater benefit. This result supports the view that the trauma-related
fear network must be fully activated for improvements to be made (Foa & Kozak,
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1986; Foa, Riggs, Massie, & Yarczower, 1993). However, although short-term
distress may be necessary for cognitive change, the amount of short-term distress was
not related to improvement.
Writing Therapy and PTSD
At the National Center for PTSD in West Haven, Connecticut, researchers at
the V.A. Medical Center have examined the utility of writing therapy in the treatment
of PTSD since the early 1990s (Feldman, Johnson, & Ollayos, 1994). The use of
writing therapy is threefold: (1) writing allows for the preservation of memories and
acts as a defense against anxiety related to death; (2) writing provides an opportunity
for the client to express and overcome shame and to integrate what are often very
fragmented experiences; and (3) writing is a way to bear witness to the horrific
experience of the client, thus bridging the gap between private image and public
language (Feldman et al., 1994).
The V.A. program utilizes writing therapy as part of a larger treatment
program, the goal of which is to place veterans experiences into a developmental
perspective, provide intensive training on management of symptoms and negative
affect, and improving family and community relationships. The program includes
intensive individual, group and family therapy, and creative arts therapies such as
music, drama, poetry, and art therapy.
The program offers a staged approach to treatment in which the writing
therapy generally follows the same sequence. Veterans are required to write, and are
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given structured guidelines in a group setting. They are then required to read their
writing in front of both staff and other veterans, often evoking emotion and
wlnerability. Feedback is given to the veteran by the group in the form of verbal
reassurance and physical comfort. Group members are encouraged to reflect upon
common experiences and discuss differences as well. Finally, the written work is
shared with significant others in the veterans life. In this way, the veteran may partake
in a "corrective experience" of revealing their innermost feelings, and being accepted.
The writing develops over time and moves through several stages. In the
beginning, veterans are resistant to sharing their experiences noted by the defensive
; .

stage. The n�xt stage is characterized by very broad, general writings about
experiences from war. This is called the conventional stage. In the conflictual stage,
the veteran allows his or her internal experience to come forward. The writing at this
stage is often fragmented or confused and is accompanied by affective arousal which
may be so intense that the veteran reverts back to the conventional stage. In the
authentic stage, veterans begin to own their experiences, and express them in
powerful1 clear, emotionally laden writing.
The writing therapy includes several types of writing. Descriptive writing
engages the veteran by asking them to write an autobiography and each of their five
most traumatic memories. Reflective writing requires the veteran to record daily
thoughts in a journal in an attempt to keep the person focused on his or her own
internal process (Fox, 1982; Progoff, 1981). In the creative writing stage, veterans are
encouraged to write poetry to access and symbolize their internal experience. Poetry
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readings are encouraged and toward the end of the program, the poems are copied
and displayed for others to share. In the latter stages of treatment, expository writing
is utilized to communicate with the world about their opinions in one of three forms:
the Book of Remembrance, letters to the living, or the ceremony for the dead.
The Book of Remembrance is derived from the literary and archival work of
Holocaust survivors and stands as a permanent testimony of the veteran's experience.
The letters to the living afford the veteran the opportunity to reconnect with people in
their lives with whom they have lost touch. This is most often family members, but
includes old friends as well. The ceremony for the dead is a tribute to the veteran's
buddies who were killed in combat. The process allows the veteran to complete the
mourning of losses that were avoided during the trauma.
The researchers suggest that it is the externalization of feeling into a concrete
form and the emotional distancing by circumventing personal demands that make the
writing therapy so powerful. In addition, they suggest that the shift in awareness
between the creator and the observer, and the use of consensual language to
communicate to others allows writing therapy to be such a powerful tool in the
treatment ofPTSD (Felman et al., 1994).
More recently, Gidron, Peri, Connolly, and Shalev (1996) examined whether
PTSD patients could disclose their trauma in writing within a brief time and what the
effects of such disclosure might be on their self-reported mental and physical health.
Fourteen trauma survivors seen at a trauma clinic in Jerusalem, Israel were visited in
their homes for the study. Participants were randomly assigned to either the disclosure
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condition (N = 8) or the casual writing control condition (N = 6). Participants in the
disclosure condition were asked to write for 20 minutes on 3 consecutive days about
their most traumatic experiences. In addition, in a brief, predetermined format,
participants were asked to elaborate orally on the most traumatic event about which
they wrote. The control group was asked to report on their daily agenda without
reference to affect, and to describe one daily activity orally.
Upon completion of their writing assignment on the third day, participants
were asked to complete the Positive and Negative Affect Schedules. Five weeks later
they were asked to complete all measures except the Mississippi Scale one more time.
The groups were not significantly different on any of the demographic
variables. However, the amount of time that had passed since the trauma for the
disclosure patients was significantly longer than for the control group. Content
analysis (Pennebaker et al., 1988) of the writing samples indicated that disclosure
participants wrote significantly more self-reference words (e.g., I, me), emotional
words (e.g., afraid, anxious), physical words (e.g.,painful, headache), and total
number of words. In addition, the disclosure group reported higher state-negative
affect at Day 3 than did the control group.
At 5 weeks, the disclosure patients reported relatively larger increases in the
number of health care visits. The percentage of written emotional words was.
positively correlated with the avoidance and intrusive symptom measures of the
Impact of Events Scale and the percentage of written physical words was positively
correlated with the number of health care visits at follow-up.
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These findings do not support the findings of previous studies with mentally
healthy subjects (Pennebaker et al., 1988, 1989) in which participants who disclosed
their trauma improved on measures of subjective distress. The researchers suggested
several possible explanations for their findings. The PTSD patients in their disclosure
sample may have failed to use coping resources to benefit from the trauma elicitation/
exposure (Pitman et al., 1991) and may have a neuropsychological difficulty in
extinction of their trauma-related responses (Charney, Dutch, Krystal, Southwick, &
Davis, 1993).
It was also suggested that the short writing sessions might not have had a
sufficient effect on PTSD patients. In essence, these patients may require longer
writing sessions in order to exhaust their conditioned aversive responses (Stem &
Marks, 1973) and may require a longer period of time after disclosure to reevaluate
the probability of threat (Foa et al., 1991) and resolve the trauma.
This study was limited by a small sample size and a lack of objective health
outcomes. Overall results of the study suggest that written disclosure with coping
skills training may be recommended for PTSD patients due to the negative
consequences of trauma disclosure for PTSD patients in this sample.
Largo-Marsh and Spates (1997) compared EMDR to a structured writing
therapy intervention. Twenty-four male and female participants were recruited and
met criteria A (experience of a traumatic event) and at least one of the remaining
criteria including re-experiencing of the event, persistent avoidance of thoughts or
activities, or hyperarousal. Subjects were randomly assigned to one of the two
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treatment conditions, participating in up to three 1-hour sessions ofeither EMDR or
structured writing directed at PTSD symptoms associated with a referenced traumatic
event. The Computerized Diagnostic Interview Schedule (CDIS; Robins et al., 1981)
was used to determine the presence ofPTSD symptoms. At the time ofintake, 18 of
the 24 participants met full DSM-IV criteria for PTSD (APA, 1994) for at least one
traumatic event. In addition, participants completed the SCL-90-R and the Impact of
Events Scale to monitor symptom change over the course ofthe study. Each was
administered during the initial screening, posttest and follow-up.
The State-Trait Anxiety Inventory (Form Y) (STAI; Spielberger, Gorsuch,
Lushene, Vagg, & Jacobs, 1983) was used to assess participants' subjective
experience ofanxiety at pretest, posttest, and follow-up, along with several measures
specific to the EMDR treatment protocol (SUDs; Wolpe, 1990; VoC; Shapiro, 1991).
The two treatments were similar in several ways. Both began with an
explanation ofand rationale for the treatment. The therapist remained with the
participant in both treatments, asking the subjects to periodically provide ratings of
subjective distress (SUDs) or VoC ratings. The therapist would direct the subject to
focus on the cognitive, emotional, and sensory aspects ofthe traumatic event as well.
The procedures for the two treatments were different, with different criteria for
termination for each. For the EMDR subjects, treatment was terminated when the
VoC score was self-reported as 6 or 7 (out ofa possible 7) at two consecutive
assessments. Termination for the writing therapy sessions was independent ofthe
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VoC scores, as participants in the writing therapy sessions were not asked to provide
VoC ratings, and consisted of only two consecutively low (0, 1, or 2) SUDs ratings.
Results of the study indicated that subjects evidenced an overall reduction in
symptoms at follow-up. Consistent with the findings of Pennebaker (1993), many
subjects evidenced greater arousal levels at the conclusion of the writing sessions, as
indicated by the STAI scores taken at the beginning and end of the first treatment
session for the writing subjects. Both EMDR and the writing procedure were effective
in significantly reducing posttraumatic symptoms and were statistically
indistinguishable from one another in this regard. However, process measures within
sessions, namely SUDs and VoC scores suggested patterns of improvement within
sessions, with a more pronounced reduction occurring between pre- and posttest in
the EMDR
group, sometimes followed by a slight increase in symptoms reported at
.
'

follow-up. In contrast, the writing therapy subjects reported a more gradual and
continual amelioration of symptoms, with characteristically more noticeable
reductions between posttest and follow-up assessments. For both groups, treatment
gains were largely maintained at follow-up, which was taken about 1 month after
posttest.
A variant of Pennebaker' s writing paradigm was developed by Gidron et al.
(2001). The researchers developed the Memory Structuring Intervention (MSI) in
which therapists approached thetrauma survivors with an a priori set of time periods.
The therapist listened to and clarified details of the trauma given by the participant
according to these time periods. The therapist then repeated th� trauma narrative in
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an organized, labeled, and logical manner, and added insightful comments where
appropriate. The participant was asked to repeat this newly constructed version of the
trauma back to the therapist. The participant was then asked to practice the re-telling
of the constructed version of the trauma to friends and/or family members in an effort
to enhance the attempted memory shift. The participant then rehearsed the retelling
one additional time with the therapist.
Using this model for the intervention, the researchers compared MSI to a
supportive-listening control group in a single-blind randomized-controlled design.
Subjects were 17 men and women survivors of a motor vehicle accident who
presented to the ER no more than 24 hours after the accident. Participants exhibited
no brain damage, were released from the ER within 24 hours of admission, thus
exhibiting only minor injuries. In addition, participants had a heart rate greater than or
equal to 95 beats per minute (a predictor of PTSD; Shalev et al., 1998).
Participants were interviewed by phone and a total of 17 participants took part
(n = 9 supportive listening; n = 8 MSI). Following the intervention, participants were
contacted 3 to 4 months later for follow-up evaluation of symptoms.
At follow-up, MSI participants reported significantly less frequent total PTSD
symptoms, including intrusion and arousal than the supportive listening group. No
significant differences were found in relation to avoidance symptoms. Although
preliminary, these results present promising possibilities for the prevention of PTSD.
The study was limited in several ways. Participants experienced a specific type
of trauma (motor vehicle accident). Follow-up studies utilizing larger populations

73

with varying traumas would help to confirm results as well as provide data regarding
generalizability of the results. In addition, no baseline levels ofPTSD symptoms were
taken which makes it impossible to say that symptoms were actually reduced by the
intervention. Finally, it was noted that the MSI participants received more attention
(time on i;he telephone) from therapists than controls, which may have influenced
results.
Brown and Heimberg (2001) also examined the effect of disclosing traumatic
memories to others. This study included 85 women college students who reported
being victim of either an attempted or completed rape. The researchers utilized a
2 x 2 design and compared writing about only factual information versus writing
about factual information and emotional response, as well as reading to oneself versus
reading to another woman. Pretest measures and I-month posttest measures were
taken to assess symptoms of dysphoria, social anxiety, and PTSD.
Results of the study indicated that rape victims who read their narratives to
another female did not experience greater improvement after 1 month than those who
read alone. In addition, rape victims who wrote about the facts and the emotional
response to the trauma did not show greater improvement in symptoms than those
who wrote about the facts only.
This study also examined the content of the written material to see whether
the degree of disclosure was associated with symptom reduction. Improvement was
predicted by two indices of degree of disclosure; the number of words (degree of
detail) and the number of self-references (degree of personalization). The number of
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words in the narrative was associated with the likelihood of sharing the trauma with
another ptrson during the I-month follow-up period. A curvilinear relationship was
shown between the number of self-references and symptom reduction. Thereby, a
moderate number of self-references was associated with a decrease in symptoms and a
high or low level associated with increased social anxiety.
The study was limited in that there was no true control condition such as
writing about a trivial event. In addition, participants sat face-to-face affording no
confidentiality or anonymity between participants, which may have increased anxiety
levels. Finally, participants also wrote on only one occasion, and without corrective
feedback. It was suggested that because of the severity of the trauma of rape, this
may not be a sufficient intervention for significant symptom improvement.
Problem Statement
Thus, a number of studies have suggested that writing about traumatic
experiences may have significant mental and physical health benefits (Feldman et al.,
1994; Largo-Marsh & Spates, 1997; Pennebaker & Francis, 1996; Pennebaker et al.,
1988; Petri et al., 1995). The current study was designed to assess the treatment
efficacy of writing therapy for individuals with varying degrees of stress related
symptoms. Specifically, the study examined to what extent writing therapy was useful
in reducing the symptoms of clinically significant levels of Post-Traumatic Stress
Disorder as measured by the CAPS-DX. In addition, this study examined the extent
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to which writing therapy was effective in reducing symptoms of burnout as measured
by the Maslach Burnout Inventory.

CHAPTERID

METHOD
Participants
Participants were recruited from the Kalamazoo, Michigan community
through newspaper advertisements and public postings (Appendix A). In addition,
classrooms on the Western Michigan University (WMU) campus were canvassed.
Participants were also recruited from the Cincinnati Metropolitan area via postings at
Xavier University in Cincinnati, Ohio (Appendix B), fliers posted at the Cincinnati
V.A. Medical Center (VAMC� Appendix C), and referrals from V.A. clinicians.
Brochures describing the study were also distributed throughout these areas
(Appendix D). Fifty-four participants volunteered to participate.
Potential participants were males and females 18 years and older who, by their
own report, either had experienced a traumatic event or were involved in a distressing
work situation. Participants were included in the study if they either met diagnostic
criteria for PTSD as measured by the Clinician Administered PTSD Scale or scored
"high" on both emotional exhaustion and depersonalization on the Maslach Burnout
Inventory.
In addition, participants were assessed for comorbid psychiatric diagnoses to
exclude individuals with concurrent DSA!-JVborderline and obsessive-compulsive
personality disorder characteristics, or reported symptoms of psychosis. These
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symptoms were assessed using a questionnaire developed by Cusack (Cusack &
Spates, 1999) and modified for this particular study. Participants were also excluded
if they reported suicidal ideation. During recruitment at the Cincinnati VAMC and
Xavier University, potential participants were also assessed for Major Depressive
Disorder. Those who met criteria for the disorder were ·subsequently referred for
medication evaluation prior to being accepted into the study. Lastly, participants who
were currently receiving psychotherapy or had not been stable on antidepressant
medication for at least 8 weeks were excluded. Ineligible volunteers were referred for
alternative treatment.
Setting
Assessment and treatment sessions were conducted in private therapy rooms
at the WMU Psychology Clinic, in private therapy rooms at the Cincinnati V.A.
Medical Center, or in private therapy rooms on the campus of Xavier University. All
assessment and therapy sessions were directed by trained research assistants and were
supervised by a licensed clinical psychologist.
Assessors and Therapists
All assessors and therapists were trained in the study procedures. Specifically,
instructions were followed for each session including specific instructions that the
research assistant read to the participants. All assistants received copies of the
assessment instruments as well as a study manual. Training sessions included verbal
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explanation of the study procedures and assessment instruments. In addition, research
assistants observed and then participated in "mock" sessions. Each assistant then
observed actual assessment and treatment sessions prior to completing these on their
own. Following training in the assessment and treatment sessions, the research
assistants were supervised an:d observed by the investigator. All assistants attended
regular team meetings to provide further clarification and training and to answer
questions throughout the course of the study.
Sixteen research assistants completed the assessment, treatment, and follow
up sessions. Thirteen of these assistants were undergraduate students majoring in
psychology from Western Michigan University. Two of these undergraduate students
served as Study Coordinators and assisted in scoring and recording data. One
assistant was a graduate student in the doctoral program in clinical psychology at
Western Michigan University. Three research assistants were undergraduate
psychology majors from Xavier University in Cincinnati, Ohio. Research assistants
conducted a majority of the screening and treatment sessions. In addition, assistants
who conducted an assessment session for a given participant did not conduct
treatment sessions for the same participant.
Measures
Two questionnaires developed by the researcher were used in this study. The
first was used for screening purposes at the beginning of the study. The second asked
about health center visits before, during, and after the study. In addition, several
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standardized clinical assessment instruments were used in this investigation. These
included the Life Events Checklist, Clinician Administered PTSD Scale-Current and
Lifetime Diagnosis Version (CAPS-DX; Blake et al., 1990, 1997), Maslach Burnout
Inventory (MBI; Maslach & Jackson, 1981) and accompanying demographic
questionnaire, Shipley Institute of Living Scale (Shipley, 1953), State-Trait Anxiety
Inventory (State Version; STAI-S; Spielberger et al., 1983), Beck Depression
Inventory- II (BDI-II; Beck, Steer, & Brown, 1996), Coping Resources Inventory
I

(CRI; Hammer & Marting, 1987), and Physical Health Questionnaire (PHQ; Bellville,
personal communication, 2002).
For participants recruited at the Cincinnati VAMC, an additional questionnaire
regarding DSM-IV diagnostic criteria for depression was included as recommended by
the University of Cincinnati Human Subjects Institutional Review Board. Participants
who endorsed symptoms indicative of a diagnosis of Major Depressive Disorder were
referred to their primary care physician for medication evaluation and medication
stabilization prior to entering the study.
Personality Questionnaire
A personality assessment based upon DSM-IV criteria for borderline and
obsessive-compulsive personality disorders was revised for use in this study (Cusack
& Spates, 1999). Questions assessing for psychotic thinking were added to the
original assessment and questions were reorganized. Subjects were read a list of 18
statements and asked to indicate "How often do you find yourself . . ." reacting to
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each situation. Scale scores of"0" (Not at all), "1" (Sometimes), or "2" (Frequently)
were used. Scores for each of the personality or thought disorders (Obsessive
Compulsive Personality Disorder, Borderline Personality Disorder, and Psychoticism)
were added together and then divided by the total number of questions for that
category (averaged). If the average score for any of the three categories was greater
than 1, indicating the presence of personality disorder characteristics, the participant
was excluded from the study.
Clinician-Administered PTSD Scale for DSM-W (CAPS-DX)
The CAPS-DX is a 30-item clinical interview developed to measure typical
signs and symptoms ofPTSD. The instrument provides a method to evaluate the
frequency and intensity of individual symptoms within the past month, as well as
assessing the impact of these symptoms on social and occupational functioning.
The majority of currently published psychometric data utilizes the original
CAPS instrument. However, two articles, submitted for publication, provide
information on the most comprehensive investigations of the psychometric properties
of the CAPS (Weathers et al., 1999). The CAPS-1 has adequate psychometric
properties and specific care was taken in the development of the CAPS-DX to ensure
backward compatibility to the original version (Weathers et al., 1999). Test-retest
reliability for the CAPS-1 ranged from .77 to .96 for the three symptom clusters and
.90 to .98 for all 17 items. Internal consistency (alpha coefficients) for the severity
scores (frequency and intensity) for each of three symptom clusters ranged from .85
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to .87 and internal consistency for all 17 items was .94. Convergent validity for the
total severity score of the instrument was r = .91 for the Mississippi Scale for
Combat-related PTSD (Keane, Caddell, & Taylor, 1988) and r = .77 for the PK scale
of the MMPI (Keane, Malloy, & Fairbank, 1984).
The Maslach Burnout Inventory (MBD
The MBI (MBI; Maslach & Jackson, 1981) was used to assess feelings and
attitudes about one's job. Three versions of the inventory are available. These include
the Human Services Survey (MBI-HSS; Maslach & Jackson, 1996), which was
designed for professionals in the human services; the Educators Survey (MBI-ES;
Maslach & Jackson, 1996) designed for use with educators; and the General Survey
'

'

(MBI-GS; Schaufeli et al., 1996) designed for use with workers in occupations other
than human services and education. However, no participants reported employment in
an educational field, so this measure was not utilized.
The MBI-Human Services Survey yields scores on three subscales: emotional
l i

•

exhaustion, depersonalization, and personal accomplishment. High scores on the
emotional exhaustion subscale are indicative of emotional overextension or being
worn out by orie's job. High scores on the depersonalization subscale are indicative of
a lack of con�rn or feeling for one's clients. Low scores on the personal
accomplishment subscore reflect feelings of incompetence or ineffectiveness in one's
work. s·eparate scores are attained for each subscale to reflect the degree to which an
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individual experiences these feelings related to his or her job. The MBI thus yields a
total of three subscales for each form used.
The MBI-HSS has adequate psychometric properties and is widely used in
burnout research. On the basis of the normative sample, internal consistency
(Cronbach's alpha) ranged from 0.89 to 0.74 across the six subscales. Test-retest
reliability coefficients at 2- to 4-week intervals were as follows: .82 (frequency) and
.53 (intensity) for Emotional Exhaustion, .60 (frequency) and .69 (intensity) for
Depersonalization, and .80 (frequency) and .68 (intensity) for Personal
Accomplishment. The authors attribute the lower reliability of the intensity subscales
to the changeable nature of feeling states. All coefficients were significant beyond the
.001 level.
Convergent validity coefficients ranged from 0.61 between the Maslach
Burnout Inventory and the Meier Burnout assessment, to 0.65 between the Maslach
Burnout Inventory and the burnout self-rating. However, measures of burnout were
also highly correlated with depression, thereby weakening support for burnout's
discriminant validity.
The MBI Human Services Demographic Data Sheet was used to identify the
subjects' age, sex, race, religion, marital status, education and employment-related
information. The entire questionnaire took about 10 minutes to complete.
The MBI-General Survey was developed to assess burnout in occupations
without direct personal contact with service recipients or with only casual contact
with people. This assessment has three subscales including Exhaustion (Ex), Cynicism
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(Cy), and Professional Efficacy (PE). Both the Exhaustion and Professional Efficacy
subscales of the MBI-GS are similar to the Exhaustion and Personal Accomplishment
subscales of the MBI-HSS, respectively. The Cynicism items on this survey reflect an
indifferent attitude toward work, referring to the work itself rather than to personal
relationships with people at work as in the Depersonalization subscale of the MBI
HSS. Similar to the MBI-HSS, a high degree of burnout is demonstrated by high
scores on both Exhaustion and Cynicism subscales and low scores on Professional
Efficacy.
A series of principal component analyses demonstrated that Exhaustion was
associated with mental and physical strain, work overload, and role conflict at work.
Professional Efficacy was related to satisfaction, organizational commitment, job
involvement, and access to resources. Cynicism was primarily related to the same
constructs as Exhaustion but with negative secondary loadings on the attitudinal
constructs associated with Professional Efficacy. Reliability studies showed stability
coefficients of .65 (Exhaustion), .60 (Cynicism), and .67 (Professional Efficacy) at a
1-year interval (Leiter & Durup, 1996).
A Demographic Data Sheet was not provided with the MBI General Survey
so one was developed by the researcher. This Demographic Data Sheet identified the
, subjects' age, sex, race, religion, marital status, education and employment-related
information. The entire questionnaire took about 10 minutes to complete.
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Shipley Institute ofLiving Scale
The Shipley Institute of Living Scale was used as an assessment ofgeneral
intellectual functioning in participants. The scale consisted oftwo, time-limited, self
administered subtests: a 40-item test ofvocabulary and a 20-item test ofabstract
thinking. Participants were allowed 10 minutes to complete each subtest. The
vocabulary portion is a multiple-choice format in which participants were asked to
choose which offour words most closely defines the targeted word. The abstraction
portion asked that participants fill in blanks with letters or numbers to logically
complete the presented sequence.
Psychometric properties of the instrument are adequate with test-retest
reliability coefficients ranging from 0.60 to 0.82 for Total score and an internal
consistency of0.92 for the Total score. Correlations between the Shipley and the
WAIS (Wechsler Adult Intelligence Scale; Wechsler, 1955) IQ range from .73 to .90
with a median correlation of0.79. A correlation of0.74 was reported between the
Shipley Total score and the WAIS-R (Wechsler Adult Intelligence Scale-Revised;
Wechsler, 1981) IQ score.
State-Trait Anxiety Inventory (State)
The state portion ofthe State-Trait Anxiety Inventory, Form Y (STAI;
Spielberger et al., 1983) was used to assess the degree ofanxiety experienced by the
participants. The inventory consists of20 items designed to measure state experiences
of anxiety. State anxiety refers to the affective response to a particular situation, in
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contrast to Trait anxiety, which is considered to be a more stable, long-standing
quality ofaffect ofthe person.
Item responses for the State inventory include endorsement scores of1-Not
at all, 2-Somewhat, 3-Moderately So, and 4-Very Much So. Scores are then
summed and may range from 20 to 80. Psychometric properties ofthe inventory are
adequate. The test-retest reliabilities for the State-Anxiety section ofthe test are
expectedly low, since the instrument measures a temporary condition. Alpha
coefficients for the internal consistency ofthe Trait and State-Anxiety scales range
from .83 to .92. Spielberger et al. (1983) correlated the instrument with the IPAT
Anxiety Scale and achieved a validity coefficient of.75, and with the Taylor Manifest
Anxiety Scale, for a validity coefficient of.80.
Beck Depression Inventory-IT
The Beck Depression Inventory-IT (BDI-IT� Beck et al., 1996) was
administered in order to measure the degree ofsyndromal depression (e.g., the
number ofstatements ofdepressed mood each participant endorsed such as sadness,
negative self-concept, sleep, and appetite disturbance). The inventory consists of21
items, each with four numbered statements which may be scored from O (denoting a
normal mood) through 3 (denoting a depressed mood). The scores for these 21 items
are summed to give a total score between O and 63. A score of0-8 indicates a normal
mood, 9-13 minimal depressive symptoms, 14-19 mild depressive symptoms, 20-28
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moderate depressive symptoms, and 29-63 indicating severe levels of depressive
symptoms.
The psychometric properties of the instrument are adequate, with a test-retest
correlation of .93 after 1 week. Convergent validity of the BDI-11 with the Hamilton
Psychiatric Rating Scale for Depression (HRSD; Hamilton, 1960) was r = . 71.
Discriminant validity was demonstrated by correlation with the Hamilton Rating Scale
for Anxiety (HARS; Hamilton, 1959) ofr = .47.
Depression Screen
The Depression Screener was added prior to data collection at the Cincinnati
VAMC and Xavier University as required by the University of Cincinnati Human
Subjects Review Board. The screening instrument was derived from the DSM-IV
diagnostic criteria for Major Depressive Disorder and questions regarding depressive
symptoms were taken directly from the DSM-IV (APA, 1994).
The Coping Resources Inventory (CRI)
The CR.I {Hammer & Marting, 1987) is a 60-item inventory that measures
coping resources or "those resources inherent in individuals that enable them to
handle stressors more effectively, to experience fewer or less intense symptoms upon
exposure to a stressor, or to recover faster from exposure" (Hammer & Marting,
1987). The CRI distinguishes five domains of coping resources: cognitive, social,
emotional, spiritual/philosophical, and physical. The inventory can be completed in
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about 10 minutes. Internal consistency reliability using Cronbach' s alpha is . 91 for the
Total Resources score and range from .71 to .84 for the subscales. Test-retest
reliability at 6 weeks was . 73 for the total score. Convergent validity coefficients
ranged from .61 for the Spiritual/ Philosophical scale to .80 for the Physical scale.
These constructs were measured against simple self-ratings of coping resources.
Physical Health Questionnaire
Participants were also asked to complete a 12-item self-report paper and
pencil instrument designed to assess overall physical health. This instrument provided
information on the health status of subjects and was used to evaluate the relationship
between physical health and traumatic stress. The instrument was developed by
Bellville (personal communication, 2002) for use with research on PTSD and takes
about 10 minutes to complete.
Health Care Visits Questionnaire
A I-item questionnaire was developed by the researcher to ascertain the
number of visits to health care professionals due to illness. Visits were assessed for 2
months before the study, during the study and at 1- and 2-month follow-up sessions.
Illness was defined as any presenting complaint that could be attributed to an acute
infection or other internal cause related to injury. Regular check-ups, health
prevention (e.g., flu shots) or maintenance (allergy shots), or other routine tests (PAP
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smears) were not counted as illness visits. More than one visit to the physician for the
same complaint in an 8-day period was coded as a single visit.
SUDs Rating Sheet
A rating sheet was developed by Cusack (Cusack & Spates, 1999) and revised
for this study. The researcher asked the participants to rate their "Subjective Units of
Distress" (Wolpe, 1990) on a scale from 1 to 10 with "l" indicating no distress and
"10" indicating the most distress the participant has ever experienced. Distress was
rated with respect to their present level of discomfort about the traumatic event or
stressful work environment about which they were writing. The researcher then
recorded that rating on the sheet. SUDs ratings were taken at the pretest session, at
each of the treatment sessions and at posttest.
Research Procedure
Individuals expressing interest in the study contacted the student researcher by
phone. After a brief description of the study was provided, the potential participant
was queried regarding traumatic experiences, posttraumatic symptoms, and job
related stress. If the individual seemed appropriate for the study, an intake
appointment was scheduled.
Informed consent for participation was obtained at the intake session
(Appendices E, F, G). At this time, participants were informed that they could seek
alternative treatment for their symptoms at any time in conjunction with or as
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replacement for the treatment in the study. If the participant chose to seek alternative
treatment, he/she was informed that the data from the study would not be used in the
study results. In addition, participants were made aware that they could contact the
student researcher at any time during the study if problems or questions arose.
A version of the Maslach Burnout Inventory (MBI} was administered based ·
upon the participant's occupation as well as the accompanying demographic
questionnaire. Subjects were also administered the Life Events Checklist to assess for
traumatic experiences. The Personality Questionnaire was then administered to
determine if a participant should be excluded on the basis of Obsessive Compulsive or
Borderline Personality Disorder characteristics or evidence of psychosis (Appendix
H). Subjects were notified as soon as possible regarding their inclusion status in the
research study, in most cases at the conclusion of the first screening session. Those
who were excluded were given the reason for exclusion and a referral to a local
practitioner if deemed necessary. A list of mental health resources (Appendices I, J)
was made available to all persons coming in for the intake session regardless of
qualification for the study.
Upon successful completion of the intake, participants were scheduled for the
90-minute assessment session. At the beginning of the assessment session, the
assessor interacted with subjects to establish rapport; clarified what the participant
could expect during the session; and ensured the subject's comfort, safety, and
willingness to continue participation.
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At pretest, subjects were administered the Shipley Institute of Living Scale.
This scale took approximately 20 minutes to administer. The Shipley was given first
to avoid the interference in cognitive abilities due to increased distress at being
reminded of the trauma, that might have resulted from administration of the CAPS
DX.
Participants were then assessed for PTSD using the CAPS-DX clinical
interview. This interview took approximately 45 minutes. Participants who endorsed
no traumatic events on the Life Events Checklist, or reported few or no distressing
responses to a trauma, were not interviewed using the CAPS-DX. These participants
were considered part of the "Chronic Stress Group" if the scores on the MBI were
sufficient. Participants who did not meet criteria for a diagnosis of PTSD were
informed that they did not qualify for the study and were given the Mental Health
Referral sheet.
Following the CAPS-DX, participants were asked to rate their current level of
comfort with respect to the traumatic event (SUDs level) (Appendix K). Participants
then completed the STAI- State, BDI-II, Depression Screener (Appendix L), Physical
Health Questionnaire (Appendix M), Health Care Visits Questionnaire (Appendix N),
and the Coping Resources Inventory. These self-report measures took about 45
minutes to complete. Subjects were then advised of and scheduled for the treatment
sessions. Participants who met criteria for PTSD were placed in the PTSD group
regardless of their score on the MBI. Participants who did not meet criteria for
PTSD, but did meet criteria for Burnout, were placed in the Burnout Group.
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Participants were phoned prior to treatment sessions to remind them of the
date and time of their appointment that week (Appendix 0). Treatment consisted of
four weekly sessions, each 30 minutes in duration. The rationale for and importance
of attending each session each week for all 4 weeks was emphasized at that time.
Participants were shown to a private therapy room with observational capacities. If
observational capacities were not available, the researcher was available outside the
room for assistance if needed. Participants were given paper and a writing utensil.
Standardized instructions on writing about their trauma or difficult work situation
were read to the participant (see Appendix P). The structured writing treatment was
targeted at the traumatic event or difficult work situation that the participant
identified as most presently distressing. Participants were asked to visualize the event
and were then asked to write about it. They were asked to include a narrative of the
trauma or difficult situation that occurred as well as their thoughts, emotions, and
physical sensations associated with the event.
At the end of each writing therapy session, the therapist read over the material
for an informal assessment of the level of distress the participant was experiencing. In
addition, participants were administered the BDI-11 and STAI- S. These assessments
were scored before the participant left the treatment session to assess for suicidality
or excessive anxiety due to the writing treatment so that appropriate measures could
be taken if necessary.
Upon completion of the BDI-11 and STAI-S, participants were asked to
remain in the therapy room to relax.for several minutes before leaving. After a period
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of relaxation, participants were asked to rate their level of comfort with respect to the
traumatic event or difficult work situation about which they wrote (SUDs level). If
the participant reported a SUDs level of 8 or less, they were permitted to leave the
treatment situation without further intervention. However, if a participant had
reported a score of 9 or 10 on the SUDs, additional measures would have been taken
to calm the patient before allowing them to leave the treatment session. No
participants reported levels of SUDs higher than 8 during the study, thus no additional
treatment or services were necessary for any participants.
One week after the final treatment session, participants were administered the
CAPS-DX, MBI, STAI-S, BDI-Il, CRI, and questionnaire regarding health care
visits. They were also asked to rate their level of comfort with respect to the
traumatic event or stressful work situation (SUDs level). At that time a 1-month
follow-up appointment was scheduled. Participants were given four Beck Depression
Inventory-Ils (BDI-11) along with stamped envelopes addressed to the student
investigator. This was so that depressive symptoms and suicidal ideation could be
monitored between sessions. Participants were phoned weekly to remind them to mail
their BDI-Ils in to the researcher. One month after the posttest assessment, the
CAPS-DX, MBI, STAI-S, BDI-Il, CRI, questionnaire regarding health care visits,
and rating of their level of comfort with respect to the traumatic event or difficult
work situation (SUDs level) were again administered. At the completion of the 1
month follow-up session, a 2-month follow-up session was scheduled and an
additional four BDI-Ils and stamped, pre-addressed envelopes were given to the
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participant. Again, participants were phoned weekly in order to remind them to mail
the BDI-Ils in to the researcher. At the second follow-up session, the CAPS-DX,
MBI, STAI-State, BDI-II, CRI, and health care visits questionnaire were then
administered for a final time. At the completion of the final follow-up session,
participants were debriefed on the study (Appendix Q). In addition, if the participant
desired further treatment, he/she was directed to the list of mental health facilities
given at the beginning of the study.
If at any time during the study a participant displayed signs of personal
distress of sufficient magnitude to warrant interruption of the interview or treatment,
the session would have been terminated with minimal effort to calm the participant.
However, no participants required additional procedures during any of the treatment
sessions.
Research data for each participant were kept in personal folders in a locked
filing system at either the WMU Psychology Clinic or the Cincinnati V.A. Medical
Center. Maintaining these file systems and participant folders was the responsibility of
the student investigator. A master list of participant information (Appendix R) was
used to ensure the confidentiality of the research data. Only coded research numbers
assigned to each participant linked participant information to the research file. All
participant data files will be kept at either the WMU Psychology Clinic or the
Cincinnati V.A. Medical Center for 3 years following completion of the study. At that
time, hard copies of the data will be destroyed.

CHAPTER IV
RESULTS
Hypotheses
For this investigation, it was hypothesized that writing therapy would reduce
symptoms ofPTSD and Burnout in individuals endorsing significant levels ofrelated
distress. Principal measures included outcome ratings on the Clinician Administered
Post-traumatic Stress Scale (CAPS-DX) and the Maslach Burnout Inventory (MBI).
Participants were randomly assigned to groups based upon meeting inclusion criteria
which included threshold scores on the CAPS-DX structured interview and the MBI
questionnaire.
It was also hypothesized that reported symptoms ofdepression, as measured
by the Beck Depression Inventory-II (BDI-11) would decrease significantly across
assessment sessions for each group.
Reports ofanxiety, as measured by the State-Trait Anxiety Inventory (State
Form) STAIS-S and Subjective Units ofDistress (SUDs) were expected to first
increase, at the start oftreatment, and then to decrease across later treatment,
posttest, and follow-up assessments. This measure was intended to reflect the process
ofchange across sessions.
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Finally, it was hypothesized that as reported symptoms of burnout and PTSD
decreased, there would be an increase in reported coping skills. It was also
hypothesized that as symptom levels decreased, health center visits would decrease.
Plan for Data Analyses
In order to test these hypotheses, the study examined symptom reports within
and between groups across assessment phases (pretest, posttest, and 1- and 2-month
follow-up). Within group analyses examined the change in reported levels of
symptoms associated with either PTSD, as measured by the CAPS-DX, or Burnout as
measured by the Maslach Burnout Inventory. Between group analyses examined the
degree of change in reported levels of anxiety, as measured by both the STAI-S and
SUDs ratings, and depressive symptoms, as measured by the BDI-II to determine
whether change occurred in these symptom reports. Significant differences in the
degree of reported change between these groups was also examined.
In order to control for drop out and missing data, a carry forward analysis was
then conducted within each group. This analysis consisted of carrying forward the last
data point for each of the subjects who had missing data or did not complete one or
more assessment sessions after pretesting.
The second hypothesis was examined using a two-way repeated measures
ANOVA to determine ifBDI-II scores differed significantly within groups across
assessment phases as well as between groups. In addition, these scores were
examined for change across treatment sessions. Again controlling for drop out, carry
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forward analyses were then conducted across assessment phases and then across
treatment sessions.
In order to test the third hypothesis, two-way repeated measures ANOVAs
were used to determine if there were significant decreases in symptom reports on the
STAI-Sand SUDs ratings within treatment sessions, across assessment times, and
across groups. Carry forward analyses were then completed to address loss of data
due to participant drop out or missing data.
For the final hypothesis, the planned correlational analyses on the use of
coping skills as measured by the Coping Resources Inventory and the number of
Health Center Visits could not be conducted due to the lack of significant
improvement in symptoms. Independent sample t tests were then conducted to
determine if differences between groups existed on these measures.
Preliminary Analyses
Twenty-five participants began treatment. Of those, I participant dropped out
following the second treatment session (PTSD group), I dropped out following the
third treatment session (PTSD group), and 2 dropped out following the fourth
treatment session (PTSD group).
Twenty-one participants completed posttest (PTSD n = 12; Burnout, n = 9).
Two participants dropped out following posttest (PTSD group) and 3 following the
I-month follow-up session (2 in the PTSD group and I participant in the Burnout
group). Eight participants completed the study through 2-month follow-up in the
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PTSD group representing a drop out rate of 50.00% from pretest. Eight participants
completed the study through 2-month follow-up in the Burnout group representing a
drop out rate of 11.11%. Table 1 depicts the dropout for each group for each session.
Table 1
Summary of Group Dropout by Time
Time

Group
PTSD

Burnout

16

9

Treatinent 1

0

0

Treatment 2

1

0

Treatment 3

1

0

Treatment 4

2

0

Posttest

2

0

1 month follow-up

2

1

Completed

8

8

Pretest

Although the rate of attrition for the PTSD group was high, no significant
differences were found in pretest CAPS scores between those who completed the 2month follow-up assessment and those who did not, t (15) = -.76, p = .46. Nor were
significant differences found in pretest MBI Emotional Exhaustion scores, t (7) =
-1.04, p = .33 or the Depersonalization/Cynicism scores, t (1) = -.92, p = .39,
between those who completed the 2-month follow-up and those who did not. This
indicated that individuals who dropped out were not more or less distressed at pretest
than those who completed the study.
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Demographics
Table 2 presents a summary of demographic characteristics for the 21
participants who completed posttest by group. Independent samples t tests and chi
square calculations were conducted to compare means between groups.
In the PTSD group (n = 12), ages ranged from 21 to 77 years (M = 45.58; SD
= 14.56). In the Chronic Stress or Burnout group (n = 9), ages ranged from 25 to 64
years (M = 40.33; SD= 12.19). There was no significant difference in the ages of
participants in the PTSD group and the Burnout group,·! (19) = .88,p = .39).
In the PTSD group, 7 participants were male (58.3%) and 5 participants were
female (41.7%). For the Burnout group, all 9 participants were female (100.0%).
There was a significant difference in gender between the groups Pearson chi-square
(1) = 7.88,p = .005).
In the PTSD group, 11 participants were Caucasian (91.7%) and 1 participant
was African American (8.3%). In the Burnout group, 8 participants were Caucasian
(88.9%) and 1 participant was African American (11.1%). There was no significant
difference in gender make-up of the groups Pearson chi-square (1) = 0.00, p = 1.0).
In the PTSD group, 5 participants were married (41. 7 %), 3 were single
(25%), and 3 were divorced (25%). One participant endorsed "other" as relationship
status (8.3%). For the Burnout group, 4 participants were married (44.4%), 3 were
divorced (33.3%), and 2 were single (22.2%). There was no significant difference in
marital status between the groups, Pearson chi-square (3) = 0.90, p = .83).
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Table 2
Summary of Group Demographics
PTSD
{n = 12}
Demographic
Age
Estimated IQ
# of Traumatic Life Events
# Health Conditions

M
45.58

102.92
6.33
1.40

Burnout
{n = 9}
SD

14.56
6.63
4.27
0.84

M

SD

40.33
104.71
3.44
0.38

12.19
3.35
2.60
0.74

t

p

.88

.39
.52
.09
.52

-.66
1.79
.65

n

p

n

p

X

2

p

1
5

58.3%
41.7%

0
9

0.0%
100.0%

7.88

.005

l

8.3%
91.7%

8

l

11.1%
88.9%

0.00

1.00

3
5
3

25.0%
41.7%
25.0%
8.3%

2
4
3
0

22.2%
44.4%
33.3%
0.0%

.90

.83

0

8.3%
83.3%
8.3%
0.0%

0
3
3
3

0.0%
33.3%
33.3%
33.3%

8.86

.01

Antidepressant Medication
Yes
No

6
6

50%
50%

0
0

0.0%
0.0%

4.09

.04

Past Psychotherapy
Yes
No

6
6

50%
50%

0
0

0.0%
0.0%

4.09

.04

Gender
Male
Female
Ethnicity
African American
Caucasian
Marital Status
Single
Married
Divorced
Other
Education
HS+

BA
MA

PhD/MD

11

l
l

10
l
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In the PTSD group, 10 participants had received a bachelor's degree (83.3%),
1 a master's degree (8.3%), and 1 participant listed high school plus additional

training (8.3%). In the Burnout group, 3 participants had received a bachelor's degree
(33.3%), 3 a master's degree (33.3%), and 3 participants had received doctoral level
education (33.3%). There was no significant difference· in education level of the
groups, Pearson chi-square (4) = 8.86,p = 0.70).
For the PTSD group, the estimated WAIS-R IQ scores, as measured by the
Shipley Institute ofLiving Scale, ranged from 90 to110 (M = 102.92; SD= 6.63). For
the Burnout group, estimated WAIS-R IQ scores, as measured by the Shipley
Institute ofLiving Scale, ranged from 100 to108 (M= 104.71; SD= 3.35). There was
no significant difference in the estimated IQ of participants in the PTSD group and the
Burnout group, t (17) =. -66, p = .52).
For the PTSD group, the total number of traumatic events experienced by
participants ranged from 1 to 13 (M = 6.33; SD= 4.27). The total number of
traumatic events experienced by participants in the burnout group ranged from Oto 7

(M= 3.44; SD= 2.60). There was no significant difference in the number of traumatic
events experienced by participants in the two groups, t (19) = 1.79,p = .09).
The number of physical health problems related to trauma ranged from Oto 3

(M = 1.4; SD= .84) in the PTSD group. The number of physical health problems
related to a stressful work environment ranged from Oto 2 (M = 0.38; SD= 0.74) in
the Burnout group. There was no significant difference in the number of physical
health problems between the two groups, t (17) = .65, p = .52).
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Half the participants in the PTSD group (n = 6) reported that they were stable
on antidepressant medication during the course of the study and the other half
reported they were taking no medication (n = 6). In the Burnout group, none of the
participants (n = 0) reported that they were taking antidepressant medication. There
was a significant difference between the groups regarding antidepressant medication,
Yates' Chi-Square Correction for Continuity (1) = 4.09,p = 0.04).
In the PTSD group, half the participants reported having received
psychotherapy in the past for their PTSD symptoms (n = 6) and half reported not
having received psychotherapy for PTSD symptoms (n = 6). No participants in the
Burnout group (n = 0) reported having received psychotherapy related to their
stressful work environment. There was a significant difference between the groups
regarding past psychotherapy, Yates' Chi-Square Correction for Continuity (1) =
4.09, p = 0.04).
The traumas experienced and written about by participants in the PTSD group
were as follows: seeing someone badly hurt or killed (n = 3), death you caused to
someone else (n = 2), sexual assault (n = 2), sudden, unexpected death of someone
close to you (n = 1), fire (n = 1), combat exposure or exposure to a war zone (n = 2),
and serious accident at home (n = 1).
Distressing work situations in the Burnout group were varied and included
customer service provider (n = 2), food service manager (n = 1), counselor (n = 2),
medical service provider (n = 1), charity fund raiser (n = 1), technical writer (n = 1),
and administrative assistant (n = 1).
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Primary Analyses
PTSD Group Analyses
All participants in the PTSD group met DSM-IV criteria for a diagnosis of
PTSD according to the DSM-IV (APA, 1994) guidelines of symptom endorsement at
pretest. Specifically, all participants reported at least one Cluster B symptom (Re
experiencing), at least three Cluster C symptoms (Avoidance/Numbing), and at least
two Cluster D symptoms (Hypervigilance).
Using the 1/3/2-symptom endorsement criteria, of the 12 participants who
completed posttest, 7 no longer met criteria for a diagnosis of PTSD at that time. At
I-month follow-up, 4 participants still did not meet criteria and I participant again
met criteria for the disorder. An additional participant no longer met criteria for the
disorder at this assessment. Two participants dropped out in this phase and I
participant had missing data for this assessment.
By the 2-month follow-up, 7 participants no longer met criteria for the
disorder and 2 participants had dropped out of the study. Table 3 depicts the
symptom status for participants in the PTSD group at each assessment phase. These
results are depicted graphically in Figure 1. Visual inspection of the data suggests that
participants no longer meeting criteria for a diagnosis of PTSD gradually increased
across follow-up, while the number of participants still meeting criteria decreased
throughout follow-up. The drop-out rate continually increased during follow-up.
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Table 3
PTSD Group Symptom Status
Assessment Phase

·······-··············�--·•·•

Posttest
{n = 12}

Symptom Status

1-Month
{n = 10}

...........................................

2-Month
{n = 8}

No longer met criteria

7

(58%)

6

(50%)

7

(58%)

Still met criteria

5

(42%)

3

(25%)

1

(08%)

Missing data

0

(00%)

1

(08%)

0

(00%)

Dropped out

0

(00%)

2

(17%)

4

(33%)

Symptom Status of Participants in PTSD Group

-+--No longer met
criteria
- Still met criteria

Phase of Assessment

Figure 1. Symptom Status of Participants in PTSD Group.
At pretest, scores on the CAPS-DX for the 12 participants ranged from 32 to
82, M = 62.50, SD= (18.63). Due to drop out following posttest, a paired samples t
test was performed to determine if there was a significant decrease in CAPS-DX total
scores following treatment. In addition to statistical significance of results, the effect
size, or magnitude of the differences between the two variables, using eta squared
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(r/), was calculated. According to Cohen (1988), the following guidelines may be
used to interpret this statistic: .01 = small effect, .06 = moderate effect, and .14 =
large effect. Results of this analysis indicated that there was no significant change
from pretest to posttest (M= 54.08, SD= 24.29, t(ll) = 1.79,p = .10. However, the
magnitude of the differences was large (r{ = .15). This -large effect size indicates that
15% of the variance in CAPS-DX scores was explained by time of assessment. This
variance suggests that with a larger sample size, statistical significance may have been
found.
In addition, a one-way repeated measures ANOVA was conducted to
determine if there were significant differences in the total CAPS-DX scores at pretest,
posttest, 1- and 2-month follow-up. For this analysis, data were available on only 7
participants.
There was no statistically significant effect for time, Wilks' Lambda = .19,
F(3, 4) = .40, p = .06 indicating that these scores did not change significantly across
assessment phases. The effect size was also calculated (r/ = .81). Again using
Cohen's (1988) guidelines, this is a very large effect size suggesting that, although no
statistically significant difference in means was found, 81% of the variance in CAPS
DX scores was accounted for by time of assessment. This supports the supposition
that a larger sample size may have produced significant differences in scores across
time.
The means and standard deviations for these assessment phases are depicted in
Table 4. These results are shown graphically in Figure 2. Visual inspection of the data
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indicates a slight decrease and then leveling of mean CAPS-DX scores across followup assessment.
Table 4
Descriptives for CAPS-DX Total Symptom Scores
Assessment Phase

n

M

SD

Pretest

7

66.00

21.91

Posttest

7

56.29

28.75

Follow-up 1

7

53.00

22.04

Follow-up 2

7

53.00

28.63
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Figure 2. Mdm CAPS-DX Scores Across Assessment Phases.
As a result of recruitment at the Cincinnati V.A Hospital, 6 participants in the
PTSD condition were veterans. In order to assess whether these 6 participants
differed from the nonveteran participants, a two-way repeated measures ANOVA was
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conducted. This analysis compared scores on the CAPS-DX from pretest to posttest
as the largest number of data points was available at these assessments.
Results indicated that scores between the two groups were not significantly
different from pretest to posttest, Wilks' Lambda = .77, F{l, 10) = 3.00, p = .11. For
a two-way ANOVA, Cohen (1988) suggests the following guidelines for
interpretation of1{ .10 = small, .25 = moderate, and .40 = large. The effect size for
this analysis was small (r{ = .23).
This analysis also indicated that there was no statistically significant main
effect for group such that the scores on the CAPS-DX were not significantly different
in the veteran and nonveteran groups, F{l, 10) = .11, p = .74. The effect size for this

r

analysis was very small (,t2 = .01

The interaction between group and time again showed no statistically
significant difference, Wilks' Lambda = .97, F{l, 10) = .28, p = .61. The effect size for
this analysis was small (r{ = .03). These results indicated that although the veteran
s�bgroup endorsed more significant trauma, they did not report more distress related
to those experiences as compared to the civilians in the PTSD condition.
Carry forward analysis of the data was performed using a repeated measures
ANOVA. Participants who completed pretest assessment and who dropped out prior
to posttest had their pretest CAPS-DX scores used as all subsequent CAPS-DX
scores. This analysis added 10 participants. Results indicated no significant differences
in CAPS-DX scores from pretest to 2-month follow-up, Wilks' Lambda = .77,
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F(3,14) = 1.41,p = .28. The effect size was also calculated (1/ = .23). Again using
Cohen's (1988) guidelines, this is a large effect size suggesting that, although no
statistically significant difference in means was found, 23% of the variance in CAPS
DX scores was accounted for by time of assessment.
Although the effect size is smaller than that of the previous analysis, it is still a
"large" effect size according to Cohen (1988) and offers additional support for the
possibility that a larger sample size may have produced significant differences in
scores across time. This is particularly notable as the carry forward analysis is a
conservative measure of change when analyzing missing data due to attrition.
The means and standard deviations for the carry forward analysis are shown in
Table 5 and Figure 3. Visual inspection of these data shows a less dramatic decrease
in the report of symptoms followed by the same leveling effect as shown in the
previous analysis. The effect sizes for these analyses are presented in Figure 4.
Table 5
Descriptives for CAPS-DX Total Symptom Scores
(Carry Forward Analysis)
Assessment Phase

n

M

SD

Pretest

17

61.71

19.22

Posttest

17

55.76

23.28

Follow-up 1

17

55.12

20.87

Follow-up 2

17

55.59

23.50

108
:M:ari CAPS-DX Scores Aaa.s
Assessrrent Pha.5es (Carried Forward I>ata)
--+-:M:ari
CAPS-DX
Soore

Ole Mcnth

Pretest

T\\O Mnth

Assesslrent Plwe
Figure 3. Mean CAPS-DX Scores Across Assessment Phases (Carry Forward
Analysis).

CAPS-DX Effect Sizes

g
�
.§
r:n

J�

OT-test
l WayRMA
Ill WayRMA(CF)

■

0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1

0+---�---�
Small

Moderate

Large

Very Large

Effect Size Category

Figure. 4. CAPS-DX Effect Sizes.
Burnout Group Analyses
Because scoring criteria for the MBI-Human Services and MBI-General
Forms are not compatible, mean comparisons could not be made. Rather, a z score
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transformation was used to change MBI Emotional Exhaustion and
Depersonalization/Cynicism scores into ranges. These ranges were designated as
"high," "moderate," and "low'' according to scoring criteria presented in the MBi
manual. At pretest, all 9 participants scored "high" on both Emotional Exhaustion and
Depersonalization. A chi-square calculation was used to show change in the ranges of
burnout in these categories.
At posttest, 2 participants' Emotional Exhaustion scores had decreased to the
"mode�ate" range and 3 participants' Depersonalization scores had decreased to the
"moderate" range. Visual inspection of the data indicated that 1 participant showed
reduced Emotional Exhaustion and Depersonalization from "high" to "moderate" by
posttest. One participant had reduced Emotional Exhaustion to "moderate" and 2
participants had reduced Depersonalization to "moderate" by posttest. This suggests
that 4 participants no longer met the study criteria for Burnout. Table 6 depicts the
MBI score category scores for participants in the Burnout group from pretest to
posttest.
Table 6
MBI Score Category Sample Sizes Pre- Posttest
Emotional Exhaustion

Depersonalization/Cynicism

Assessment Phase

High

Moderate

High

Moderate

Pretest

n=9

n=O

n=9

n=O

Posttest

n=1

n=2

n=6

n=3
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A carry forward analysis was not performed on the Burnout group data as this
analysis would have contributed only 1 participant who dropped out after the I-month
follow-up assessment.
Between Group Analyses-Dependent Measures
Two-way, repeated measures ANOVAs were conducted to determine if
dependent measure scores differed between groups across assessment times. These
analyses examined the change in BDI-II scores from pretest through 2-month follow
up as well as the change in STAI-S and SUDs ratings from pretest through treatment
sessions to posttest.
Beck Depression Inventory-II (BDI-II)
Due to drop-out following posttest, an analysis of scores on the Beck
Depression Inventory II (BDI-11) at pretest and posttest for the two groups was
conducted first. Results indicated that there was a statistically significant main effect
for time indicating that the scores on the BDI-II changed significantly from pretest to
posttest, Wilks' Lambda = .63, F(l, 18) = 10.23, p = .01. For a two-way ANOVA,
Cohen (1988) suggests the following guidelines for interpretation of1t .10 = small,
.25 = moderate, and .40= large. The effect size for this analysis was moderate (1/ =
.36).
This analysis also indicated that there was a statistically significant main effect
for group such that the scores on the BDI-II were significantly different in the PTSD
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and Burnout groups, F(l,18) = 5.86,p = .03. The effect size for this analysis was
small (r{ = .20). These analyses indicate that the Burnout group means decreased
significantly from pre- to posttest and were significantly smaller than the PTSD group
means at posttest. The interaction between group and time approached significance
but no statistically significant difference was found Wilks' Lambda = .80, F(l,18) =
4.38, p = .051. The effect size for this analysis was moderate (r{ = .25). Table 7 and
Figure 5 depicts these results in tabular and graphical form. The effect sizes for this
analysis are presented in Figure 6.
Table 7
Group Descriptives for BDI-II Scores Pre- Posttest
PTSD Group
(n = 12)

Burnout Group
(n = 8)

Assessment Phase

M

SD

M

SD

Pretest

19.08

9.44

12.88

10.54

Posttest

17.33

10.19

4.50

5.43

A two-way repeated measures ANOVA was also used to determine ifBDI-II
scores differed between groups across all assessment phases (pretest, posttest, and l
and 2-month follow-ups). In the PTSD group, data for these assessment phases were
available on 6 participants. In the Burnout group, 7 participants had data at all phases.
Results of this analysis showed that there was no statistically significant main effect
for time indicating that the scores on the BDI-II did not change significantly
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Figure 6. BDI-II Two-Way RM ANOVAEffect Sizes (Pre-Post).
throughout assessment phases, Wilks' Lambda = .49, F(3, 9) = 3.19, u. = .08.
However, the effect size for this analysis was large (rl = .52) indicating that 52% of
the variance in scores between groups was accounted for by time of assessment.
Visual inspection of the data suggests that BDI-II scores decreased slightly but
continuously in the PTSD group. The Burnout group showed more dramatic and
lasting decreases in their scores upon visual inspection of the data.
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No statistically significant main effect for group was found such that the
scores on the BDI-II were not significantly different in the PTSD and Burnout groups
across assessment phases, F(l,11) = 4.62,p = .06. The effect size for this analysis
was moderate (r12 = .30) indicating that 30% of the variance in scores across time was
accounted for by group. Again, visual inspection suggests both lower scores across
sessions for the Burnout group as compared to the PTSD group and a more dramatic
decrease from pretest across follow-up sessions for the Burnout group.
No statistically significant effect was found for the interaction between group
and time indicating that neither group nor time of assessment distinguished mean
scores, Wilks' Lambda = .78, F(3,9) = .85, p = .50. The effect size for this analysis
was small (ri

2=

.22). See Table 8 for means and standard deviations for these groups.

Figure 7 displays these results in graphical form. The effect sizes for this analysis are
presented in Figure 8.
In addition, a two-way repeated measures ANOVA was used to examine
effects for time and group across the dependent measures at Pretest, Treatment 1 (TX
1), Treatment 2 (TX 2), Treatment 3 (TX 3), Treatment 4 (TX 4), and Posttest. For
the BDI-II dependent measure scores, there were 12 participants in the PTSD group
and 7 participants in the Burnout group.
Results of this analysis revealed no main effect for time, Wilks' Lambda = .58,

F(5, 13) = 1.89,p = .16. However, the effect size was large (ri2 = .42) mdicating that
42% of the variance in scores was accounted for by time of assessment.

114
Table 8
BDI-11. Group Mean� Pretest to 2-Month Follow-up
n,

M

SD

Pretest

6

20.67

11.27

Posttest

6

18.50

14.64

FUl

6

17.83

11.75

FU2

6

18.00

12.65

Pretest

7

13.43

11.25

Posttest.

7

4.86

5.76

FUl

7

6.14

2.65

FU2

7

5.00

5.42

Group Assignment
PTSD

Burnout
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Figure 7. Mean BDI-11 Scores Across Assessment Phases.
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Figure 8. BDI-II Two-Way RM ANOVAEffect Sizes (Pre-2MF-Up).
There was a main effect for group, F(l, 17) = 5.31, p = .03, indicating that
scores were significantly different between the PTSD and Burnout groups. The effect
size for this analysis was moderate (r{ = .24). Again, no interaction effect was found,
Wilks' Lambda = .62, F(5, 13) = .16,p = .23. The effect size of the interaction was
also moderate (r{ = .38). The means and standard deviations for these participant
groups are depicted in Table 9. Figure 9 illustrates these results in graphical form. The
effect sizes for this analysis are presented in Figure 10.
Upon visual inspection of these data, it may be noted that the PTSD group
had higher mean BDI-II scores overall, across all sessions. Additionally, both groups
showed an increase in BDI-II mean scores at Treatment 2 followed by a general
decrease in scores across the following treatment sessions to posttest. Scores for the
PTSD group are less consistent than those of the Burnout group, but indicate a
general downward trend. The Burnout group also shows variability in mean BDI-II
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Table 9
BDI-II Group Means Across Assessment and Treatment Sessions

n

M

SD

Pretest

12

· 19.08

9.44

TXl

12

20.00

9.16

TX2

12

22.00

11.85

TX3

12

18.92

12.60

TX4

12

19.50

11.66

Posttest

12

17.33

10.19

Pretest

7

13.43

11.25

TXl

7

10.29

9.57

TX2

7

12.43

8.73

TX3

7

9.71

8.26

TX4

7

7.86

7.71

Posttest

7

4.86

5.76

Group Assignment
PTSD

Burnout

scores from pretest to Treatment 2, but again, an overall trend toward decreased
mean scores is apparent.
Independent sample t tests were conducted to describe these differences
statistically. These analyses indicated that the mean BDI-II scores between groups
were not significantly different at pretest; PTSD group (M = 19.08, SD= 9.44);
Burnout group (M= 14.33, SD= 10.78), t(19) = 1.07,p = .30. At Treatment 1,
significant differences were found in BDI-II scores between the PTSD group (M =
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Figure 9. Mean BDI-II Scores Across Assessment and Treatment Sessions.

BDI-11 Effect Sizes 2WRMA
(pre-tx.-post)

■ ME:Time

0.45

llME:Grp•

0.4

IITimexGrp

0.35
0.3

.M
<:ll

I

0.25
0.2
0.15
0.1
0.05
0
Small

Moderate

Large

Very Large

Effect Size Category

Figure 10. BDI-II Effect Sizes 2WRMA (Pre-Tx-Post).
20.00, SD= 9.16) and the Burnout group (M = 11.00, SD = 10.19), t{l9) = 2.13, p =
.05. At Treatment 2, significant differences were again found in BDI-II scores
between the PTSD group (M = 22.00, SD = 11. 85) and the Burnout group (M =
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11.89, SD = 9.13), t(19) = 2.13,p = .05. At Treatment 3, no significant differences
were noted between the PTSD group (M = 18.92, SD = 12.59) and the Burnout
group (M = 12.75, SD= 11.50), t(18) = 1.11,p = .28. However, it should be noted
that 1 participant had missing data for Treatment 3, further reducing the participant
data available for that analysis.
At Treatment 4, significant differences were again found in BDI-II scores
between the PTSD group (M = 19.50, SD= 11.66) and the Burnout group (M= 9.33,

SD= 8.70), t(19) = 2.19,p = .04. These analyses also revealed significant differences
in scores at posttest between the PTSD group (M = 17.33, SD = 10.19) and the
Burnout group (M = 4.5, SD = 5.42), t(18) = 3.25,p = .00.
The PTSD and MBI conditions were then collapsed and assessed for change
over time. This analysis was performed on all participants who completed the study
through the 2-month follow-up session (n = 13). Results of a one-way, repeated
measures ANOVA showed no significant decrease in symptom reports across
assessment phases, Wilks' Lambda = .52, F(3, 10) = 3.13, p = .01. The effect size of
the interaction was large (1,2 = .48). Figure 11 presents the effect sizes for the
dependent measure collapsed data analysis.
Measures of State Anxiety
The State-Trait Anxiety "?-ventory-State Form (STAI-S) and Subjective Units
of Distress Rating (SUDs) were taken at pretest, throughout treatment, and at
posttest. It was hypothesized that, although these scores would increase at the
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Figure 11. DV Effect Sizes-Collapsed Group Data.
beginning of treatment, as treatment progressed, these scores would decrease. In
order to test these hypotheses, two-way, repeated measures ANOVAs were again
computed.
State-Trait Anxiety Inventory-State (STAI-S). For the analyses using the
STAI-S dependent measure, there were 12 participants in the PTSD group and 8
participants for the Burnout group. Analysis of STAI-S scores across pretest,
treatment sessions, and posttest for these groups indicated that there was no main
effect found for time, Wilks' Lambda = .57, F(5, 14) = 2.10,p = .13. The effect size
2

was large (rt = .43) indicating that 43% of the variance of the STAI-S mean score
was explained by time of assessment. No main effect for group, F(l, 18) = 2.73, p =
2

.12, was found in this analysis. The effect size was moderate for this analysis (11 =
.36), indicating that 36% of the variance in scores was explained by the group
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variable. No interaction effect was found, Wilks' Lambda = .64, F(S, 14) = 1.55,p =
.24. The effect size was small (r{ = .13).
Table 10 and Figure 12 depict the means and standard deviations for the
STAI-S mean scores in tabular and graphical forms, respectively. Visual inspection of
the data indicated that as with the BDI-II scores, the PTSD group had higher overall
scores on the STAI-S. For the PTSD condition, contrary to the hypothesized initial
increase, then decrease in reported anxiety, the graph shows variability in scores
across treatment sessions with no general trend toward decrease. The scores for the
Burnout group are more stable and do hint at the predicted increase then decrease;
however, the increased scores continued over a longer period of time and the
decrease was not as substantial as hypothesized. The effect sizes for this analysis are
presented in Figure 13.
Carry forward analyses were conducted on these data as well. Specifically, for
participants who dropped out of the study prior to posttest, the last data point for the
STAI-S was subsequently used and carried forward through posttest. This added 5
participants to the PTSD group and 1 participant to the Burnout group.
Results of these analyses indicated no significant differences in scores across
assessment times, Wilks' Lambda = .71, F(S, 20) = 1.63,p = .20, with a moderate
effect size (r{ = .29). Between group analyses uncovered no significant differences
either, Wilks' Lambda = .82, F(5, 20) = .88, p = .51, with a small effect size (ri

2=

.07). Again, no interaction was found, F(l, 24) = 1.77,p = .20, with a small effect
size (ri2 = .18).
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Table 10
STAI-S Group Means Across Assessment and Treatment Sessions

n

M

SD

Pretest

12

45.67

12.29

TXl

12

52.33

12.57

TX2

12

55.92

11.77

TX3

12

50.42

13.15

TX4

12

55.50

15.26

Posttest

12

48.67

11.42

Pretest

8

43.13

12.05

TXl

8

44.38

9.53

TX2

8

46.25

14.10

TX3

8

44.13

12.67

TX4

8

42.88

10.16

Posttest

8

40.00

14.63

Group Assignment
PTSD

Burnout

Table 11 and Figure 14 depict these results. These data indicated the same
general pattern of symptom report as that of the previous analysis: The effect sizes for
this analysis are presented in Figure 15.
The PTSD and MBI conditions were then collapsed and assessed for change
over time. This analysis was performed on all participants who completed the study
through the posttest assessment (n = 20).
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Figure 12. Mean STAI-S Scores Across Assessment and Treatment Sessions.
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Table 11
STAI-S Group Means Across Assessment and Treatment Sessions
(Carry Forward Analysis)
n

M

SD

Pretest

17

46.24

11.07

TXl

17

51.71

11.08

TX2

17

51.71

13.43

TX3

17

46.41

14.61

TX4

17

50.29

16.71

Posttest

17

42.53

15.72

Pretest

9

42.89

11.30

TXl

9

42.56

10.45

TX2

9

44.22

14.52

TX3

9

46.41

14.61

TX4

9

42.00

9.86

Posttest

9

39.67

13.72

Group Assignment
PTSD

Burnout

Results of the one-way, repeated measures ANOVA showed no significant
change in reports of state-anxiety across these assessment phases, Willes' Lambda =
.56, F(5, 15) = 2.37,p = .09. The effect size of the interaction was large (112 = .44).
Figure 11 presents the effect size for the STAIS-S collapsed data analysis.
Subjective Units of Distress Ratings (SUDs). A two-way repeated measures
ANOVA was used to examine the SUDs dependent measure scores across pretest,
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Figure 14. Mean STAI-S Scores Across Assessment and Treatment Sessions (Carry
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Figure· 15. STAI-S Effects Sizes 2WRMA (Pre-Tx-Post) Carry Forward Analysis.
treatment sessions, and posttest for each group.· There were 12 participants in the
PTSD group and 8 participants in the Burnout group for this analysis.
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Results indicated that there was no main effect for time, Wilks' Lambda = .62,
F(S, 14) = 1.71, p = .20. The effect size for time was moderate (r..2 = .38), indicating

that 38% of the variance in SUDs scores was accounted for by time of assessment.
No main effect for group was found, F(l, 18) = 2.21,p = .16. The effect size was
large, however (rl = .46), indicating that 46% of the v�ance in SUDs ratings was
attributable to the group variable. No interaction effect was found for time by group,
Wilks' Lambda = .54, F(5, 14) = 2.41,p = .09. The effect size was small (TJ

2=

.11).

The means and standard deviations for these groups are depicted in Table 12. Figure
16 illustrates these results in graphical form. The effect sizes for this analysis are
presented in Figure 17.
It had been hypothesized that these ratings would increase at the beginning of
treatment and then decrease throughout treatment. Visual inspection of Figure 12
indicated that, although scores for the PTSD group did appear to increase within the
first two treatment sessions, the expected subsequent decrease did not occur and this
group remained anxious throughout treatment and posttest sessions. Posttest scores
were slightly less than those reported at pretest but the difference was very slight. For
the Burnout group, scores varied much more across sessions but did show an overall
trend toward reduction by posttest.
Carry forward analyses were conducted on these data as well. Specifically, for
participants who dropped out of the study prior to posttest, the last data point for the
SUDs rating was subsequently used and carried forward through posttest. This added
5 participants to the PTSD group and 1 participant to the Burnout group.
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Table 12
SUDs Group Means Across Assessment and Treatment Sessions

n

M

SD

Pretest

12

5.17

2.63

TXl

12

5.75

2.77

TX2

12

6.50

2.54

TX3

12

5.15

2.93

TX4

12

6.00

2.73

Posttest

12

5.25

2.77

Pretest

8

5.13

2.70

TXl

8

3.88

3.00

TX2

8

5.13

2.00

TX3

8

4.63

2.13

TX4

8

3.25

1.58

Posttest

8

3.38

2.13

Group Assignment
PTSD

Burnout

Results of these analyses indicated no significant differences in scores across
assessment and treatment sessions, Wilks' Lambda = .71, F(5, 20) = 1.62,p = .20,
with a moderate effect size (rl = .29). Between group analyses uncovered no
significant differences either, Wilks' Lambda = .68, F(5, 20) = 1.93,p = .13, with a
2
moderate effect size (11 = .33).

Again, no interaction was found, F(l, 24) = 1.97,p === .17, with a small effect
2

size (11 = .08). Table 13 and Figure 18 depict these results. These data indicated the
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Figure 16. Mean SUDs Ratings Across Assessment and Treatment Sessions.
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same general pattern of symptom report as that of the previous analysis. The effect
sizes for this analysis are presented in Figure 19.
Table 13
suns Group Means Across Assessment and Treatment Sessions
(Carry Forward Analysis)

n

M

SD

Pretest

17

5.24

2.46

TXl

17

5.59

2.35

TX2

17

5.88

2.42

TX3

17

5.06

2.86

TX4

17

5.24

2.77

Posttest

17

5.65

2.74

Pretest

9

5.33

2.60

TXl

9

3.67

2.87

TX2

9

4.89

1.96

TX3

9

4.44

2.07

TX4

9

3.44

1.59

Posttest

9

3.33

2.00

Group Assignment
PTSD

Burnout

Collapsing the PTSD and MBI conditions, scores on the Suns ratings were
assessed from pretest, through treatment sessions, to posttest (n = 20). A one-way,
repeated measures ANOVA revealed.no significant change in subjective reports of
distress across these assessment phases, Wilks' Lambda = .64, F(5, 15) = 1.70,p =
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2

.20. The effect size of the interaction was large (ri = .36). Figure 11 shows the effect
sizes for the SUDs collapsed data analysis.
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Figure 18. Mean SUDs Across Assessment and Treatment (Carry Forward Data).
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Coping Resources Inventory (CRI) and Health Center Visits
The fourth set of hypotheses related to the functional relationships between
reported symptom levels and coping skills and the number of health care facility visits
made throughout the study. Specifically, it was hypothesized that as reported
symptoms of burnout and PTSD decreased, there would be an increase in reported
coping skills. It was also hypothesized that as symptom levels decreased, health center
visits would decrease.
Due to the small sample size,
these hypotheses could not be tested as planned.
I
Paired samples t tests were conducted within groups on these variables to determine
if, despite the lack of significant decreases in symptom reports, participants showed
increases in coping skills or decreases in health center visits for illness.
Coping Resources Inventory (CRI). Results of this analysis on the Coping
Resources Inventory showed no statistically significant difference in scores for the
PTSD group from pretest (M= 149.92, SD= 25.50) to posttest (M= 156.17, SD=
19.99), t(ll), =-1.21,p = .25. The T]2 statistic (.12) indicated a moderate effect size,
however.
For the Burnout group, no statistically significant difference was found
between pretest CRI scores (M = 169.11, SD= 36.51) and posttest scores either
(M = 171.33, SD= (22.64), t(9), = -.30, p = .11. The T]2 statistic (.01) indicated a
small effect size. The effect sizes for these analysis are presented in Figure 20.
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Figure 20. CRI Effect Sizes (Pre-Post).
Results of independent samples t tests indicated that at pretest, the PTSD
group (M = 149.92, SD= 25.50) was not significantly different than the Burnout
group (M= 169.�l, SD= 36.51), t(19) = 1.76,p = .17, in their utilization of coping
skills as measured by the Coping Resources Inventory (CRI). Additionally, the PTSD
group (M = 156.17, SD= 19.99) was not significantly different than the Burnout
group on the CRI (M = 171.33, SD= 22.64), t(19) = -1.63, p = .12 at posttest
assessment.
Health Center Visits. Paired samples t tests within groups comparing the
number of health center visits at pre-and posttest were then conducted as data on the
largest number of participants were available at these assessments. No statistically
significant difference in scores was found for the PTSD group (n =12) from pretest
(M= .75, SD= 1.29) to posttest (M= .50, SD= .67), t(ll), = .61,p = .56. The effect
size was small (r{ = .03).
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For the Burnout group the sample size was smaller (n = 8) and no statistically
significant difference was found between the number of pretest health center visits
(M = . 75, SD = . 71) and the number of posttest health center visits (M = .13, SD =
.35), t(7), = 1.93, p = .10. The 11 statistic (.25) indicated a large effect size, however.
2

Since this questionnaire was administered throughout follow-up, a two-way
repeated measures ANOVA was conducted to determine if differences existed
between groups across follow-up phases. For this analysis, data were available on
only 6 participants in the PTSD group and 7 in the Burnout group.
Results indicated no significant effect for time, Wilks' Lambda = .74, F{3, 9)
= 1.04, p = .42. The effect size for time was moderate (ri2 = .25). No main effect for
group was found, F{l, 11) = 1.81, p = .20. The effect size was small (,.2 = .14). No
interaction effect was found for time by group, Wilks' Lambda = .79, F(3, 9) = .81,
p = .51. The effect size was moderate (112 = .21). The effect sizes for these analyses
are presented in Figure 21.
Post-hoc Analyses
In order to consider the effect of past and concurrent therapies on the results
of this study, the role of past psychotherapy and the concurrent use of antidepressant
medication during the investigational treatment was examined. Six of the 12
participants who entered treatment in the PTSD group reported having engaged in
psychotherapy in the past related to their symptoms ofPTSD. These same
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Figure 21. HCV Effect Sizes.
participants reported taking antidepressant medication for symptoms of PTSD prior
to and during the course of the study. No participants in the Burnout group reported
engagement in psychotherapy in the past related to their stressful work experience,
nor did they report current use. of psychiatric medication for these symptoms.
Independent samples t tests were conducted to compare participants with a
history of psychotherapy and current use of medication {PM) with those who had no
therapy and were taking no medication (NPM). At pretest, scores on the CAPS-DX
were not significantly different between the PM participants (M = 62.67, SD= 22.15)
and the NPM participants (M = 62.33, SD= 16.52), t(lO), = -.03, p = .98. The effect
s�e was very small (ri2 = .00). Nor were these scores significantly different at posttest
between the two: PM (M = 48.33, SD= 22.91); NPM (M = 59.83, SD= 26.35),
t(lO), = -.81,p = .44. The effect size was moderate (1i2 = .06).
A two-way repeated measures ANOVA was conducted on CAPS-DX scores
to determine if significant differences existed between these groups from pretest to
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posttest as well. Results indicated no significant effect for time, Wilks' Lambda = .75,
F(l,10) = 3.41,p = .09. The effect size for time was moderate (r/ = .25). No main
effect for group was found, F(l, 10) = .22, p = .65. The effect size was very small
(ri2 = .02). No interaction effect was found for time by group, Wtllcs' Lambda = .86,
F(l,10) = 1.69,p = .22. The effect size was moderate (r/ = .14). Although significant
differences were not detected, the graphical depiction of these results suggest that
those with a history of psychotherapy and currently taking antidepressant medication
showed sharper decreases in total CAPS-DX mean score reductions than those
without past psychotherapy or current medication. These results are depicted
graphically in Figure 22.
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Figure 22. Pre-Post CAPS-DX Scores for Med/Therapy Groups.
These same analyses were used to compare the groups on mean BDI-II
scores. Again, independent samples t tests were first conducted to compare pre- and
posttest scores between groups. Pretest scores on the BDI-II were not significantly
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different between PM (M= 19.33, SD= 10.52) and the NPM (M= 18.83, SD=
9.24), t(l0), = -.09,p = .93. The effect size was very small (r{ = .00. These scores
were not significantly different at posttest either: PM (M= 13.83, SD= 8.77), NPM
2

(M � 20.83, SD= 11.05), t(lO), = 1.22, p = .25. The effect size was moderate (ti =
.13).
A two-way repeated measures ANOVA was conducted to determine if
significant differences existed between these groups from pretest to posttest. Results
indicated no significant effect for time, Wilks' Lambda = .90, F(1,10) = 1.15, p = .31.
2

The effect size for time was small (,. = .10). No main effect for group was found,
F(l, 10) = .35, p = .51. The effect size was very small (r.

2=

.03). However, a

significant interaction effect was found for time by group, Wilks' Lambda = .65,
F(l,10) = 5.28,p = .04. The effect size was moderate (ri

2=

.35). Graphical

illustration of these data indicates that those without past psychotherapy or current
medication actually showed a slight increase in BDI-II scores from pre- to posttest.
Those with a history of psychotherapy and currently taking antidepressant medication
showed some improvement in these symptoms. Figure 23 depicts these results.
Diagnostic Outcome and Recovery
In addition to the statistical significance found in this study, clinically
significant decreases in symptom reports across groups were also examined. Based on
categorical symptom analysis of the CAPS-DX, MBI, and BDI-II, both groups
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Figure 23. Pre-Post BDI-:U Scores for Med/fherapy Groups.
reported a general trend toward symptom reduction following treatment. At pretest,
all participants met criteria for a diagnosis ofPTSD using the 1/3/2 symptom
endorsement guideline oftheDSM-JV(APA, 1994). At the completion ofthe study, 7
ofthe 8 individuals no longer met these criteria.
For participants in the Burnout group, 4 ofthe 8 participants had reduced
scores on both Emotional Exhaustion and Depersonalization categories, which was
the equivalent ofno longer meeting scoring criteria for the syndrome.
Regarding scores on the BDI-11, the mean score for participants in the PTSD
group fell in the high-mild to low-moderate level ofdepressive symptoms at pretest.
By posttest, these scores had fallen to the "mild depressive symptom" category. This
reduction was maintained at the 2-month follow-up assessment.
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Mean scores for participants in the Burnout group fell into the "minimal" level
of depressive symptoms at pretest. At posttest, these scores had fallen into the
category of"normal mood" and were maintained at 2-month follow-up.
In addition, the post-hoc analyses of the PTSD participants who reported a
past history of psychotherapy and current antidepressant medication use showed
improvement in CAPS-DX total symptoms scores over those without a prior history
of treatment or concurrent use of medication.
Mean BDI-11 score comparison from pre- to posttest also indicated some
improvement in depressive symptoms in the group who reported prior psychotherapy
and current use of antidepressant medication.

CHAPTERV
DISCUSSION
The purpose of the present study was to test the effectiveness of a writing
therapy treatment with individuals expressing symptoms along a continuum of
stressful conditions. Specifically, participants in the study reported symptoms of either
Post-Traumatic Stress Disorder or Burnout. This study utilized the writing treatment
developed by Pennebaker (1986) which demonstrated improvement in physical and
mental health "well-being" (Pennebaker & Beall, 1986; Pennebaker, Kiecolt-Glaser,
& Glaser, 1988; Smyth, 1998) as well as significant reductions in clinical levels of
Post-Traumatic Stress Disorder (Largo-Marsh & Spates, 1997).
Based upon the supportive literature available on writing treatment, this study
hypothesized that participants in both the Burnout and PTSD conditions would report
significantly fewer symptoms related to the distressing experience about which they
chose to write. In addition, it was hypothesized that depressive symptoms, anxiety,
coping skills, and physical health symptoms would improve following treatment.
Preliminary Outcomes
Statistical analyses comparing individuals in the PTSD and Burnout groups on
demographic variables indicated that the groups were significantly different on three
characteristics. Regarding gender, participants in the Burnout group were all female.
138
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Gender make-up of the PTSD condition was nearly evenly distributed with 58% of
this group being male and 42% being female.
In addition, only participants in the PTSD group reported having received
psychotherapy in the past related to the distressing situation about which he/she chose
to write. Within that group, 50% reported having received psychotherapy in the past
and 50% reported having never received psychotherapy related to the distressing
situation about which each wrote.
Also of note was that only participants in the PTSD condition indicated that
they were taking antidepressant medication for symptoms of PTSD. Within this
group, the same participants who endorsed past psychotherapy were those currently
on antidepressant medication. No participants in the Burnout condition reported
taking antidepressant medication during the course of the treatment study.
Main Outcomes
Regarding the main hypotheses examined for this study, statistical analyses did
not support the first hypothesis, that symptoms of PTSD as measured by the CAPS
DX and reports of burnout, as measured by the MBI, would be significantly
decreased following the writing treatment. These results support the findings of
several other studies in which no significant improvement in PTSD symptoms was
found following writing treatment (Donnelly & Murray, 1991; Gidron et al., 1996).
Gidron et al. (1996) suggested that simply writing about a traumatic experience
without reflection or feedback from the therapist was not sufficient to facilitate
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positive change in the individual's cognitive processing of the traumatic experience.
This study further suggested that additional positive cognitive restructuring may have
improved outcomes.
Although statistical significance was not found in the present study, notably
large effect sizes were found for the pre-post comparison of mean CAPS-DX scores
which indicated a large variance in the scores accounted for by time. This effect size
suggested that the lack of significance may be in part due to the small sample size (n =
12). Visual inspection of the graphical results showed trends toward improvement in
reported symptoms of PTSD further supporting this possibility.
Further statistical analyses of the mean CAPS-DX scores from pretest through
2-month follow-up were again, nonsignificant. However, the effect s,ize for this
analysis was very large, supporting the supposition that a larger sample size would
have uncovered significant improvements in these scores.
Carry forward analyses, in which scores for participants who completed at
least the pretest assessment were "carried forward" throughout the remainder of
assessment sessions showed large effect sizes as well, despite nonsignificant changes
in scores. Although no statistical significance was found in this conservative statistical
analysis, the large effect sizes again supported prior indications that the sample size
may have been the rate-limiting factor. Visual inspection of the analyses also
suggested a trend toward improvement in symptom reports in these scores.
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Although statistical significance was not found for mean score improvement in
these groups, diagnostically, 7 of the 8 participants in the PTSD condition no longer
met criteria for a diagnosis ofPTSD at 2-month follow-up.
It was also notable that 6 of the 12 participants in the PTSD group who
completed posttest were combat veterans of the armed forces. Research indicates that
historically, despite substantial amounts of treatment, including both
psychotherapeutic and pharmacological interventions, improvement in symptoms and
functioning in veterans has been modest, with questionable clinical significance
(Fontana & Rosenheck, 1997). In spite of the apparent resistance ofPTSD symptoms
to remit in the veteran population in general, in this group, 4 of the 6 veteran
participants who completed the 2-month follow-up no longer met criteria for a
diagnosis ofPTSD as measured by the 1/3/2 symptom cluster criteria.
In addition, statistical analyses revealed no significant difference in the
pretest-posttest scores of these participants when compared to the "civilian"
participants also diagnosed with PTSD. This finding indicated that, at least for this
sample of veterans, the writing treatment was helpful in reducing the number of
symptoms·ofPTSD reported.
Regarding the Burnout condition, statistical comparisons on the data were not
conducted due to the incompatibility of scores across occupational category
questionnaires. However, results ofz-score transformations of the mean scores into
score ranges of"high," "moderate," and "low'' indicated that half of the participants
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no longer met the criteria for the syndrome of Burnout at posttest and these decreases
remained stable through the 2-month follow-up.
Statistical significance was found for the second set of hypotheses in which
scores on the Beck Depression Inventory-II were examined between the two
conditions. Results indicated that scores between the two conditions were
significantly different at both pretest and posttest, with the Burnout condition
reporting significantly fewer depressive symptoms at both assessment times.
Analyses of within group BDI-11 mean scores from pretest through 2-month
follow-up revealed no significant change in scores. The effect size for the analysis of
time was large indicating that a substantial portion of the variance in scores on the
BDI-11 could be accounted for by the time of the assessment. As visual inspection of
the data indicated, these scores showed a gradual but obvious trend downward.
Again, it is important to consider that the lack of significant findings is likely related
to the small sample size, as in this analysis, data were available on a total of only 13
participants.
The effect sizes for the nonsignificant findings related to group comparison of
the BDI-11 scores from pretest through the 2-month follow-up were large and
moderate for time and group analyses, respectively. This again suggested that a larger
sample might well have resulted in a statistically significant difference in mean scores
between groups as this analysis was based on 6 participants' data in the PTSD
condition and 7 in the Burnout condition. Based on visual inspection and the previous
analyses, it is likely that the MBI condition would have yielded lower scores when
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compared to the PTSD group.

As discussed

earlier, symptoms of depression are

highly correlated with the syndrome of Burnout thus making the finding of significant
decreases in BDI-II scores, but not overall MBI scores, more ambiguous. It is
possible that the significant decreases in reported symptoms of depression accounted
for the decreased overall, but nonsignificant scores on the MBI. The treatment may
simply have not been sufficient to decrease the additional negative feelings associated
with Burnout.
Additionally, this finding is of note, since only participants in the PTSD group
were concurrently taking antidepressant medication and it would reason, that the
effects of the medication might bolster the effects of the treatment, or vice versa. This
finding also brings to light the issue of comorbidity between PTSD and depression. In
particular, it is unclear whether the effectiveness of antidepressant medication with
PTSD is simply due to the amelioration of the symptoms that overlap between the
two disorders as opposed to improving symptoms unique to PTSD.
The question of symptom clusters and the distinction between PTSD and
depression has been addressed in the literature as researchers have sought to
determine if the effectiveness of antidepressant medication for PTSD is due solely to
the reduction of depression-related symptoms ofPTSD. One recent study found that
sertraline was effective in reducing both the depression-related symptoms ofPTSD
and the re-experiencingfmtrusion cluster of symptoms (Gaffuey, 2003) but that the
depressive symptoms were relatively more responsive to sertraline treatment. The
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participants in the present study reported taking a number of d�erent classes of
antidepressant medications, so further investigation into this area was not possible.
/

Additional statistical comparisons with the BDI-11, specifically from pretest
across treatment sessions to posttest failed to produce significant results for time of
assessment. However, the effect size for this analysis was large, suggesting that
significant differences in scores may have been detected in a larger sample. Significant
differences were detected between groups and follow up analyses indicated that the
Burnout condition showed greater improvement in reported symptoms of depression
across these assessment sessions. It should be noted that the third treatment session
was an exception, with no significance found; however, this group had one less data
point available for analysis than the others. This, along with the moderate effect size
for this analysis bolster the possibility that had a larger sample been examined,
significant differences may have been detected.
In sum, the Burnout group showed statistically significant decreases in reports
of depressive symptoms from pretest through treatment to posttest. These symptom
reductions were maintained at the 2-month follow-up, suggesting that writing therapy
had a positive effect on "mild" levels of self-reported depressive symptoms. Based on
the effect sizes, there is evidence to suggest that the treatment was effective in
improving "moderate" levels of depression seen in the PTSD group as well and with a
larger sample size this may have been demonstrated.
Regarding the demographic make-up of the two conditions, it may be relevant
that the Burnout group consisted entirely of women. This is notable since, in this
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treatment, participants were asked to disclose personal and potentially distressing
information about themselves. Women are generally considered to be more socially
oriented toward developing and maintaining intimate relationships than men, which
requires a certain degree of self-disclosure. Perhaps these socially constructed
qualities allowed the female sample to divulge more and thus reap greater benefit
from this treatment.
Examination of the degree of"state" anxiety (STAI-S) and self-reported
distress (SUDs ) did not support the hypotheses presented in this study. Initially
increased levels of anxiety followed by consistent decreases in reported state anxiety
and subjective distress were expected. Analyses yielded no significant changes
between groups on the STAI-Sor within groups across assessment phases. Of note,
however, were the "very large" effect sizes reported with both of the analyses
suggesting that a substantial proportion of the variance in these scores was accounted
for by group assignment as well as time of assessment. This is noteworthy because
statistical significance is only one way of determining the degree of the relationship
between variables, and certainly sample size is a consequential factor in that
determination.
When the more conservative, carry forward analyses were conducted to
ameliorate some of the problem of attrition, no statistically significant results were
found between groups or across assessment phases on the STAi-S. The effect size for
time was moderate suggesting that scores may have changed significantly across
assessment phase had a larger sample size been available for analysis. Effect sizes for
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group and the interaction were both small, supporting the lack of significant
difference demonstrated between the group scores, and between scores at a particular
phase of assessment. When data for the STAI-Sin the two treatment conditions were
collapsed, no statistically significant differences were found. However, the effect size
for this analysis was large, suggesting that significant differences in scores may have
been found in a larger sample.
Analyses yielded no significant changes between groups on the SUDs or
within groups on this measure across assessment phases. The effect sizes for time and
group in the SUDs analysis were large, however, suggesting that significant
differences across assessment phases may have been found in a larger sample.
The more conservative carry forward analysis with the SUDs ratings again
failed to yield significance. However, effect sizes were moderate again lending
support to the suggestion that significance may have been detected with a larger
sample. Collapsing data for the two groups in the analysis ofSUDs scores yielded no
significant differences but again showed a large effect size.
Aside from the lack of statistically significant decreases in scores, the results
did not show the hypothesized initial increase and subsequent decrease of anxiety
during this study. Rather the reported levels of anxiety and subjective distress seemed
to increase during the treatment phase only to return to pretest levels by posttest.
No change in coping skills as measured by the Coping Resources Inventory
(CRI) was found from pretest to posttest within either treatment condition. A
moderate effect size was found suggesting that with a larger sample size, significant
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increases may have been noted. In addition, visual inspection of the data revealed that
the PTSD group had lower scores on the CRI at both pretest and posttest, suggesting
that these individuals began with and then developed fewer coping skills than those in
the Burnout group.
Nor were significant differences in the number of Health Center Visits made
from pretest to posttest detected. The effect size was small supporting this finding.
Visual inspection of the data indicated that individuals in both groups made no visits
or one visit from pretest throughout follow-up, however. Of note, visits for illness did
not increase during the treatment study, suggesting that no participants were more ill
during or after treatment through follow-up.
In sum, those in the Burnout condition showed significantly improved levels
of depressive symptoms following the writing treatment. Although the primary
hypothesis regarding decreased levels of reported PTSD and Burnout was not
supported, the results lend credence to the work of Pennebaker (1988) that writing
about stressful event results in increased feelings of "well-being." Regarding the
analyses of the CAPS-DX and MBI visual inspection of the data indicated trends
toward reduction of reported symptoms on each of these measures. However, it is
important to consider the effect sizes when interpreting this data as well. The large
and moderate effects sizes suggest that although statistical significance was not
detected, the treatment may show statistical significance when administered to a
larger sample of participants.
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When compared to the PTSD condition in which half the participants were
concurrently taking antidepressant medication, it is surprising that participants in the
Burnout condition exhibited greater decreases in depressive symptoms although no
participants in that group were taking antidepressant medication. Perhaps the
treatment is simply more effective with less severe levels of distress. As one study
suggested (Gideon et al., 1996), writing about a traumatic event without the benefit of
active cognitive restructuring in a treatment setting may not be enough to ameliorate
the symptom� resulting from such an experience. It may be that the .greater the degr�e
of trauma associated with an experience, the greater the need for additional or
alternative treatments to address the substantial amount of cognitive change which
occurs in individuals following such an experience.
Another factor for consideration of these nonsignificant results is related to
the amount of time that had passed since the trauma occurred. In the PTSD condition,
over half of the participants wrote about traumatic events which occurred at least 20,
and more often 30 or more years ago. Research on writing therapy indicates that
participants who wrote about a more recent trauma showed greater improvement in
symptoms than those who chose to wnte about a trauma farther in the past (Smyth,
1998). It is possible that over time, beliefs about the trauma and behaviors that result
from the experience may simply be too well-established to be changed without
additional treatment components.
Although no significant decreases in symptoms emerged, participants in both
groups exhibited clinically relevant reductions in symptoms. The majority of
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participants in the PTSD group no longer met criteria for a diagnosis ofPTSD at
posttest and these symptom reports were maintained at the 2-month follow-up. In
addition, scores on the BDI-II were also reduced overall for this group. These score
reductions were the equivalent to participants improving from "moderate" to "mild"
depressive symptoms. Again, these reductions were maintained at the 2-month
follow-up assessment.
Following treatment, half of the participants in the Burnout group reported
reduced scores in either the Emotional Exhaustion and/or Depersonalization
categories. This was the equivalent of no longer meeting syndromal levels of
symptom endo�sement. The level of reported depressive symptoms was also
j!,
!

significantly r�uced in participants in the Burnout condition. This group
. ' .i

demonstrated reductions in scores which were equivalent to moving from "minimal"
, '

I

levels of depressive symptoms at pretest, to a exhibiting a "normal mood" at posttest.
Again, t�ese reductions were maintained at the 2-month follow-up assessment.
Secondary Outcomes
Post hoc comparisons were made in this investigation between participants
who were and �ere not being treated with antidepressant medication. In this study,
only participants in the PTSD group reported taking medication. These same
participants reported having received psychotherapy at some time in the past for their
symptoms ofPtSD as well.

As

antidepressant medications continue to be prescribed

150
for individuals with Post-Traumatic Stress Disorder, it is important to evaluate the
effectiveness of combining treatments for this disorder.
The medication and no medication individuals were statistically compared at
pretest, posttest and 1- and 2-month follow-up. While no statistically significant
differences in symptom reports were found between the two groups, effect sizes for
these analyses were moderate, suggesting that in a larger sample size, statistically
significant decreases may have been detected. Visual inspection of the data also
suggested a greater improvement in symptoms in the individuals concurrently taking
medication.
Limitations of This Study
A number of limitations affected the results of this study. The most obvious
and relevant factor was the small sample size. This study suffered from both difficulty
with recruitment and the rate of attrition in participants. Regarding recruitment, the
study was conducted on two college campuses as well as a Veteran's Administration
Medical Center. These sites would appear to have an adequate flow of potential
participants who would both desire and qualify for the treatment study. However,
despite recruitment efforts including newspaper advertisement, the posting of
informational fliers, distribution of brochure advertisements, requests for referrals
from mental and physical health care professionals, the study suffered from a lack of
appropriate volunteers.
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One possible reason for this lack of volunteers was that no monetary
compensation was available for participation. For an investigational treatment that
offers no promise of symptom reduction, additional incentive may be necessary to
attract potential candidates.
In addition, research related to treatment of anxiety disorders indicates that
patients often complain of and seek treatment for comorbid physical health problems
before pursuing psychological assistance (Burstein, 1986). Possible factors related to
this observation include lack of knowledge regarding the connection between PTSD
symptoms and the disorder and discomfort with seeking help from a psychiatrist
(Burstein, 1986). The association between psychiatric aid and social stigma cannot be
overlooked. Many individuals are reluctant to admit to symptoms for fear of being
judged as "crazy." In addition, the symptoms ofPTSD in particular may be
embarrassing or frightening for an individual further lessening the likelihood of
disclosing this experience by seeking treatment. The social pressure for individuals to
handle problems on their own is an important factor as well. Self-sufficiency is prized
in our society and "needing help" is often viewed as at best a weakness, and at worst
a character flaw. All of these factors may have contributed to the reluctance of
individuals to take part in this "treatment" study.
Research indicates that treatment seeking is generally related to the degree to
which symptoms interfere with daily living (Koenen, Goodwin, Struening, Hellman, &
Guardino, 2003). However, this same research found that high levels of impairment
were reported in individuals with PTSD who never sought treatment. Specifically,
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these individuals reported that their anxiety interfered with their lives 40-60% of the
time. Thus individuals with high levels of distressing symptoms may never seek
treatment, perhaps for some of the reasons discussed above.
Researchers have also hypothesized that since treatment for PTSD generally
involves having to talk about a frightening or uncomfortable experience, high levels of
avoidance of trauma reminders may cause patients to actively avoid treatment (Lindy,
Grace, & Green, 1981). One study found that although 36% of motor accident
victims agreed to take part in the collection of longitudinal data, only 13% were
willing to participate in an intervention study, despite high reported rates of distress
(Brom, Kleber, & Defares (1989).
Early studies examining the rates of drop-out in patients with PTSD found
that for patients who entered treatment within the first 9 weeks following the
traumatic event the drop-out rate was 27%. This same study reported that for
participants who entered treatment after the 40th week post-trauma, the drop-out rate
increased to 82% (Burstein, 1986). In the present study, about half of the participants
in the PTSD group dropped out during treatment or follow up sessions. Comparison
of pretest CAPS-DX scores showed no significant differences in the levels of
symptoms reported by those who dropped out compared to those who remained in
the study. However, the tendency of individuals with PTSD to avoid of reminders of
the trauma may have outweighed the desire for treatment.
The Burnout group did not suffer such dramatic attrition. However, by
definition, participants in the PTSD condition were experiencing a greater degree of
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distress than those in the Burnout condition and avoidance of distress is not
associated with the syndrome of Burnout. Thus, it is likely that confronting the
emotional response to a stressful work environment is simply more tolerable than
confronting a traumatic memory.
Consideration should also be given to the fact that, in a writing treatment,
participants decide what to write about and how much to reveal. In this way, each
participant was in control over the "dose" of exposure to which he/she was exposed.
Studies have suggested that individuals with more severe symptoms and those with
higher levels of comorbid depression may be the one's least likely to tolerate exposure
treatments (Scott & Stradling, 1997).
This may have affected the results of the study in two ways. Participants who
were experiencing higher levels of PTSD and depressive symptoms may have been
able to stay in the study because they were in control of the· degree to which each
disclosed traumatic material. Participants may simply have chosen to limit the amount
of disclosure related to the experience of trauma. On the other hand, higher degrees
of symptom reduction may have resulted had participants been coached during the
treatment related to what and how much to disclose.
Due to the high rates of attrition in this study, generalizability of the results
was compromised. Even after collapsing the two groups and examining change in
symptom reports, the sample size remained small. Thus, although the sample was
varied with respect to demographics, traumatic events experienced, and work
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situations discussed, the small sample size restricts the degree to which the
conclusions of the study may be interpreted.
Several other factors related to the lack of generalizability of results. This
sample of participants "self-selected" to take part in this investigation. It is unclear
what if any characteristics differentiate this group from the larger population of
individuals with PTSD and Burnout. Related to this, no formal assessment was made
as to the type and degree of treatment participants in the PTSD group had received in
the past. Based on the degree of improvement in PTSD symptom scores between
those with and without prior psychotherapy, it is possible that having talked about
and actively worked on these issues in the past made writing about them both easier
and more productive.
There were also several limitations related to the inclusion/exclusion criteria
utilized for this study. Regarding inclusion criteria, participants in the Burnout
condition were included in the study if they endorsed symptoms which met the "high"
range for both Emotional Exhaustion and Depersonalization/Cynicism score
categories. No consideration was given to scores on the Personal Accomplishment
category, for which low scores are necessary for a "pure" definition of burnout. As
high scores on Personal Accomplishment are hypothesized to mediate the effects of
both Emotional Exhaustion and Depersonalization/Cynicism, it is unclear what if any
effect this more lenient definition of Burnout may have had on the resulting
improvements reported by this sample. Because of this, these results may not
generalize to the population of individuals with "pure" burnout syndrome.
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To some degree, the exclusion criteria which were used in this study restricted
the generalizability of the results. Participants who were suicidal, reported comorbid
personality disorder characteristics, and/or thought disorders were excluded.
Individuals with a diagnosis ofPTSD commonly report comorbid personality
disorders as well as suicidal ideation. Less often, psychosis is reported, and is more
likely when the traumatic experience is of greater severity or more prolonged.
However, exposure treatment is contraindicated when individuals are actively suicidal
or experiencing significant thought disorder. Thus, these exclusions did not likely
reduce generalizability of the results since in a "real-world" setting, trauma processing
would not be advisable until theses symptoms had stabilized. Regarding personality
disorder characteristics however, this study reduced the generalizability of results as
personality disorders are highly comorbid with PTSD.
Future Investigation and Conclusion
Due to the small sample size, the results of this study are best viewed as pilot
data for future research. Several additions to the study protocol should be considered.
Future studies in which participants are asked to confront potentially
traumatic or distressing memories of past events should consider making the incentive
to participate more immediately rewarding. This could aid with both the difficulty in
recruitment and the high rates of attrition that hindered this study.
Additionally, based on feedback given by individuals following the debriefing,
future researchers would do well to include an opportunity for participants to verbally
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reflect on the process of the writing treatment. This may aid researchers in
understanding the effects of the writing treatment during the time it is occurring. In
this way, researchers can address any potentially intolerable effects of the treatment
experienced by participants and aid in "working through" these negative cognitions,
thus increasing the likelihood that individuals would return to complete treatment.
Regarding the inclusion criteria, future studies may wish to apply a more
stringent definition of Burnout, taking into account scores on the Personal
Accomplishment category as well. In this way, the results of the study may be
generalized to individuals with "pure" Burnout.
Future research should also address the issues discussed in relation to
exclusionary criteria set up in this study. In "real-world" settings, participants
particularly those with PTSD are likely to exhibit suicidal ideation, comorbid
personality disorders and less often, psychosis. Although suicidal ideation and
psychosis counter-indicate trauma processing, examination of the treatment with
individuals with comorbid personality disorders would greatly enhance the
generalizability of the results.
In conclusion, despite the lack of overall significant findings in the present
study, diagnostically significant improvements resulted. The findings suggested that in
a larger sample, overall statistical significance may have been found as well. These
results support the further investigation of the use of writing therapy as. a short-term
and cost-effective means of improving symptoms of both PTSD and depression.
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Have you experienced a traumatic event?
(accident, assault, natural disaster)
Are you currently having symptoms
such as trouble sleeping,
irritability,
and/or difficulty concentrating?
You may be eligible.for a treatment study
atWMU.

Please contact Jennifer Lewis at (513) 484-8803
for more information.
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Are you a "helping professional"?
(Counselor, nurse, home-health care
worker, EMT, fireman, or police?)
Are you experiencing fatigue, irritability,
and difficulty concentrating?

You may be eligible for a treatment study
now being conducted at Xavier University.

Please contact Jennifer Lewis at (513) 484-8803
for more information.
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Have you experienced a traumatic event?
(accident, assault, natural disaster)
Are you currently having symptoms
such as trouble slee·ping,
irritability,
and/or difficulty concentrating?
You may be eligible for a treatment study
now being conducted at Xavier University.

Please contact Jennifer Lewis at (513) 484-8803
for more information.
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Have you experienced a traumatic event?
(accident, assault, natural disaster)
Are you currently having symptoms
such as trouble sleeping,
irritability,
and/or difficulty concentrating?
You may be eligible for a study of
an investigational treatment
now being conducted at the
Cincinnati VA Medical Center.
Please contact Jennifer Lewis at (513) 484-8803
for more information.
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Are you a helping professional? (Counselor,
nurse, home-health care worker, EMT,
fireman, or police?)
Are you experiencing fatigue, irritability,
and difficulty concentrating?

You may be eligible for a study of
and investigational treatment
now being conducted at the
Cincinnati VA Medical Center.
Please contact Jennifer Lewis at (513) 484-8803
for more information.
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"Burnout" refers to a syndrome often
reponed by those who do "people
work." This includes individuals who

ARE YOU

work with people in distress as pan of
their job (nurses, police officers, duld

§

A

Protective Service workers, Emergency .

"HELPING

Medical Technicians, medical doctors,
firefighters, counselors, or people caring

PROFESSIONAL"

for sick or mentally ill children, elders or
other family members in the home). If

The Cincinnati VA Medical C.enter is located
·at 3200 Vine Street in Cincinnati Ohio.

BURNOUT?

you are experiencing symptoms such as
lack of energy, loss of motivation, or
feeling emotionally drained by your

EXPERIENONG

§

work, you may be eligible to panicipate
in a study of an investigational treatment
currently taking place at the Cincinnati
VA Medical Center.

-°'
-..J

dinical Researchers at the Cincinnati VA
Medical C-enter are seeking individuals to
take part in a study of an investigational
treatment for "Burnout" or work-related
chronic stress.

How long will the stu dy take?
Involvement in the study may take up to 4
months. This is from the initial screening
through the last follow-up session.

What is Burnout?

How long is each session?

Burnout is the term used to describe chronic
feelings of dissatisfaction, ineffectiveness,
and/ or lack of motivation toward work
Usually associated with the "helping
professions", the syndrome may cause a lack
of energy or excitement about work, feelings
of increased stress while at work, as well as a
loss of enjoyment of activities outside of
work that you used to enjoy.

The initial screening takes about 20 minutes.
If you qualify, you will be asked to return for
a more in depth screening which may last
from 45-90 minutes. Each treatment session
lasts approximately 45 minutes.

What types of therapies are usually
prescribed for Burnout?
"Burnout" is not currently recognized as a
psychological disorder. Therefore, no
treatments are available specifically for this
syndrome. However, traditional therapies
such as psychotherapy and/ or medication
may be prescribed for chronic stress
conditions such as burnout.
What type of therapy can I expect to
receive if I decide to take part in this
study?
Participants in this study will be offered a
non-traditional forin of therapy including
the completion of several questionnaires, a
one-on-one interview, and a series of writing
therapy treatments. All sessions will be
conducted at the Gncinnaci VA Medical
Center.

In addition, we invite you to return for 1 and
2 month follow-up sessions after your last
treatment session. These sessions typically
take about one hour to complete.
What is my obligation if I decide to
participate?
There is no obligation and you are free to
discontinue your participation at any time
without penalty.
What if I can't participate right now, but
might be interested in the future?
The study is currently in progress and will
continue to run through October 2002. You
may call at any time to get more information
or to schedule the first screening session.
How do I know if I am eligible to take
part?
To be eligible for this study, you must be a
veteran and at least 18 year.; of age. In
addition you must not be receiving any other
form of treatment specifically for these
symptoms.

Will I be paid for my participation?
We are not offering any monetary
compensation for pa,rticipation. However,
you may have the benefit of experiencing a
reduction in your symptoms of '' burnout"
due to the treatment. · In addition, you have
the knowledge that you are contributing to
research in the area of treatments for
chronic stress conditions.
Who will have access to my information?
Everything discussed or written during the
study is regarded as confidential information.
This means that the researchen. and
supervising psychologist cannot discuss the
information you give with anyone outside
the project unless they have your written
consent. Any exceptions to· this
confidentiality will be discussed with you
before the study begins.
In addition, when you come in for the initial
screening, you will be asked to read and sign
an informed consent. This is the only
document that will have your name on it. It
· will be kept separate from your research file.
After the initial screening, you will only be
identified by a research number.
How do I get more information?
If you are interested in hearing more about
the study, simply contact Jennifer Lewis at
(513) 484-8803. You may leave a voice
message with your name and number and a
researcher will return your call.
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When a person experiences a
traumatic event such as an
automobile accident, combat
exposure, a natural disaster, a
sexual or physical assault, or
witnessing these events against

HAVE

others, he or she may develop

YOU

symptoms of PTSD. If you have
had_ such an experience at any time

The Cincinnati VA Medical C.enter is located
at 3200 Vine Street in Cincinnati Ohio.

A

· in your life and are currently
having trouble sleeping, feel
irritable, and are having difficulty
concentrating, you may be eligible
to participate in a study of an
investigational treatment currently
taking place at the Cincinnati VA
I

Medical Center.

EXPERIENCED

§

TRAUMATIC
EVENT?

Clinical Researchers at the Cincinnati V A
Medical Center are seeking individuals to
take part in an investigational study to
evaluate a treatment for Post Traumatic
Stress Disorder (PTSD).
What is PTSD?
PTSD stands for Post Traumatic Stress
Disorder. When a person experiences a
traumatic event outside the range of usual
human experience he or she may develop
symptoms such as being overly anxious or
alert, having nightmares about the trauma,
and/ or difficulty sleeping or concentrating.
Reactions such as these to a traumatic event
are normal and may go away after several
weeks. However, if these symptoms are still
present a month after the traumatic incident
occurred it becomes "Post Traumatic Stress
Disorder" or "PTSD" and may req�e some
type of treatment.
· What types of therapies are usually
prescribed for PTSD?
Traditional therapies for these types of
symptoms may include psychotherapy
and/ or medication.
What type of therapy can I expect to
receive if I decide to take part in this
study?
Participants in this study will be offered a
non-traditional form of therapy including
the completion of several questionnaires, a
one-on-one interview, and a series of writing
therapy treatments.. All sessions will be
conducted at the Cincinnati VA Medical
Center.

How !ong will the study take?

Will I be paid for my participation?

Involvement in the study may take up to 4
months. 'Ibis is from the initial -screening
through the last follow-up session.

We are not offering any monetary
compensation for participation. However,
you may_have the benefit of experiencing a
reduction in your PTSD symptoms due to
the treatment. In addition you will be
making a contribution to research in the area·
of treatments for PTSD.

How long is each session?
The initial screening takes about 20 minutes.
If you qualify, you will be asked to return for
a more in depth screening which may last
from 45-90 minutes. Each treatment session
lasts approximately 45 minutes.
In addition, we invite you to return for 1 and
2 month follow-up sessions after your last
treatment session. These sessions typically
take about one hour to complete.
What is my obligation if I decide to
participate?
There is no obligation and you are free to
discontinue your participation at any time
without penalty.
What if I can't participate right now, but
might be interested in the future?
The study is currently in progress and will
continue to run through October 2002. You
may call at any time to get more information
or to schedule the first screening session.
How do I know if I am eligible to take
part?
To be eligible for this study, you must be a
veteran and at least 18 years of age. In
addition you must not be receiving any other
form of treatment specifically for these
symptoms.

Who will have access to my information?
Everything discussed or written during the
study is regarded as confidential information.
'Ibis means that the researchers and
supervising psychologist cannot discuss the
information you give with anyone outside
the project unless they have your written
consent. Any exceptions to this.
confidentiality will be discussed with you
before the study begins.
In addition, when you come in for the initial
screening, you will be asked to read and sign
an informed consent. This is the only
document that will have your name on it. It
will be kept separate from your research file.
After the initial screening, you will only be
identified by a research number.
How do I get more information?

If you are interested in learning more about the

study, simply contact Jennifer Lewis at (513) 4848803. You may leave a voice message with your
name and number ·and a researcher will return
your call.
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Western Michigan University, Department of Psychology
Effects of Writing Therapy across PTSD, Subclinical PTSD and Chronic Stress
Principal Investigator: C. Richard Spates, Ph.D.
Student Investigator: Jennifer Lewis, M. A.
Consent for Participation in an Investigation
I have been invited to participate in a research project entitled, "Effects of Writing Therapy across
PTSD, Subclinical PTSD and Chronic Stress." This project is intended to study the treatment
efficacy of writing therapy across several levels of stress. This project will be conducted under the
direction of Dr. C. Richard Spates and will serve as Jennifer Lewis' Doctoral Dissertation project.
All interviews and treatments will be conducted by Jennifer Lewis_ or a trained research assistant. I
am aware that there are other treatments available for PTSD and related disorders including
traditional psychotherapy, psychopharmacological interventions and exposure related therapies. A
referral list has been made available to me in the event I choose to seek alternative treatment. I
have also been made aware that if I choose to seek alternative treatment during the research
study, I am free to continue in the study, but my data will be excluded from the study results.
If I agree to participate in this research, I will be asked to take part in a 30.minute intake session, a
2 hour initial assessment session, and 4- 40 minute treatment sessions. In addition, I will be asked
to return to the Psychology Clinic or Anxiety Disorders Research Facility approximately one week,
one month and two months after the last treatment session. These additional sessions will involve
the completion of questionnaires and follow-up_interviews. All sessions will be conducted by
researchers trained in the use of these procedures.
During the intake session I will be asked to complete two paper and pencil questionnaires and
answer a list of questions asked me by the interviewer. The first paper and pencil questionnaire,
the Life Events Checklist, will inquire about a number of potentially traumatic incidents which I may
or may not have been exposed to. The second questionnaire, the Maslach Burnout Inventory, will
inquire about my employment experiences and demographic information. The questions asked of
me by the interviewer on the Personality Questionnaire will consist of questions about the way I
view myself and my relationships with others. As a result of these assessments, I may not qualify
for participation in the study. In such a case, if I desire counseling, I will be provided a list of mental
health agencies which might assist me in locating suitable treatment at my own expense if I so
choose. In addition, the research associate is prepared to provide additior:ial immediate help if it is
needed (e.g., relaxation techniques).
During the assessment session, I will be asked to take part in one structured interview and to
complete seven questionnaires. The Clinician Administered PTSD Scale (CAPS-DX) will be
administered to me by a trained researcher and will inquire about my thoughts, feelings and
physical responses to the traumatic event(s) that I experienced. In addition, I will be asked to
complete the Shipley Institute of Living Scale which is a general measure of my verbal skills, the
State-Trait Anxiety Inventory, State Form (STAI-S) and the Beck Depression Inventory- II (BDl-11)
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which will inquire about my feelings. The Coping Resources Inventory (CRI) will inquire about the
ways in which I cope with stressors in my life. The Physical Health Questionnaire (PHQ) will inquire
about my past and current physical health and a final questionnaire will inquire about the number
of health care visits I have made recently. Finally, I will be asked to rate my level of distress.
There will be four treatment sessions, each 30 minutes long. These sessions are to be attended
once a week for a period of one month. Treatment will consist of my writing about my traumatic
experience(s) or my troublesome work experiences or both. At the end of each treatment session,
my writing will be reviewed with me by a research associate and I will be debriefed following my
writing session. In addition, at the end of each of the four treatment sessions I will be asked to
complete the STAI-S, BDl-11 and again rate my level of distress.
I have been told that in addition to the treatment sessions, I will be asked to return to the clinic for
one post-test assessment and two follow-up assessment sessions. Each of these will take
between 60 and 90 minutes. At post-test, I will be given a number of Beck Depression Inventories
(BDl-11) and stamped, pre-addressed envelopes. I will be asked to complete one BDl-11 per week
and mail it to the clinic between follow-up visits as a means of monitoring my progress after
treatment. At the final follow-up session, I will be debriefed on the study. I have also been made
aware that if issues arise at any time during the research and I require additional therapy, I may
·
contact the researchers.
All of the information collected from me will be kept entirely confidential. To facilitate confidentiality,
a ra.ndom code n!Jmber will be assigned to my name which will then be used to identify all
information relating to me (with the exception of this informed consent which bears identifying
information to be used solely to schedule the assessment session). Jennifer Lewis will keep a
master list which matches my name to the coded. data. This master list, along with my informed
consent form and all other coded data will be kept in a locked filing cabinet in the Psychology Clinic
(3rd floor, Unified Clinics, WMU) accessible only to Jennifer Lewis, her advisor and trained research
assistants. Once all of the data is collected and analyzed, the master list of names and codes will ·
be destroyed. The remaining data will be retained for three years in a locked file in the Psychology
Clinic. At the end of three years the data will be destroyed.
As in all research there may be unforseen risks to the participant. If an accidental injury occurs,
appropriate emergency measures will be taken; however no compensation or treatment will be
made available to me except as otherwise specified in this consent form. One potential risk of my
participa�on in this �t!Jdy may be my emotional upset from the initial questionnaire, structured
interview or treatment sessions. However, I am aware that I may withdraw my consent to the
research or discontinue participation in the research at any time without prejudice, penalty, or risk
of any loss of service I might otherwise have received. Furthermore, if I should become emotionally
distressed during the interview, the researcher is prepared to terminate the interview and
implement a relaxation exercise with me. In addition, the researcher is prepared to make a referral
if I choose to seek counseling about this topic. I will be responsible for the cost of therapy if I
choose to pursue it.
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One possible benefit of participating in this study may be the opportunity to discuss and write about
the traumatic event(s)/situation(s) I have experienced and to share my related thoughts and
feelings. Research indicates that this may be beneficial to individuals who have suffered from a
traumatic event. In addition, as a result of participating in this study, I may contribute to the
knowledge base regarding treatments for post traumatic stress disorder and other stress related
disorders.
If, at the completion of this research study, I would like to seek further treatment, I may do so at my
own expense at the Psychology Clinic at Western Michigan University or one of the facilites listed
on the referral sheet I have received with this consent document.
If I have any questions or concerns about this study, I may contact either Jennifer Lewis at
3874332 or 552-9447 or Dr. Spates at 387-4329. I 'may also contact the Chair, Human Subjects
Institutional Review Board (387-8293) or the Vice President for Research (387-8298) if questioris
or problems arise during the course of the study, This consent document has been approved for
use for one year by the Human Subjects Institutional Review Board (HSIRB) as indicated by the
stamped date and signature of the board chair in the upper right corner. Subjects should not sign
this document if the corner does not show a sta,mped date and signature on each page.
My signature below indicates that I have read and fully understand this document and agree to
participate in this study.

Name (Please Print)
Signature

Date
Subject Number

Appendix:F
Xavier University Informed Consent
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Western Michigan University, Department of Psychology
Xavier University, Department of Psychology
Effects of Writing Therapy across Post Traumatic Stress Disorder a·nd Chronic Stress
Principal Investigator: Jennifer Lewis, M.A.
Co-Principal Investigator: C. Richard Spates, Ph.D. (WMU)
Faculty Advisor: Karl Stukenberg, Ph.D. (XU)

I have been invited to take part in the research study, "Effects of Writing Therapy across Post Tra_umatic
Stress Disorder and Chronic Stress." This study will look at a treatment for stress related disorders. This
study will show if the treatment is useful in reducing the symptoms of these disorders.
There are other treatments available for these disorders. These treatments include traditional
psychotherapy, medicine, and behavior therapies. 1 have been given a referral list that I may use if I
decide to try a differ-ent type of treatment. If I choose to receive another treatment after I begin the study,
I can continue to participate in this study.
I will be asked to attend two screening meetings. These meetings will show whether I qualify for the
study. I will be asked to meet the researcher at the Psychological Services Center at Xavier University.
During the first meeting I will be given the Life Events Checklist. I will be asked to show which of the
events has happened to me. The second set of questions, The Demographic Questionnaire, will ask for
some general information about me. I will then be asked about my feelings toward my work on the
Maslach Burnout Inventory. The interviewer will also ask me questions about the way I think of myself
and my relationship with others. As a result of all of these questions, I may not qualify to take part in the
study. If this happens, I will be provided a list of mental health agencies in the area. This list is to help
me find treatment somewhere else if I wish. If I decide to get treatment at one of these places, I will have
to pay for this therapy. In addition, if I become distressed during the treatment session, the researcher is
prepared to provide crisis counseling if necessary.
- During the second meeting, I will be interviewed with the CAPS-DX. I will be asked about my thoughts,
feelings and physical responses to the stressful event(s) that happened to me. I will also be asked to
answer questions on the Shipley Institute of Living Scale. This is a general measure of my verbal skills. I
will then be asked to fill out the Beck Depression Inventory-II (BDl-11) and asked some additional
questions about depressive symptoms I may be experiencing. In addition, I will be asked to complete the
State-Trait Anxiety Inventory (State Form) (STAI-S} which will ask a number of questions about my
feelings. The Coping Resources Inventory (CRI) will ask about the way I cope with stress. I will also be
asked about my past and current physical health on the Physical Health Questionnaire. I will then be
asked about the number of visits to the doctor that I have made recently. Finally, I will be asked to rate
my level of distress.
Again, as a result of.all of these questions, I may not qualify to take part in the study. If this happens, I
will be provided a list of mental health agencies so that I may find treatment somewhere else if I wish. I
will have to pay for this therapy if I contact one of these places.
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There will be four writing treatment sessions. These sessions will take about 40 minutes. These
sessions will take place once a week for four weeks. I will be asked to write about an experience I have
had which continues to cause me distress or to write about a stressful work situation. My writing will be
read by the researcher at the end of each treatment session. My level of distress will be monitored. I will
also be asked about my feelings at that time.
After the last treatment session, I will be asked to come back a week later to complete several
questionnaires. I will then be asked to return once a month for two months to complete these
questionnaires again. Each of these meetings will take about 60 minutes. At the first and second
sessions following treatment, I will be given four 8OI-ll's and asked to complete one BDl-11 per week and
mail it to the researcher. This is to keep track of my progress after treatment. At the final meeting, a
researcher will talk with me about my thoughts and feelings about taking part in this study.
If I would like to get more treatment when I finish the study, I will have to pay for it myself. I have been
given a mental health resource sheet which I may use to find treatment. If any problems arise at any time
during the research and I require more help I may contact the principal investigator at (513) 484-8803. If I
am unable to contact a researcher I may contact one of the resources on the mental health resource
sheet.
As in all research there may be risks to the participant that we do not expect. If an accidental injury
occurs, appropriate emergency measures will be taken. No compensation or treatment will be made
available to me except as otherwise specified in this consent'form. One possible risk of my participation
· in this project is that I may be upset by the content of the interview. I may also become upset when
writing about my stressful experience. However, the researcher is prepared to provide crisis counseling if
needed. S/he is also prepared to make a referral if I need further counseling about this topic. I will be
responsible for the cost of therapy if I choose to pursue it.
One way in which I may benefit from this activity is having the chance to talk and write about the
experience(s) I have had. Studies have shown that this may help people who have experienced a
stressful event. In addition, others who experience stres:;ful events may benefit from the knowledge that
is gained from this research.
All of the information collected from me is confidential. That means that my name will not appear on any
papers on which this information is recorded. The forms will all be coded and Jennifer Lewis will keep a
separate master list with the names of participants and their code numbers. Once the data has been
collected and analyzed, the master list will be destroyed. All other forms will be retained for three years in
a locked file in the Psychological Services Center at Xavier University.
My participation is voluntary and I may refuse to participate, or may discontinue my participation AT ANY
TIME; without penalty or loss of benefits to which I am otherwise entitled. The investigator has the right
to withdraw me from the study AT ANY TIME. My withdrawal from the study may be for reasons related
solely to me (e.g. not following study-related directions from the Investigator; a serious adverse reaction)
or because the entire study has been terminated. If I have any questions or concerns about this study, I
may phone either Jennifer Lewis at (513) 484-8803 or Dr. Stukenberg at (513) 745-3531.
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I may also contact the Jennifer Lewis by email at jennifer.lewis@wmich.edu or the Western Michigan
University Human Subject's Institutional Review Board at research-compliance@wmich.edu.
This consent document has been approved for use for one year by the HSIRB at WMU as indicated by
the stamped date and signature of the board chair in the upper right corner. Subjects should not sign this
form if the corner does not show a stamped date and signature on each page. My signature below shows
that I have read the purpose and requirements of the study and that I agree to take part.

Name {Please Print)

Date

Signature

Subject Number

AppendixG
Cincinnati VAMC Informed Consent
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Western Michigan University
C. Richard Spates, PhD
Jennifer Lewis, MA
University of Cincinnati
Cincinnati VA Medical Center
Megan Murray, PhD
Consent to Participate in a Research Study
TITLE OF STUDY:

"Effects of Writing Therapy across PTSD and Chronic Stress

INVES"fl<3ATOR INFORMATION:
Jennifer Lewis. MA
Principal Investigator

Pager: 230-6578
861-3100 X 4719
Telephone Number/ 24 hour Emergency Contact

INTRODUCTION:
Before agreeing to participate in this study, it is important that the following explanation of the proposed
procedures be read and understood. It describes the purpose, procedures, risks, and benefits of the
study. It also describes the right to withdraw from the study at any time. It is important to understand that
no guarantee or assurance can be made as to the results of the study.
I, ___________________ have been asked to participate in the research
study under the direction of Jennifer Lewis, MA and supervised by Dr. Megan Murray. Other professional
persons associated with the study may assist or act for them.
This research is not sponsored.
I will be one of approximately 13 subjects to participate in this trial.
A total of 20 subjects at two institutions across the country will be taking part in this study.
PURPOSE:
The purpose of this research study is to examine an experimental treatment for stress related conditions
including Post Traumatic Stress Disorder (PTSD) and Burnout. PTSD is a psychological disorder that
may result from exposure to an event which involves life threat or serious injury. Burnout is a syndrome
which may result from a stressful and/or unpleasant work environment. This study will show if the
treatment is useful in reducing the symptoms of these conditions. I have been asked to enroll in this
study because I have been diagnosed with either Post Traumatic Stress Disorder or report symptoms .
indicative of burnout.
DURATION:
My participation in this study will require a total -of 8-10 hours of my time and may iast up to four months.
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PROCEDURES:
During the course of the study, I will be asked to attend two screening meetings. These meetings will
show whether I qualify for the study. I will be ·asked to meet a researcher at the Cincinnati VA Medical
Center. During the first meeting, which will take about 20 minutes, I will be given the Life Events
Checklist. I will be asked to show which of the events have happened to me. The second set of
questions, The Demographic Questionnaire, will ask for some general information about me. I will then
be asked about my feelings toward my work on the Maslach Burnout l_nventory. The interviewer will also
ask me questions about the way I think of myself and my relationship with others. As a result of all of
th.ese questions, I may not qualify to take part in the study. If this happens, I will be provided a list of
• mental health agencies. This list is to help me find treatment somewhere else if I wish. If I decide to get
treatment at one of these places, I have been told that this study will not cover those costs. The
researcher is also prepared to provide more help at that time if it is needed.
During the second meeting which will take between 60-90 minutes, I will be interviewed with the Clinician
Administered Post Traumatic Stress Disorder Survey for DSM-IV (CAPS-DX) which will ask about my
thoughts, feelings and physical responses to the stressful event(s) that happened to me. I will also be
asked to answer questions on the Shipley Institute of Living Scale. This is a general measure of my
verbal skills. I will then be asked to fill out the Beck Depression Inventory-II (801-11) and the State-Trait
Anxiety Inventory (State Form) (STAI-S). These forms will ask a number of questions about my feelings.
The Coping Resources Inventory (CRI) will ask about the way I cope with stress. I will also be asked
about my past and current physical health on the Physical Health Questionnaire. I will then be asked
about the number of visits to the doctor that I have made recently. Finally, I will be asked to ra.te my level
of distress.
These tests will determine my eligibility to enroll in the treatment part of the study. Again, as a result of all
of these questions, I may not be eligible for this treatment. If this happens, I will be provided a list of
mental health agencies so that I may find treatment somewhere else if I wish. If I chose to engage in
treatment at another facility, I will have to pay for this therapy myself.
If I qualify for the study, I have been asked to attend four writing treatment sessions. These sessions will
take about 40 minutes each. These sessions will take place once a week for one month. I will be asked
to write about an experience I have had which continues to cause me distress. My writing will be read by
the researcher at the end of each treatrnent session. My level of distress will be monitored. I will also be_
asked about my feelings at that time.
I will be asked to come back three more times after treatment is finished for follow-up meetings. Each of
these meetings will take 60 to 90 minutes. I will be given four BDl-ll's after the first meeting. I will be
asked to complete one 801-11 per week and mail it to the researcher. This is to keep track of my progress
after treatment. At the final meeting, a researcher will talk with me about my thoughts and feelings about
taking part in this study.
If I would like to get more treatment when I finish the study, I will have to pay for it myself. I have been
given a mental health resource sheet, which I may use to find treatment. If any problems arise at any
time during the research and I require more help I may contact the researchers. If I am unable to contact
a researcher, I unders-tand that I may contact one of the resources on the mental health resource sheet.
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EXCLUSION:
I should not participate in this study if any of the following apply to me:
1. I am not at least 18 years old.
2. I am enrolled in any form of psychotherapy for my PTSD or chronic stress symptoms.
3. I am enrolled in another treatment study for my PTSD or chronic stress symptoms.
4. I am experiencing suicidal or homicidal thoughts.
5. I am experie'ncing hallucinations or delusions.
If I am taking medication for a psychological condition, the dosage has not been changed for the six
, weeks prior to beginning the study and I do not plan to change the medication dosage during the study. If
· my doctor changes the dosage, I agree to notify the researcher of this change.
RISKS/DISCOMFORTS:
As in all research there may be risks to the participant that the investigators do not expect. If �m
. accidental injury occurs, appropriate emergency measures will be taken. One possible risk of my.
participation in this project is that I may be upset by the content of the interview. I may also become
upset when writing about my stressful experience. I have been informed that if I have Post Traumatic
Stress Disorder, my-symptoms may become worse during the course of treatment. However, the
researcher is prepared to provide crisis counseling if needed. S/he is also prepared to make a referral if I
need further counseling or psychotherapy about this topic. I will be responsible for the cost of therapy if I
choose to pursue it.
I have been informed that if any of the questions or assessments are too stressful, I may discontinue at
any time. I understand that if I do not complete the assessments or answer certain questions, I may still
take part in the study, but my information will not be used in the study results.
There also may be risks and discomforts which are not yet known.
BENEFITS:
One way in which I may benefit from this activity is having the chance to talk and write about the
experience(s) I have had. Studies have shown that this may help people who have experienced a
stressful event. In addition, others who experience stressful events may benefit from the knowledge that
is gained from this research.
ALTERNATIVES:
The following alternative procedure or treatments are available if I choose not to participate in this study:
Traditional psychotherapy, medicine, and behavior therapies are available for treatment of my Post
Traumatic Stress Disorder symptoms. I have been told that there are no currently recognized treatments
for burnout. I have been given a referral list that I may use if I decide to try a different type of treatment. I
have also been made aware that if I choose to receive another treatment during the study I can still take
part in the study if I would like.
NEW FINDINGS:
I have been told that I will receive any new information during the course of the study concerning
significant treatment findings that may affect my willingness to continue my participation.
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CONFIDENTIALITY:
Every effort will be made to maintain the confidentiality of my study records. My name will not appear on
any papers on which my study information is recorded. The forms will all be coded and Jennifer Lewis
will keep a separate master list with the names of participants and their code numbers. Once the data
are collected and analyzed, the master list will be destroyed. All other forms will be retained for three
years in a locked file at the Psychology Clinic at Western Michigan University. In addition, this data will
accessible to the Institutional Review Board at the University of Cincinnati. The data from the study may
be published; however, I will not be identified by name. My identity will remain confidential unless
disclosure is required by law. If, during this study, I report that I plan to hurt myself or another person this
confidentiality will be broken and appropriate actions will be taken as required by law.
..FINANCIAL COSTS TO THE SUBJECT:
Funds are not available to cover the costs of any ongoing medical care and I remain responsible for the
cost of non-research related care. Tests, procedures, or other costs incurred solely for the purposes of
research will not be my financial responsibility. If I have questions about my medical bill relative to
research participation, I may contact Jennifer Lewis.
Department of Veterans Affairs Medical Center (VA) patients may be financially responsible for care at
the Department of Veterans Affairs Medical Center, FINANCIAL RESPONSIBILITY IS INDIVIDUALLY
DETERMINED BASED UPON LEGISLATIVE CRITERIA.
COMPENSATION IN CASE OF INJURY:
If I am injured as a result of research, I will contact Jennifer Lewis at 513-861-3100 extension 4719 or the
Chairman of the Institutional Review Board at 513-558-5259. The University of Cincinnati Medical Center
makes decisions concerning reimbursement for medical treatment for injuries occurring during or caused
by participation in biomedical or behavioral research. In the event I become ill or injured as a direct result
of my participation in the research study, necessary medical care will be made available to me. The
University, at its discretion, will pay medical expenses necessary to treat such injury (1) to the extent I
am not otherwise reimbursed by my medical or hospital insurance, or by third party or governmental
programs providing such coverage, and (2) provided I have used the study treatment as directed by the
study director in accordance with the study protocol. Financial compensation for such things as lost
wages, disability or discomfort due to injury during research is not routinely available.
PAYMENTS TO PARTICIPANTS:
I have been told that I will receive no payment for my participation in this study.
RIGHT TO REFUSE OR WITHDRAW:
It has been explained to me that my particiption is vountary and I may refuse to particpate, or may
discontinue my particiation AT ANY TIME. without penalty or loss of benefits to which I am otherwise
entitled. I have been told that the investigator has the right to withdraw me from the study AT ANY TIME.
I have been told that my withdrawal from the study may be for reasons related solely to ine (e.g. not
following study-related directions from the Investigator; a serious adverse reaction) or because the entire
study has been terminated.
OFFER TO ANSWER QUESTIONS:
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This study has been explained to my satisfaction by _____________ and my questions·
were answered. If I have any other questions about this study, I may call Jennifer Lewis at 513-8613100, extension 4719.
If I have any questions about my rights as a research subject, I may call the IRB Chairperson at 513-5585259.
IF RESEARCH RELATED INJURY OCCURS, I WILL CALL Jennifer Lewis at 513-861-3100 extension
4719.
• LEGAL RIGHTS:
Nothing in this consent form waives any IP.gal right I may have nor does it release the investigator, the
institution, or its agents from liability or negligence.
I HAVE READ THE INFORMATION PROVIDED ABOVE. I VOLUNTARILY AGREE TO PARTICIPATE
IN THIS STUDY. AFTER IT IS SIGNED, I WILL RECEIVE A COPY OF THIS CONSENT FORM.
This consent document has been approved for use for one year by the Human Subjects Institutional
Review Board at Western Michigan University as indicated by the stamped date and signature of the
board chair in the upper right corner. -Subjects should not sign this form if the corner does not show a
stamped date and signature on each page. My signature below shows that I have read the purpose and
requirements of the study and that I agree to take part.

Subject Signature

Subject Name (Please Print)

Signature or Title of Person Obtaining Consent and
· Identification of Role in Study

Date

For Research use: Subject Number

Date

""
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AppendixH
Personality Questionnaire
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Personality Questionnaire
Q#

IA

Not at all
(0)

Sometimes
(1)

Frequently

How often do you find yourself:

(2)

2B

Being preoccupied with details, rules, lists, order,
organintion or schedules to the extent that the
major J)()int of the activity is lost
Having the idea that someone else can control your
thoughts
Engaging in frantic efforts to avoid real or imagined
abandonment (not including self-mutilating or
suicidal behavior)
Showing perfectionism that interferes with task
completion (i.e., unable to complete a project
because overly strict standards are not met
Being overconscientious, scrupulous, and inflexible
about matters of morality, ethics, or values (not
accounted for by cultural or religious identification)
Hearing voices that other people do not hear

'

3C
4A

SA
6B

7C

'

8A
9B

l

lOA

UC

'

Having a pattern of unstable and intense
interpersonal relationships characterized by
alternating between extremes of ideafu.ation and
devaluing the other nerson
Being reluctant to delegate tasks or to work with
others unless they submit to exactly your way of
doing things
Believing that other people are aware of your private
thou�hts
Showing rigidity and stubbornness
Engaging in recurrent suicidal behavior, gestures, or
threats, or self-mutilating behavior
Exhibiting emotional instability due to a distinct
,eactivity of mood- mood swings (i.e., intense
episodic depressed mood, irritability, or anxiety
usually lasting a few hours and rarely more than a
few ¢lys)

12C

13C

Having chronic feelings of emptiness

14B

Having thoughts that are not your own

15A

'

16B
17B
18C

A= OCPD; B= Psy; C= BPD

Having to repeat the same actions such as
touching, counting or washing
Having thoughts about sex that bother you a lot
Having the idea that you should be punished for
your sins
Having inappropriate, intense anger or difficulty
controlling anger (frequent displays of temper,
constant anger, recurrent physical fights)

Appendix I
Mental Health Resources (Kalamazoo, MI)
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Michigan Community Mental Health Services Programs
Allegan County CMH
3285 122nd Avenue
P.O. Drawer 130
Allegan, MI 49010
(616) 673- 6617
24-Hour Emergency: (616) 673-6617

Gryphon Place
1104 S. Westnedge Avenue
Kalamaroo, MI 49008
(616) 381-1510
24-Hour Emergency: (616) 381-HELP

Barry County CMH
915 West Green Street, Suite 201
Hastings, MI 49058
(616) 948-8041
24-Hour Emergency: (800) 442-7315

Kalamaroo County CMH
3299 Gull Road, P.O. Box63
Naz.areth, MI 49074
(616) 373-5220
24-Hour Emergency: (616) 373-5220

Berrien Mental Health Authority
(formerly Berrien County CMH)
1485 M-139, P.O. Box547
Benton Harbor, MI 49023
(616) 925-0585
24-Hour Emergency: (616) 925-0585

Kalamaroo Consultation Center
920 John Street
Kalamazoo, MI 49001
(616) 343-6109

Behavioral Health Systems of
Calhoun County
140 West Michigan Avenue
Battle Creek, MI 49017
(616) 966-1460
24-Hour Emergency: (616) 966-1456

Van Buren County CMH
801 Hazen Street, Suite C
P.O. Box249
Paw Paw, MI 49079
(616) 657-7702
24-Hour Emergency: (800) 922-1418

AppendixJ
Mental Health Resources (Cincinnati, OH)
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EMERGENCY HELP (24 HOUR)
9-1-1

Crisis Intervention:
UNIVERSITY HOSPITAL PSYCHIATRIC
EMERGENCY SERVICES

Battered Women's
Shelter/Crisis Helpline:
YWCA

1-800-618-652.3

OR (513) 863-7099

crisis intervention; screening; referral

(5132 584-8577
234 Goodman, Cincinnati, OH

YWCA OF HAMILTON

(513) 856-9800

24 hour psychiatric emergency care;
suicidal crisis intervention

244 Dayton Street, Hamilton, OH

Rape/Domestic Violence
Hotlines:

Offers housing on sliding fee; support
groups; referrals to domestic violence
shelters such as Dove House

Cincinnati Area

Mental Health

WOMEN HELPING WOMEN
(5132 872-9259

216 East 9th Street, 3n.1 Floor, Cincinnati,
OH

Resources

No fee-free services; crisis counseling;
individual counseling; court advocates for
sexual assault, domestic violence, and
stalking
WOMEN'S CRISIS CENTER

(859) 491-3335
835 Madison Avenue, Covington, KY
No fee-free services; services to. victims
of domestic violence; individual and
group counseling; court advocates; safe
shelter

'°
0
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Counseling/Psychological Services:
FAMILY SERVICES OF CINCINNATI

�

This brochure is presented to assist you
in finding alternative mental health
treatment in the event you experience
difficulties during the study and are
unable to contact the researcher for

(513) 381-6300

Multiple facilities throughout the area;
Sliding fee based on income and number
of people in household; $5 minimum
pmt; adults, children, family therapy;
anger management groups, parenting
classes, crisis counseling; outpatient
substance abuse counseling
Also offers services in Sharonville,
Eastgate, Hyde Park, Covington

assistance. It may also be used as a

XAVIER UNIVERSITY

starting point if you decide to seek

(513) 745-3531

alternative treatment and discontinue
your participation in the study. It is not
intended to be a comprehensive list of
mental health facilities in the afea nor is
it intended to promote one service over
another.

PSYCHOLOGICAL SERVICES CENTER

3818 Winding Way (off Dana Avenue)
Sliding fee; student therapists;
individuals, couples, families, children
CATHOLIC SERVICES OF BUTLER
COUNTY

(513) 863-6129

140 North 5 th Street, Hamilton, OH

�

Sliding fee based on income and # people
in household; individual, couples, family,
and child therapy; parent aid program;
home visits; parenting classes; adoption
services

LIFESPAN, INC. OF HAMILTON
(FORMERLY FAMILY SERVICES)

(513) 867-7545

11 Buckeye Str.eet, Hamilton, OH
Sliding fee based on income; individual,
family, and child therapy; crisis counseling
CLERMONT COUNSELING CENTER (513)

248-0421

512 High Street, Milford, OH
Sliding fee based on income; individual,
couples, and family therapy (no child
therapy); domestic violence group thera
MIAMI UNIVERSITY PSYCHOLOGY
CLINIC

1-513-529-2423

18 Benton Hall, High Street; Oxford,
OH

$10/visit with sliding fee available;
student therapists addressing a range of
mental health issues; crisis counseling,
ADHD evaluations
COMPREHENSIVE COUNSELING
SERVICES

1-513-424-0921

1659 South Breiel Blvd; Middletown,
OH
Service for Butler County residents only:
sliding fee based on household income;
Facility treats all mental health issues;
Offers individual, couple, and family
therapy; Offers drug and alcohol
treatment
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SUDs Rating Sheet

Subject#: _________
Initial SUDs at Pretest: ---------SU Os at Treatment#1:

---------

SUDs at Treatment#2: _________
SUDs at Treatment#3:

---------

SUDs at Treatment#4:

---------

SUDs at Post-test: ___________

"On a scale from 1 to 10, with 10 being the most distress you have
ever experienced, and 1 being no distress at all (or totally calm), how
would you rate your present level of distress?"

AppendixL
Depression Screener

194

195
Depression Screener
-- .A- Five or more of the following symptoms during the same 2 week

period and represent a change from previous functioning; at least
one of the symptoms is either (1) depressed mood or (2) loss of
interest or pleasure.

(1) depressed mood most of the day, nearly every day, as indicated by either
subjective report (e.g., feels sad or empty) or observation made by others
(e.g., appears tearful)
(2) markedly diminished interest or pleasure in all, or almost all, activities

most of the day, nearly every day(as indicated by either subjective
account or observation made by others

(3) significant weight loss when not dieting or weight gain (e.g., a change of
more than 5% of body weight in a month), or decrease or increase in
appetite near1y every day
(4) insomnia or hypersomnia near1y every day
(5) psychomotor agitation or retardation near1y every day (observable by
others, not merely subjective feelings of restlessness or being slowed
down)
(6) fatigue or loss of energy near1y every day
(7) feelings of worthlessness or excessive or inappropriate guilt (which may
be delusional) near1y every day (not merely self-reproach or guilt about
being sick)
(8) diminished ability to think or concentrate, or indecisiveness, near1y every
day (either by subjective account or observed by others)
(9) recurrent thoughts of death (not just fear of dying), recurrent suicidal
ideation without a specific plan, or a suicide attempt or specific plan for
committing suicide
__ B. Symptoms do not meet criteria for a mixed episode
__ C. Symptoms cause clinically significant distress or impairment in social,
occupational, or other important areas of functioning
__ D. Symptoms not due to direct physiological effects of a substance (drug
abuse or medication) or GMC (e.g.; hypothyroidism)

-- E. Symptoms not better accounted for by bereavement (sx longer than 2
months following loss of loved one)

criteria for MDD- refer for medication evaluation and
--- Meets
continue with assessments.

--- Does not meet criteria for MDD. Continue with assessments.
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Code:

Physical Health Questionnaire

-----

Date: _____

Your name will not appear on this questionnaire,· so-please answer as honestly and accurately as possible. Thank you for your time.
1) Have you ever suffered from any of the following health conditions or symptoms? Please circle all that apply to you.
2) To the best of your recollection, please indicate how long ago the condition(s) or symptom(s) developed (please circle the appropriate time
length.
3) How much distress has the condition(s) or-symptom(s) caused you? Please circle the appropriate distress level.
- .

--

Amount of distress it caused

How long ago did this health- issue develop?

Conditions/Symptoms·

Weeki

Months

Years

_1 2 3 4

l 2 3 4 S 6 7 8 9 10 11

Seizures

l 2 3 4

Neurolo�cal Problems

None

Slight

Moderate

Extreme

l 2 3 4 S 6 7 8 9 10

0

l

2

3

l 2 3 4 S 6 7 8 9 10 11

1 2 3 4 S 6 7 8 9 10

0

l

2

3

l 2 3 4

l 2 3 4 S 6 7 8 9 10 11

l 2 3 4 S 6 7 8 9 10

0

l

2

3

Back Pain

1 2 3 4

1 2 3 4 S 6 7 8 9 10 11

1 2 3 4 S 6 7 8 9 10

0

l

2

3

Gastrointestinal Problems

l 2 3 4

l 2 3 4 S 6 7 8 9 10 11

l 2 3 4 S 6 7 8 9 10

0

l

2

3

Ulcer

1 2 3 4

l 2 3 4 S 6 7 8 9 10 11

l 2 3 4 S 6 7 8 9 10

0

l

2

3

Hvoertension

1 2 3 4

l 2 3 4 S 6 7 8 9 10 11

l 2 3 4 S 6 7 8 9 10

0

l

2

3

Diabetes

l 2 3 4

1 2 3 4 S 6 7 8 9 10 11

l 2 3 4 S 6 7 8 9 10

0

l

2

3

Heart Disease

l 2 3 4

l 2 3 4 S 6 7 8 9 10 11

l 2 3 4 S 6 7 8 9 10

0

l

2

3

Cancer

l 2 3 4

l 2 3 4 S 6 7 8 9 10 11

1 2 3 4 S 6 7 8 9 10

0

l

2

3

Headaches

Other

\0

Health Questionnaire (Continued)
Conditions/Symptoms

How long ago did this health issue develop?
Weclcs

Months

Years

Chest Pains

1 2 3 4

1 2 3 4 S 6 7 8 9 10 II

Fatilrue

I 2 3 4

Stroke

Amount of distress it caused
None

Slight

Moderate

Extreme

I 2 3 4 S 6 7 8 9 10

0

1

2

3

1 2 3 4 S 6 7 8 9 10 11

1 2 3 4 5 6 7 8 9 10

0

1

2

3

1 2 3 4

1 2 3 4 5 6 7 8 9 10 11

1 2 3 4 5 6 7 8 9 10

0

1

2

3

Audiolo2ical Problems

I 2 3 4

1 2 3 4 5 6 7 8 9 10 11

1 2 3 4 S 6 7 8 9 10

0

1

2

3

Wei�ht Loss (unintentional)

1 2 3 4

1 2 3 4 5 6 7 8 9 10 11

1 2 3 4 5 6 7 8 9 10

0

1

2

3

Chronic Pain

1 2 3 4

1 2 3 4 5 6 7 8 9 10 11

1 2 3 4 5 6 7 8 9 10

0

1

2

3

Arthritis

1 2 3 4

1 2 3 4 5 6 7 8 9 10 11

1 2 3 4 5 6 7 8 � 10

0

1

2

3

Nausea

1 2 3 4

1 2 3 4 5 6 7 8 9 10 11

1 2 3 4 5 6 7 8 9 10

0

1

2

3

Skin Rashes

1 2 3 4

1 2 3 4 S 6 7 8 9 10 11

1 2 3 4 5 6 7 8 9 10

0

1

2

3

Asthma

1 2 3 4

1 2 3 4 S 6 7 8 9 10 11

1 2 3 4 S 6 7 8 9 10

0

1

2

3

Sexual Dvsfunction

1 2 3 4

1 2 3 4 5 6 7 8 9 10 11

1 2 3 4 5 6 7 8 9 10

0

1

2

3

Other (please"

1 2 3 4

1 2 3 4 S 6 7 8 9 10 11

1 2 3 4 5 6 7 8 9 10

0

1

2

3

1 2 3 4

1 2 3 4 5 6 7 8 9 10 11

1 2 3 4 5 6 7 8 9 10

0

1

2

3

1 2 3 4

1 2 3 4 5 6 7 8 9 10 11

1 2 3 4 5 6 7 8 9 10

0

1

2

3

1 2 3 4

1 2 3 4 5 6 7 8 9 10 11

1 2 3 4 5 6 7 8 9 10

0

1

2

3

. ,-v,..

Other

\0

Health Questionnaire (Continued)

4)

If you circled any of the health issues above, please lsit the condition and indicate how long each condition and/or symptom preisted by
circling the appropriate time length.
How long; did each condition and /or s mmtom oersist?

Conditions/Symptoms

Other

Weeks

Months

Years

1 2 3 4

1 2 3 4 5 6 7 8 9 10 11

1 2 3 4 5 6 7 8 9 10

Still Present

1 2 3 4

1 2 3 4 5 6 7 8 9 10 11

1 2 3 4 5 6 7 8 9 10

Still Present

1 2 3 4

1 2 3 4 5 6 7 8 9 10 11

1 2 3 4 5 6 7 8 9 10

Still Present

1 2 3 4

1 2 3 4 5 6 7 8 9 10 11

1 2 3 4 S 6 7 8 9 10

Still Present

1 2 3 4

1 2 3 4 5 6 7 8 9 10 11

1 2 3 4 5 6 7 8 9 10

Still Present

.S) Were any of these health conditions or symptoms diagnosed and/or treated by a physician?
No_________
Yes_______
6) If you answered YES to #5, to which health conditions were you referring?
Condition/Symptom:

Approximate date of diagnosis (month & year):

\0
\0

Health Questionnaire (Continued)
7)

Were any of the health conditions or symptoms related to the traumatic stressor(s) you experienced?
No_______
Yes_____
Not sure_________

8)

If you answered YES to #7, to which health conditions were you referring?
Condition/Symptom:

9) Do you currently smoke?

Yes____ No, but I used to ______ _ No, I have never smoked ____

10) If you currently smoke/used to smoke, how long did you smoke and how many packs per day did/do you smoke?
Length of time smoking ________
Number of packs/day ________
11) Do you consume alcohol? Yes______ No, but I used to ______ No ________
12) If you currently consume alcohoVused to consume alcohol, how often did/do you?
__Less than once a month
__Once a month
__Several times a month
__Once a week
__Several times a week
__Evecy day
__Other (please specify) ___________

N
0
0
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Health Center Visits for Illness
(Pre-test)

In the past two months, how many times have you been to a
medical facility (doctor's office, community clinic or university health
center) for illness? Illness is defined as any presenting complaint that
could to attributed to an acute infection or other internal cause related to
injury. Please note: regular check-ups, health prevention (e.g., flu shots)
or maintenance (allergy shots), or other routine tests (PAP smears) are not
counted as illness visits. More than one visit to the physician for the same
complaint in an 8-day period should be considered as a single visit.

Please circle the number of visits:
1 visit

2 visits

3 visits

4 visits

More (specify) __

203

Health Center Visits for Illness
(Post-test)

Since your pre-test assessment, how many times have you been to
a medical facility (doctor's office, community clinic or university health
center) for illness? Illness is defined as any presenting complaint that
could to attributed to an acute infection or other internal cause related to
injury. Please note: regular check-ups, health prevention (e.g., flu shots)
or maintenance (allergy shots), or other routine tests (PAP smears) are not
counted as illness visits. More than one visit to the physician for the
same complaint in an 8-day period should be considered as a single visit.

Please circle the number of visits:

1 visit

2 visits

3 visits

4 visits

More (specify) __
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Health Center Visits for Illness
(Follow-up 1)

Since you had your last appointment with us, how many times

have you been to a medical facility(doctor's office, community clinic or
university health center) for illness? Illness is defined as any presenting
complaint that could to attributed to an acute infection or other internal
cause related to injury. Please note: regular check-ups, health prevention
(e.g., flu shots) or maintenance(allergy shots), or other routine tests (PAP
smears) are not counted as illness visits. More than one visit to the
physician for the same complaint in an 8-day period should be considered
as a single visit.
Please circle the number of visits:

1 visit

2 visits

3 visits

4 visits

More(specify) __
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Health Center Visits for Illness
(Follow-up 2)

Since your last appointment with us, how many times have you

been to a medical facility (doctor's office, community clinic or university
health center) for illness? Illness is defined as any presenting complaint
that could to attributed to an acute infection or other internal cause related
to injury. Please note: regular check-ups, health prevention (e.g., flu
shots) or maintenance (allergy shots), or other routine tests (PAP smears)
are not counted as illness visits. More than one visit to the physician for
the same complaint in an 8-day period should be considered as a single
visit.
Please circle the number of visits:

1 visit

2 visits

3 visits

4 visits

More (specify) __
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Scripts for phoning study participants with reminders
(1) Before each treatment session:
"Hi, this is (name of researcher that is calling). I'm calling to remind you of
your scheduled appointment tomorrow (date), at (time). We have you
schedule to meet with (name of researcher that is overseeing therapy session).
Does that time still work for you?
If participant indicates that he/she will be unable to make it, researcher will
respond with:
"Is there another time that would be more convenient for you to come in?"
If participant indicates that there is not another time, researcher will respond
with:
"Would you like to discontinue your participation in this study?"
If participant indicates that he/she would like to discontinue participation, the
researcher will respond with"
"Okay, well, Thank You for your time. Good bye."
If participant indicates that he/she will attend the prescheduled time, the
researcher will respond with:
"Okay, we will see you tomorrow at (time). Thank you, Good-bye.

(2) To remind participants to send BDI-Il's in between post-test and follow-up
sessions:
"Hi this is (name of researcher that is calling). I am just calling to remind you
of the weekly mail-in of the BDI-Il in conjunction with the writing therapy
study in which you are participating. Thank you for your time."
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Standardized Writing Instructions

"During each of the four writing days I want you to write about
the traumatic and upsetting experience you discussed with the
interviewer. Please write about this same topic for all 4 days. It is most
important that you write about your deepest thoughts and feelings.
Ideally, whatever you write about should deal with an event or
experience that you have not talked with others about in detail.
Again, we thank you for your participation in this study. Do you
have any questions before you begin writing?"
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Debriefing Script
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DEBRIEFING SCRIPT
► Conduct the debriefing immediately after completing Follow up 2.
► Read the italicized portions of this document to the participant.
► Make notes of the participants' responses on the Debriefing Script (Participant
Comments) sheet.
"Now that you have completed the study, I would like to go over a few things with you. We
call this the "Debriefing" portion of the study. I would like to give you a description of the
study, tell you about some of the ways we hope the research will benefit you and/or others,
and give you the opportunity to ask any questions or express any concerns you may have
about the study with me today. "
Description and Purpose:
".A. number of studies have suggested that writing about traumatic experiences may
have significant mental and physical health benefits.
In this study, we examined whether the writing treatment would be effective in
reducing symptoms of PTSD such as unwanted memories, difficulty sleeping and
concentrating, irritability or angry outbursts. For the group with burnout, we wanted to see
if writing about their work experiences would reduce their stress, improve their attitude
about their work or increase their positive feelings about work.
We gave you a number of assessments before the treatment sessions, and then
followed the treatment with the same assessments. By comparing the scores on these sets of
assessments, we were able to determine whether the treatment was effective in reducing
these symptoms. "
Benefits of Research:
"Research indicates that writing therapy is effective in reducing physical health
problems and increasing positive feelings. Participants in this study may benefit by a
decrease in their self-reported symptoms ofpost traumatic stress disorder. Decreases in the
reported levels of burnout should result following treatment as well. In addition, this study
will contribute to the base of information available on treatments of populations with
varying degrees of stress related symptoms. "
Common Reactions to this Treatment:
"When writing about traumatic or stressfal experiences, it is common to have an
increase in unpleasant or unwanted memories and/or thoughts about these experiences. You
may also have experienced an increase in negative feelings during the course of the
treatment study. Research indicates that these negative feelings are usually short lived.
During the course of the study these negative feelings are often replaced by a sense of well
being and a more positive outlook. These results may be experienced in addition to the
decrease in symptoms associated with PTSD or burnout. "
"However each individual is different and your experiences may have been
somewhat different from those of other people. We would be interested in your experiences
in particular. Do you have any comments, suggestions,_ or questions now that the study is
completed?"
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DEBRIEFING SCRIPT
(Participant Comments)
Participant Number:

Debriefer:

Date:

Please make detailed notes about the comments, questions, or experiences the participant
brings up.

We are also offering to send copies of the final project results to participants if they are

interested:

"Would you be interested in receiving a copy of the final results ofthe study when it is
completed? This may take a year or more. Ifyou would like to provide us with an address,
we will mail those results to you when the project is co!"pleted. "

Name:
Address:
City:

State:

Zip:

"Finally, we would like to thank you for your participation in this study. Your
willingness to share your intimate thoughts, feelings, and experiences is greatly
appreciated and without you this research would not have been possible. Thank you
again for being a part of this study."
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PARTICIPANT STATUS LIST
Subj#

Name

-·

Phone
(HJ
(W)

(HJ
(W)

(HJ
(W)

(HJ
(W)

'"'

(W)

(HJ
(W)

IHJ
(W)

(HJ
(W)

(HJ
(W)

(HJ
(W)

(HJ
(W)

Intake

Pretest.

-TX1

TX2. ·-·

TX3

TX4

Posttest

Follow-up2

Follow-up 1

--
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Effects of Writing Therapy for PTSD and Chronic Stress
STUDY OVERVIEW

Recruitment

Intake
(30-45 minutes)

Pretest
(1 ½ - 2 hours)

Treatments
(45 minutes)

1 week Post-test
(60-90 minutes)

Newspaper
advertisements
Requests for referrals

Informed Consent

Shipley Institute of
Living Scale
CAPS-DX

4 weekly sessions; ½
hour each
BDI-II administered at
the end of each tx
session
SUDS Rating wrt
present level of
discomfort about the
traumatic event

CAPS-DX

1 &l Month
Follow-up (60-90
minutes)
CAPS-DX

BDI-II (provide 4
add'l with SASE)

BDI-11 (provide 4
add'l with SASE)

Life Events Checklist

Public postings

Personality
Questionnaire

SUDS Rating wrt
present level of
discomfort about the
traumatic event

XU Classrooms

(MBI) Demographic
Questionnaire

STAI-S

Maslach Burnout
Inventory

BDI-11
Depression Screen

Provide
Mental Health
Resource Sheet

Physical Health
Questionnaire

(Informed of
qualification for
study)

STAI-S administered at
the end of each tx
session
(Participants phoned 24
hours before tx session
as reminder)

SUDS Rating wrt
present level of
discomfort about the
traumatic event
STAI-S
Maslach Burnout
Inventory

Maslach Burnout
Inventory

Question about clinic or
Dr. office visits

Question about clinic
or Dr. office visits

Question about
clinic or Dr. office
visits

Coping Resources
Inventory
(Group Assignment)

Coping Resources
Inventory
Final Debriefing
N

0\
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Human Subjects Institutional Review Board

Kalamazoo. Michigan '19008-3899
616 387-8293

WESTERN MICHIGAN UNIVERSllY

Date: 4 June 1999
To:

Richard Spates, Principal Investigator
Jennifer Lewis, Student Investigator for dissertation

From: Sylvia Culp, Chair �
Re:

&_,____;1r

HSIRB Project Number 99-04-13

This letter will serve as confirmation that your research project entitled "Effects of
Writing Therapy Across PTSD, Subclinical PTSD and Chronic Stress" has been
approved under the full category of review by the Human Subjects Institutional
Review Board. The conditions and duration of this approval are specified in the .
Policies of Western Michigan University. You may now begin to implement the
research as described in the application.
Please note that you may only conduct this research exactly in the form it was
approved. You must seek specific board approval for any changes in this project.
You must also seek reapproval if the project extends beyond the termination date
noted below. In addition if there are any unanticipated adverse reactions or
unanticipated events associated with the conduct of this research, you should
. immediately suspend the project and contact the Chair of the HSIRB for
consultation.
The Board wishes you succ_ess in the pursuit of your research goals.
Approval Termination:

4 June 2000
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Institutional. Review Board
3800 Victory Parkway
Cincinnati, 0liio 45207-7361
Phone 513 745-2870
Fax 513 745-4267

December 17, 2001
Jennifer E. Lewis
1178 Herschel Avenue
Cincinnati, OH 45208
Dear Ms. Lewis,
Your protocol #0178-4, Effects of Writing Therapy across PTSD, Subclinical PTSD, and Chronic
Stress, was received on November 30, 2001. It was reyiewed and approved by the Xavier
University IRB on December 17, 200 I. The brochures and ads were also approved.
Please fill out and return the enclosed Status/Final Report form at the conclusion of your study or
one-year from this date. This form will be available on XU's web site shortly.
If there are adverse events or modifications, please notify the IRB immediately.
We wish you every success with your research.
Sincerely,

,&d¥--Yt! /½P�t:c:..f�; >J

Robert C. Baumiller, SJ.

IRB Chair and Administrator

RCB:nm.
Enc:

Final Status Report

CC:

Karl Stukenberg, Ph.D.
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UNIVERSITY OF CINCINNATI MEDICAL CENTER
INSTiTUTiONAL REVIEW BOARD
NOTIFICATION FORM
PRINCIPAL INVESTIGATOR:

Megan Murray, Ph.D.

SUB-INVESTIGATOR(S):
PROTOCOL:

Jennifer Lewis, MA

02-2-6-7-"Effects of Writing Theapy Across PTSD and Chronic Stress"
XXX *APPROVED - lnitial_:x_ Full Board J_ Expedited_
(Approval includes informed consent document and advertising, if applicable)

Sponsor:
DATE: May 15, 2002
The approval for this research activity expires on: May l5, 2003
1.

If the study involves a drug, you must complete the Pharmacy Committee Drug Information Sheet
(available at the In-Patient Pharmacy, University Hospital).

2.

You are required to immediately report to the Institutional Review Board: 1) any serious adverse event,
or 2) any non-serious event which is both related to the study and is unexpected.

3.

The period of approval of this research project is stated above. A progress report form must be filed
with the Institutional Review Board on at least an annual basis, and sometimes more frequently at the
discretion of the Board. If the progress report is not returned by the specified date, your department
head will be notified.

4.

There may be no change or addition to the project, or changes of the investigators involved, without
prior approval of the iRB.

5.

If this protocol has not been initiated within two years of this date, you will be required to resubmit the
study for reconsideration by the :nstitutional Review Board. However, this regulation is not intended to
negate the requirement that a progress report be filed with the IRS office on at least an annuat basis.

6.

Notification of approval by the Institutional Review Board does not necessarily indicate approval by
other committees of the Medicai Center with u·,e exception of Radiation Safety.

7.

You are required to modify this study, subject to IRB approval, if subsequent information regarding any
drug, device or procedure utilized in the study is received from the manufacturer or any other reliable
source, that could reasonably increase or alter potential harm to subjects. The informed consent
statement must be modified to include this new information or an addendum must be prepared as a
means to assure subject .. otification. In cases wnere the subject has completed the study, the
modification or addendum is only necessary if the additional information received could impact the
subJecJs ;, Jhe futuce.

Chiiirperson
DHHS Assurance No. M1138
Identification No. 01

� ·

· ard

�

*The attached consent has been approved by the IRB. Please copy this ICS document and use for all
subjects entered into the study.
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DEPARTMENT OF
VETERANS AFFAIRS

MEMORANDUM

Date: May 23, 2002
From: Chairman, R& D Committee
Subj: Research Protocol
To: Jennifer E. Lewis, MA
I.

Your protocol entitled "Effects of Writing Therapy Across PTSD and Chronic
Stress" was reviewed by the Research and Development Committee on March 12, 2002
and a motion was made and seconded to make the protocol acceptable with receipt
training certification and receipt of IRB letter of approval and stamp dated
informed consent form. You have fulfilled the requested requirement; you now
have full committee approval.

2.

If your protocol involves human subjects, VA policy requires that signed information
consent statements be made a permanent part of their medical records. Furthermore, it is
required that if investigational drugs are used these drugs and a list of the· principal
investigator's authorized designees prescribing the drug be placed in the Pharmacy prior
to the initiation of your study (this requires the completion of form VA I 0-9012).

3.

In the case of human subjects, it is your responsibility to provide this office with a copy
of the approval from the University of Cincinnati Committee on Human Research (if you
have already done so, please disregard). Upon receipt of this approval, you may initiate
_your proposal.

4.

The approval of this protocol is contingent on the related activity or actlv1hes not
adversely affecting, displacing, or otherwise occupying priorities that would exclude the
developing of VA-funded and approved activities.

5.

Suggestions/comments from the reviewers may be attached.

6.

If we may be of any further assistance to you, please feel free to call the Research Office

Jt;;;�
/ Kenneth Wagner, Ph.D.//
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